status	generic_name	brand_name	synonym	form	class	moa	indication	description	year_launched	date_launched	country_launched	date_shortage	year_shortage	URL	year_adr_report	year_withdrawn	date_withdrawn	country_withdrawn	reason_withdrawn	year_remarketed	source	unii	smiles
Withdrawn	Acetanilide	NA	NA	NA	Analgesic	Metabolised to paracetamol	Analgesia	NA	1886	NA	NA	NA	NA	NA	1940	1971	NA	Japan	Aplastic anemia	NA	Withdrawn because of adverse drug reactions	SP86R356CC	CC(=O)NC1=CC=CC=C1
Withdrawn	Acetarsol	NA	NA	NA	Antimicrobial	Unknown	Syphilis|Trichomoniasis	NA	1921	NA	NA	NA	NA	NA	1941	1982	NA	Mauritius	Hematologic	NA	Withdrawn because of adverse drug reactions	806529YU1N	CC(=O)NC1=CC(=CC=C1O)[As](O)(O)=O
Withdrawn	Acetylfuratrizine	NA	NA	NA	Antimicrobial	Damages ribosomal proteins	Bacterial infection	NA	1962	NA	NA	NA	NA	NA	1977	1977	NA	Japan|Saudi Arabia|Venezuela	Superseded by safer products: carcinogenic	NA	Withdrawn because of adverse drug reactions	C50C4V19SU	CC(=O)NC1=NN=C(\C=C\C2=CC=C(O2)[N+]([O-])=O)C=N1
Withdrawn	Acitretin	NA	NA	NA	Retinoid	Binds to the retinoic acid receptor (RAR)	Psoriasis	NA	1989	NA	NA	NA	NA	NA	1989	1990	NA	Netherlands|France	Teratogenicity	NA	Withdrawn because of adverse drug reactions	LCH760E9T7	COC1=CC(C)=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(C)=C1C
Withdrawn	Acridine derivatives	NA	NA	NA	Antimicrobial	Unknown	Topical disinfectant	NA	1922	NA	NA	NA	NA	NA	1975	1979	NA	Denmark|Venezuela	Mutagenic	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Adenosine phosphate	NA	NA	NA	Antiarrhythmic	Direct nodal inhibition	Cardiac arrhythmia	NA	1930	NA	NA	NA	NA	NA	1957	1973	NA	US	Cardiovascular	NA	Withdrawn because of adverse drug reactions	415SHH325A	NC1=NC=NC2=C1N=CN2[C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O
Withdrawn	Alatrofloxacin	NA	NA	NA	Antimicrobial	Inhibit DNA gyrase	Bacterial infection	NA	1997	NA	NA	NA	NA	NA	1998	2000	NA	Armenia|Singapore|Europe	Liver	NA	Withdrawn because of adverse drug reactions	7QVV6I50DT	C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]1[C@H]2CN(C[C@@H]12)C3=NC4=C(C=C3F)C(=O)C(=CN4C5=C(F)C=C(F)C=C5)C(O)=O
Withdrawn	Alclofenac	NA	NA	NA	Analgesic	Inhibit COX-1 & COX-2	Analgesia	NA	1972	NA	NA	NA	NA	NA	1974	1977	NA	Ireland|Cyprus|Germany|UK|Italy|New Zealand|Egypt|Greece|Denmark|Indonesia|India|Jordan|Morocco	Immunologic|Liver|Skin|Urinary tract	NA	Withdrawn because of adverse drug reactions	M9CP5H21N8	OC(=O)CC1=CC=C(OCC=C)C(Cl)=C1
Withdrawn	Aliskiren	NA	NA	NA	Antihypertensive	Direct renin inhibitor	Hypertension	NA	2007	NA	NA	NA	NA	NA	2011	2011	NA	Europe	Angioedema	NA	Withdrawn because of adverse drug reactions	502FWN4Q32	COCCCOC1=C(OC)C=CC(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)=C1
Withdrawn	Alosetron	NA	NA	NA	Antispasmodic	5HT3 receptor antagonist	Irritable bowel syndrome	NA	2000	NA	NA	NA	NA	NA	2000	2000	NA	US	Gastrointestinal	NA	Withdrawn because of adverse drug reactions	13Z9HTH115	CN1C2=CC=CC=C2C3=C1CCN(CC4=C(C)N=CN4)C3=O
Withdrawn	Alphacetylmethadol	NA	NA	NA	Analgesic	OP1 receptor agonist	Analgesia	NA	1993	NA	NA	NA	NA	NA	2001	2003	NA	US	Cardiovascular	NA	Withdrawn because of adverse drug reactions	BXF83S0HEL	CC[C@@H](OC(C)=O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
Withdrawn	Alpidem	NA	NA	NA	Anxiolytic	GABA-A receptor antagonist	Anxiety	NA	1991	NA	NA	NA	NA	NA	1994	1994	NA	France	Liver	NA	Withdrawn because of adverse drug reactions	I93SC245QZ	CCCN(CCC)C(=O)CC1=C(N=C2C=CC(Cl)=CN12)C3=CC=C(Cl)C=C3
Withdrawn	Alfaxalone	NA	alphadolone/alphaxolone	NA	Sedative-hypnotic	Potentiation of the GABA-A chloride channel	Anesthesia	NA	1972	NA	NA	NA	NA	NA	1973	1984	NA	UK|Germany|France	Immunologic	NA	Withdrawn because of adverse drug reactions	BD07M97B2A	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C
Withdrawn	Amfepramone	NA	NA	NA	Psychostimulant	Norepinephrine releasing agent	Obesity	NA	1957	NA	NA	NA	NA	NA	1974	1975	NA	Turkey|Sweden|Oman|UAE|Norway|Venezuela|EU|France|UK	Cardiotoxicity	NA	Withdrawn because of adverse drug reactions	Q94YYU22B8	CCN(CC)C(C)C(=O)C1=CC=CC=C1
Withdrawn	Amfetamine	NA	NA	NA	Psychostimulant	TAAR1 agonist	Obesity	NA	1939	NA	NA	NA	NA	NA	1957	1973	NA	US|UAE|Turkey|Oman|Malaysia|Nigeria	Drug dependence	NA	Withdrawn because of adverse drug reactions	CK833KGX7E	CC(N)CC1=CC=CC=C1
Withdrawn	Amineptine	NA	NA	NA	Antidepressant	Dopamine receptor antagonist	Depression	NA	1960	NA	NA	NA	NA	NA	1984	1999	NA	France|Thailand|UAE|Bangladesh|Morocco|Vietnam	Drug dependence|Liver|Skin	NA	Withdrawn because of adverse drug reactions	27T1I13L6G	OC(=O)CCCCCCNC1C2=CC=CC=C2CCC3=CC=CC=C13
Withdrawn	Aminoglutethimide	NA	NA	NA	Anxiolytic	Steroid synthesis inhibitor	Anxiety	NA	1960	NA	NA	NA	NA	NA	1966	1966	NA	US|Saudi Arabia|Norway	Endocrine	NA	Withdrawn because of adverse drug reactions	0O54ZQ14I9	CCC1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
Withdrawn	Aminophenazone	NA	aminopyrine	NA	Analgesic	Inhibit COX-1 & COX-2	Analgesia	NA	1887	NA	NA	NA	NA	NA	1936	1965	NA	10 European countries|14 Asian countries|4 African countries|Australia|US|Canada|Chile|Brazil|Venezuela	Hematologic|Carcinogenic	NA	Withdrawn because of adverse drug reactions	01704YP3MO	CN(C)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2
Withdrawn	Aminophylline	NA	NA	NA	Anti-asthmatic	Nonselective phosphodiesterase inhibitor	Asthma	NA	1908	NA	NA	NA	NA	NA	1955	1992	NA	Netherlands	Immune-mediated reactions	NA	Withdrawn because of adverse drug reactions	27Y3KJK423	NCCN.CN1C2=C(N=CN2)C(=O)N(C)C1=O.CN3C4=C(N=CN4)C(=O)N(C)C3=O
Withdrawn	Aminorex fumarate	NA	NA	NA	Psychostimulant	Catecholamine release	Obesity	NA	1962	NA	NA	NA	NA	NA	1967	1967	NA	Germany|Venezuela	Respiratory	NA	Withdrawn because of adverse drug reactions	WSK05IH80K	OC(=O)\C=C\C(O)=O.NC1=NCC(O1)C2=CC=CC=C2
Withdrawn	Amobarbital	NA	NA	NA	Sedative-hypnotic	GABA-A receptor agonist	Hypnosedation	NA	1961	NA	NA	NA	NA	NA	1979	1985	NA	Sweden|New Zealand	Respiratory depression	NA	Withdrawn because of adverse drug reactions	GWH6IJ239E	CCC1(CCC(C)C)C(=O)NC(=O)NC1=O
Withdrawn	Amoproxan	NA	NA	NA	Antianginal	Nonselective β-blocker	Angina	NA	1969	NA	NA	NA	NA	NA	1970	1970	NA	France	Sensory systems|Skin	NA	Withdrawn because of adverse drug reactions	27RL57FCYM	COC1=CC(=CC(OC)=C1OC)C(=O)OC(COCCC(C)C)CN2CCOCC2
Withdrawn	Anabolic steroids	NA	NA	NA	Hormones	Androgen-receptor modulation	Aplastic anemia|Breast cancer|Osteoporosis	NA	1952	NA	NA	NA	NA	NA	1966	1989	NA	Thailand|India	Androgenic effects	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Anagestone acetate	NA	NA	NA	Hormones	Inhibition of ovulation	Contraception	NA	1968	NA	NA	NA	NA	NA	1969	1969	NA	Worldwide	Tumorigenicity	NA	Withdrawn because of adverse drug reactions	GNT396G9QT	C[C@H]1C[C@H]2[C@@H]3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CC[C@@H]2[C@@]4(C)CCCC=C14
Withdrawn	Anti-D immunoglobulin	NA	NA	NA	Immune prophylaxis	Binds to the erythrocyte D antigen	Idiopathic thrombocytopenic purpura	NA	1968	NA	NA	NA	NA	NA	2000	2009	NA	Europe	Safety concerns: hemoglobinemia	NA	Withdrawn because of adverse drug reactions	48W7181FLP	NA
Withdrawn	Anti-histamine	NA	NA	topical	Phenothiazine derivatives	H1-antagonism	Hypersensitivity	NA	1942	NA	NA	NA	NA	NA	1947	1986	NA	Malaysia|Sri Lanka	Immune-mediated reactions	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Antrafenine	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1977	NA	NA	NA	NA	NA	1979	1984	NA	France	Urinary tract	NA	Withdrawn because of adverse drug reactions	21FS93Y6OE	FC(F)(F)C1=CC(=CC=C1)N2CCN(CCOC(=O)C3=C(NC4=CC=NC5=CC(=CC=C45)C(F)(F)F)C=CC=C3)CC2
Withdrawn	Aprobarbital	NA	NA	NA	Sedative-hypnotic	GABA-A receptor receptor modulation	Hypnosedation	NA	1920	NA	NA	NA	NA	NA	1966	1985	NA	Sweden	Respiratory depression	NA	Withdrawn because of adverse drug reactions	Q0YKG9L6RF	CC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Withdrawn	Aprotinin	NA	NA	NA	Antifibrinolytic	Pancreatic trypsin inhibitor	Bleeding	NA	1959	NA	NA	NA	NA	NA	1964	2007	NA	Worldwide	Anaphylaxis	NA	Withdrawn because of adverse drug reactions	04XPW8C0FL	NA
Withdrawn	Arsenate	NA	NA	NA	Chemotherapeutic agent	Oncoprotein expression	Cancer	NA	1951	NA	NA	NA	NA	NA	1973	1988	NA	Austria|Spain|Italy|France|Philippines	Drug abuse|Carcinogenic	NA	Withdrawn because of adverse drug reactions	G1DBI405OK	[O-][As]([O-])([O-])=O
Withdrawn	Aspirin	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1899	NA	NA	NA	NA	NA	1970	1986	NA	UK|US|Hong Kong|Nigeria|Spain	Liver	NA	Withdrawn because of adverse drug reactions	R16CO5Y76E	CC(=O)OC1=CC=CC=C1C(O)=O
Withdrawn	Astemizole	NA	NA	NA	Antihistamine	H1-receptor antagonist	Allergy	NA	1977	NA	NA	NA	NA	NA	1986	1987	NA	Norway|New Zealand|Philippines|US|Canada|South Africa|UAE|Mauritius|Brunei|Tanzania|Armenia|Brazil|Spain|Argentina|Singapore|India|Chile	Cardiovascular|Drug interactions	NA	Withdrawn because of adverse drug reactions	7HU6337315	COC1=CC=C(CCN2CCC(CC2)NC3=NC4=C(C=CC=C4)N3CC5=CC=C(F)C=C5)C=C1
Withdrawn	Azaribine	NA	NA	NA	Antipsoriatic	Inhibition of orotidine-5'- monophosphate decarboxylase	Psoriasis	NA	1975	NA	NA	NA	NA	NA	1976	1976	NA	US|Thailand|Mauritius|Saudi Arabia|Venezuela	Hematologic|Psychiatric	NA	Withdrawn because of adverse drug reactions	K1U80DO9EB	CC(=O)OC[C@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)N2N=CC(=O)NC2=O
Withdrawn	Barbital	NA	NA	NA	Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation	NA	1903	NA	NA	NA	NA	NA	1913	1971	NA	Italy	Respiratory depression	NA	Withdrawn because of adverse drug reactions	5WZ53ENE2P	CCC1(CC)C(=O)NC(=O)NC1=O
Withdrawn	Beclobrate	NA	NA	NA	Antilipemic	Activates PPAR	Hyperlipidemia	NA	1985	NA	NA	NA	NA	NA	1990	1990	NA	Switzerland	Hepatotoxicity	NA	Withdrawn because of adverse drug reactions	USZ5MY269R	CCOC(=O)C(C)(CC)OC1=CC=C(CC2=CC=C(Cl)C=C2)C=C1
Withdrawn	Bendazac	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1983	NA	NA	NA	NA	NA	1987	1993	NA	Spain	Liver	NA	Withdrawn because of adverse drug reactions	G4AG71204O	OC(=O)COC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
Withdrawn	Benfluorex	NA	NA	NA	Psychostimulant	Fenfluramine analogue	Obesity	NA	1976	NA	NA	NA	NA	NA	2003	2009	NA	Europe	Cardiotoxicity	NA	Withdrawn because of adverse drug reactions	403FO0NQG3	CC(CC1=CC=CC(=C1)C(F)(F)F)NCCOC(=O)C2=CC=CC=C2
Withdrawn	Benoxaprofen	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1980	NA	NA	NA	NA	NA	1982	1982	NA	Worldwide	Liver|Skin|Urinary tract	NA	Withdrawn because of adverse drug reactions	17SZX404IM	CC(C(O)=O)C1=CC=C2OC(=NC2=C1)C3=CC=C(Cl)C=C3
Withdrawn	Benzarone	NA	NA	NA	Thrombolytic	Antagonistic on mediators of muscle contraction, direct action on smooth muscle cells	Varicose veins	NA	1964	NA	NA	NA	NA	NA	1987	1992	NA	Germany|Portugal|France	Liver	NA	Withdrawn because of adverse drug reactions	23ZW4BG89C	CCC1=C(C(=O)C2=CC=C(O)C=C2)C3=C(O1)C=CC=C3
Withdrawn	Benzbromarone	NA	NA	NA	Uricosuric agent	Xanthine oxidase inhibitor	Gout	NA	1976	NA	NA	NA	NA	NA	1994	2003	NA	Portugal|France	Liver	NA	Withdrawn because of adverse drug reactions	4POG0RL69O	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C3=C(O1)C=CC=C3
Withdrawn	Benziodarone	NA	NA	NA	Uricosuric agent	Inhibits hURAT1	Gout	NA	1962	NA	NA	NA	NA	NA	1964	1964	NA	UK|France|Spain	Liver	NA	Withdrawn because of adverse drug reactions	75CL65GTYR	CCC1=C(C(=O)C2=CC(I)=C(O)C(I)=C2)C3=C(O1)C=CC=C3
Withdrawn	Benzydamine	NA	Difflam	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1967	NA	NA	NA	NA	NA	1980	1995	NA	Germany	Skin|Psychiatric|Sensory	NA	Withdrawn because of adverse drug reactions	4O21U048EF	CN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
Withdrawn	Benzyl alcohol	NA	NA	NA	Antimicrobial	Alteration of bacterial membrane permeability	Decontamination of IV lines in neonates	NA	1972	NA	NA	NA	NA	NA	1981	1982	NA	Israel|US|Oman|Iraq	Metabolic acidosis	NA	Withdrawn because of adverse drug reactions	LKG8494WBH	OCC1=CC=CC=C1
Withdrawn	Benzylpenicillin sodium	NA	NA	topical preparations	Antimicrobial	Inhibits cell wall biosynthesis	Bacterial infection	NA	1944	NA	NA	NA	NA	NA	1953	1972	NA	US|Italy|Philippines|Ethiopia|Bangladesh|India|Chile|Cyprus|Spain|Thailand|Venezuela	Skin|Immune	NA	Withdrawn because of adverse drug reactions	YS5LY7JF4N	[Na+].CC1(C)S[C@@H]2[C@H](NC(=O)CC3=CC=CC=C3)C(=O)N2[C@H]1C([O-])=O
Withdrawn	Bepridil	NA	NA	NA	Antiarrhythmic	Calcium channel blockers	Cardiac arrhythmia	NA	1981	NA	NA	NA	NA	NA	1982	2004	NA	US	Cardiovascular	NA	Withdrawn because of adverse drug reactions	755BO701MA	CC(C)COCC(CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3
Withdrawn	Phenacetin	NA	NA	NA	Analgesic	Metabolized to paracetamol?	Analgesia	NA	1886	NA	NA	NA	NA	NA	1978	1986	NA	Germany	Tumorigenicity|Urinary tract	NA	Withdrawn because of adverse drug reactions	ER0CTH01H9	CCOC1=CC=C(NC(C)=O)C=C1
Withdrawn	Bezitramide	NA	NA	NA	Analgesic	Unknown	Analgesia	NA	1961	NA	NA	NA	NA	NA	1983	2004	NA	Netherlands	Overdose	NA	Withdrawn because of adverse drug reactions	3KXW0Y310I	CCC(=O)N1C(=O)N(C2CCN(CCC(C#N)(C3=CC=CC=C3)C4=CC=CC=C4)CC2)C5=C1C=CC=C5
Withdrawn	Bicalutamide	NA	NA	NA	Chemotherapeutic agent	Androgen receptor modulation	Prostate cancer	NA	1995	NA	NA	NA	NA	NA	2001	2003	NA	Canada|UK	Accelerated deaths	NA	Withdrawn because of adverse drug reactions	A0Z3NAU9DP	CC(O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F
Withdrawn	Bismuth salts	NA	NA	NA	Antidyspepsia	Unclear. Forms insoluble complexes	Dyspepsia	NA	1875	NA	NA	NA	NA	NA	1930	1978	NA	France|Egypt|Japan|Greece|Austria|Bangladesh|Turkey|Mauritius|Oman|Cuba|India	Nervous|Cardiovascular	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Bithionol	NA	NA	NA	Antihelminth	Exact mechanism unclear	Worm infestation	NA	1958	NA	NA	NA	NA	NA	1960	1967	NA	US|Canada|Japan	Skin	NA	Withdrawn because of adverse drug reactions	AMT77LS62O	OC1=C(Cl)C=C(Cl)C=C1SC2=CC(Cl)=CC(Cl)=C2O
Withdrawn	Boric acid	NA	NA	NA	Antimicrobial	Destruction or inhibition of growth of pathogenic organisms	Skin rash	NA	1875	NA	NA	NA	NA	NA	1945	1990	NA	Ireland|Malaysia|Korea|Philippines|Thailand|Germany|Japan|Costa Rica|UK|India|Peru|US	Deaths from neurotoxicity	NA	Withdrawn because of adverse drug reactions	R57ZHV85D4	OB(O)O
Withdrawn	Bovine tissue-derived medicines	NA	NA	NA	Various: heparin, glucagon, insulin, blood factors	Various	Various	NA	1982	NA	NA	NA	NA	NA	1986	1989	NA	Ireland|Switzerland|France	Neurotoxicity	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Bromfenac	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1997	NA	NA	NA	NA	NA	1998	1998	NA	US|Saudi Arabia	Liver	NA	Withdrawn because of adverse drug reactions	864P0921DW	NC1=C(CC(O)=O)C=CC=C1C(=O)C2=CC=C(Br)C=C2
Withdrawn	Bromisoval	NA	NA	NA	Sedative-hypnotic	Similar to barbiturates	Hypnosedation	NA	1909	NA	NA	NA	NA	NA	1930	1987	NA	Netherlands	Drug dependence	NA	Withdrawn because of adverse drug reactions	469GW8R486	CC(C)C(Br)C(=O)NC(N)=O
Withdrawn	Bromocriptine mesylate	NA	NA	NA	Anti-lactation	D2 and D3 agonist	Lactation prevention	NA	1976	NA	NA	NA	NA	NA	1983	1989	NA	US	Cardiovascular|Drug interactions|Nervous system|Pregnancy|Psychiatric	NA	Withdrawn because of adverse drug reactions	FFP983J3OD	CS(O)(=O)=O.CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C
Withdrawn	Brotizolam	NA	NA	NA	Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation	NA	1982	NA	NA	NA	NA	NA	1983	1989	NA	UK	Tumorigenicity	NA	Withdrawn because of adverse drug reactions	5XZM1R3DKF	CC1=NN=C2CN=C(C3=C(SC(Br)=C3)N12)C4=CC=CC=C4Cl
Withdrawn	Broxyquinoline	NA	NA	NA	Antiprotozoal	Production of free radicals	Amoebiasis	NA	1960	NA	NA	NA	NA	NA	1968	1970	NA	Japan|UAE|Saudi Arabia	Sensory	NA	Withdrawn because of adverse drug reactions	UK4C618C8T	OC1=C2N=CC=CC2=C(Br)C=C1Br
Withdrawn	Bucetin	NA	NA	NA	Analgesic	Phenacetin analogue	Analgesia	NA	1968	NA	NA	NA	NA	NA	1985	1986	NA	Germany	Urinary tract: Mutagenic|Carcinogenic	NA	Withdrawn because of adverse drug reactions	6M7CVQ8PF8	CCOC1=CC=C(NC(=O)CC(C)O)C=C1
Withdrawn	Budipine	NA	NA	NA	Antiparkinsonian	Muscarinic & NMDA receptor antagonist	Parkinson's	NA	1979	NA	NA	NA	NA	NA	2000	2000	NA	Germany	Cardiovascular	NA	Withdrawn because of adverse drug reactions	L9026OPI2Z	CC(C)(C)N1CCC(CC1)(C2=CC=CC=C2)C3=CC=CC=C3
Withdrawn	Bufexamac	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1973	NA	NA	NA	NA	NA	1973	1990	NA	France	Skin	NA	Withdrawn because of adverse drug reactions	4T3C38J78L	CCCCOC1=CC=C(CC(=O)NO)C=C1
Withdrawn	Buflomedil	NA	NA	NA	Vasodilator	α-adrenergic blockade	Peripheral arterial occlusive disease	NA	1970	NA	NA	NA	NA	NA	1981	2006	NA	France|Europe	Neurotoxicity; cardiotoxicity	NA	Withdrawn because of adverse drug reactions	V7I71DQ432	COC1=CC(OC)=C(C(=O)CCCN2CCCC2)C(OC)=C1
Withdrawn	Buformin	NA	NA	NA	Hypoglycemic	Reduce gluconeogenesis	Diabetes	NA	1950	NA	NA	NA	NA	NA	1969	1978	NA	Germany|Austria|Belgium|Ireland	Metabolism	NA	Withdrawn because of adverse drug reactions	W2115E9C7B	CCCCNC(=N)NC(N)=N
Withdrawn	Bumadizone	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Rheumatism	NA	1972	NA	NA	NA	NA	NA	1978	1986	NA	Oman	Hematologic	NA	Withdrawn because of adverse drug reactions	ATD81G944M	CCCCC(C(O)=O)C(=O)N(NC1=CC=CC=C1)C2=CC=CC=C2
Withdrawn	Bunamiodyl	NA	NA	NA	Radiography	Selective secretion in bile	Radiography	NA	1958	NA	NA	NA	NA	NA	1962	1964	NA	US|Sweden|Venezuela	Kidney	NA	Withdrawn because of adverse drug reactions	IX9VVF69JR	CCCC(=O)NC1=C(I)C(C=C(CC)C(O)=O)=C(I)C=C1I
Withdrawn	Buprenorphine	NA	NA	NA	Analgesic	Agonist–antagonist opioid receptor modulator	Analgesia	NA	1978	NA	NA	NA	NA	NA	1983	1986	NA	Egypt	Fatalities (IV use)	NA	Withdrawn because of adverse drug reactions	40D3SCR4GZ	CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]4CC5=C6C(O[C@@H]2[C@@]36CCN4CC7CC7)=C(O)C=C5
Withdrawn	Bupropion	NA	NA	NA	Antidepressant	Norepinephrine-dopamine reuptake inhibitor	Depression	NA	1985	NA	NA	NA	NA	NA	1985	1986	NA	US	Nervous system	NA	Withdrawn because of adverse drug reactions	01ZG3TPX31	CC(NC(C)(C)C)C(=O)C1=CC=CC(Cl)=C1
Withdrawn	Butamben	NA	NA	NA	Anesthetic	↓ neuronal membrane permeability to sodium ions	Local anesthesia	NA	1923	NA	NA	NA	NA	NA	1947	1964	NA	UK	Allergic|Psychiatric|Skin	NA	Withdrawn because of adverse drug reactions	EFW857872Q	CCCCOC(=O)C1=CC=C(N)C=C1
Withdrawn	Cadralazine	NA	NA	NA	Antihypertensive	Peripheral arteriolar vasodilator	Hypertension	NA	1989	NA	NA	NA	NA	NA	1991	1992	NA	Norway	Immunologic	NA	Withdrawn because of adverse drug reactions	8T96I3U713	CCOC(=O)NNC1=NN=C(C=C1)N(CC)CC(C)O
Withdrawn	Camazepam	NA	NA	NA	Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation	NA	1978	NA	NA	NA	NA	NA	1984	1984	NA	Netherlands	Immunologic	NA	Withdrawn because of adverse drug reactions	HZ3XRH03C3	CN(C)C(=O)OC1N=C(C2=CC=CC=C2)C3=CC(Cl)=CC=C3N(C)C1=O
Withdrawn	Canrenone	NA	NA	NA	Antihypertensive	Diuresis, aldosterone antagonist	Aldosteronism|CHF|Hypertension	NA	1966	NA	NA	NA	NA	NA	1976	1986	NA	Germany	Tumorigenicity	NA	Withdrawn because of adverse drug reactions	78O20X9J0U	C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]25CCC(=O)O5
Withdrawn	Carbinoxamine	NA	NA	NA	Antihistamine	Competes with free histamine for binding at HA-receptor sites	Allergy	NA	1953	NA	NA	NA	NA	NA	1987	2008	NA	Iraq	Neurotoxicity	NA	Withdrawn because of adverse drug reactions	982A7M02H5	CN(C)CCOC(C1=CC=C(Cl)C=C1)C2=CC=CC=N2
Withdrawn	Carisoprodol	NA	NA	NA	Muscle relaxant	Unknown	Sprain|Muscle injury	NA	1959	NA	NA	NA	NA	NA	2002	2007	NA	Sweden|EU|Indonesia	Abuse	NA	Withdrawn because of adverse drug reactions	21925K482H	CCCC(C)(COC(N)=O)COC(=O)NC(C)C
Withdrawn	Cartilage + bone marrow	NA	NA	NA	Antiarthritic	Unknown	Degenerative joint disease	NA	1960	NA	NA	NA	NA	NA	1989	1992	NA	Germany	Skin	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Catechic extract	NA	NA	NA	Antiinflammatory	Unclear	Benign prostatic hyperplasia	NA	1972	NA	NA	NA	NA	NA	1979	1982	NA	France	Hematologic	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Cefaloridine	NA	NA	NA	Antimicrobial	Disruption of cell wall synthesis	Bacterial infection	NA	1964	NA	NA	NA	NA	NA	1969	1989	NA	Spain	Nephrotoxic	NA	Withdrawn because of adverse drug reactions	LVZ1VC61HB	[O-]C(=O)C1=C(C[N+]2=CC=CC=C2)CS[C@@H]3[C@H](NC(=O)CC4=CC=CS4)C(=O)N13
Withdrawn	Celecoxib	NA	Onsenal	NA	Analgesic	COX-2 inhibitor	Familial adenomatous polyposis	NA	2003	NA	NA	NA	NA	NA	2006	2011	NA	Europe	Increased risk of serious cardiovascular events	NA	Withdrawn because of adverse drug reactions	JCX84Q7J1L	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
Withdrawn	Cell preparations	NA	NA	NA	Antiageing	Unknown	Adjuvant; antiaging	NA	1931	NA	NA	NA	NA	NA	1957	1987	NA	Austria|Germany|Switzerland	Immunologic	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Cerivastatin	NA	NA	NA	Antilipemic	HMG CoA reductase inhibition	Hyperlipidemia	NA	1997	NA	NA	NA	NA	NA	1998	2001	NA	Worldwide	Renal|Musculoskeletal	NA	Withdrawn because of adverse drug reactions	AM91H2KS67	COCC1=C(C2=CC=C(F)C=C2)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
Withdrawn	Chenodeoxycholic acid	NA	NA	NA	Antilipemic	↓ cholesterol saturation of bile	Cholelithiasis (gallstones)	NA	1975	NA	NA	NA	NA	NA	1976	1987	NA	Norway	Tumorigenicity	NA	Withdrawn because of adverse drug reactions	0GEI24LG0J	C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
Withdrawn	Chloral hydrate	NA	NA	NA	Sedative-hypnotic	GABA receptor modulation	Hypnosedation	NA	1869	NA	NA	NA	NA	NA	1986	2001	NA	US|France|India	Tumorigenicity	NA	Withdrawn because of adverse drug reactions	418M5916WG	OC(O)C(Cl)(Cl)Cl
Withdrawn	Chloramphenicol	NA	NA	NA	Antimicrobial	Disruption of cell wall synthesis	Bacterial infection	NA	1947	NA	NA	NA	NA	NA	1950	1978	NA	France|Spain|Hungary|India	Hematologic	NA	Withdrawn because of adverse drug reactions	66974FR9Q1	OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
Withdrawn	Chlormadinone acetate	NA	NA	NA	Hormones	Inhibition of ovulation	Contraception	NA	1965	NA	NA	NA	NA	NA	1970	1972	NA	US|UK|Italy|Egypt|Venezuela	Tumorigenicity	NA	Withdrawn because of adverse drug reactions	0SY050L61N	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O
Withdrawn	Chlormezanone	NA	NA	NA	Muscle relaxant	GABA receptor modulation	Anxiolytic|Muscle sprain & injury	NA	1960	NA	NA	NA	NA	NA	1983	1996	NA	Worldwide	Skin|Drug dependence|Liver	NA	Withdrawn because of adverse drug reactions	GP568V9G19	CN1C(C2=CC=C(Cl)C=C2)S(=O)(=O)CCC1=O
Withdrawn	Chlornaphazine	NA	NA	NA	Chemotherapeutic agent	Cell hydrolysis	Polycythemia & Hodgkin's disease	NA	1964	NA	NA	NA	NA	NA	1964	1964	NA	Denmark|Venezuela	Tumorigenicity	NA	Withdrawn because of adverse drug reactions	U46E473275	ClCCN(CCCl)C1=CC=C2C=CC=CC2=C1
Withdrawn	Chloroform	NA	trichloromethane	NA	Anesthetic	Depression of the respiratory centres	Anesthesia	NA	1847	NA	NA	NA	NA	NA	1976	1976	NA	Greece|Turkey|Japan|US|Panama|Saudi Arabia|Brazil|Italy|Canada|Norway|Philippines|UK|Denmark|NZL|Ethiopia|Zimbabwe|Bangladesh|Dominican Republic|Belgium|Nigeria|Ireland|Oman|Cuba|India	Cardiovascular|Liver|Tumorigenicity|Urinary tract	NA	Withdrawn because of adverse drug reactions	7V31YC746X	ClC(Cl)Cl
Withdrawn	Chloroquine	NA	NA	NA	Antiprotozoal	Cell lysis	Malaria	NA	1939	NA	NA	NA	NA	NA	1959	1975	NA	Japan|Guinea Bissau	Eyes	NA	Withdrawn because of adverse drug reactions	886U3H6UFF	CCN(CC)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1
Withdrawn	Chlorphentermine	NA	NA	NA	Psychostimulant	TAAR1 agonist	Obesity	NA	1962	NA	NA	NA	NA	NA	1970§	1969	NA	Germany|Venezuela	Respiratory|Cardiovascular	NA	Withdrawn because of adverse drug reactions	NHW07912O7	CC(C)(N)CC1=CC=C(Cl)C=C1
Withdrawn	Chorionic gonadotrophin	NA	NA	NA	Hormones	Spermatogenesis	Hypogonadism	NA	1934	NA	NA	NA	NA	NA	1961	1972	NA	US	Immunologic	NA	Withdrawn because of adverse drug reactions	20ED16GHEB	NA
Withdrawn	Cianidanol	NA	NA	NA	Antioxidant	Free radical scavenger	Hepatitis	NA	1976	NA	NA	NA	NA	NA	1980	1985	NA	Worldwide	Hematologic	NA	Withdrawn because of adverse drug reactions	5J4Y243W61|8R1V1STN48	O[C@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C3=CC=C(O)C(O)=C3
Withdrawn	Cinchophen	NA	NA	NA	Analgesic	Adrenal stimulation	Gout	NA	1910	NA	NA	NA	NA	NA	1923	1991	NA	Germany|Italy	Liver	NA	Withdrawn because of adverse drug reactions	39Y533Z02M	OC(=O)C1=CC(=NC2=C1C=CC=C2)C3=CC=CC=C3
Withdrawn	Cinepazide	NA	NA	NA	Vasodilator	Phosphodiesterase inhibition	Cerebrovascular disease	NA	1974	NA	NA	NA	NA	NA	1985	1988	NA	Egypt|Spain	Hematologic	NA	Withdrawn because of adverse drug reactions	67Y4P5C84X	COC1=CC(=CC(OC)=C1OC)\C=C\C(=O)N2CCN(CC(=O)N3CCCC3)CC2
Withdrawn	Cisapride monohydrate	NA	NA	NA	Prokinetic agent	5-HT4 receptor agonist	Gastro-esophageal reflux	NA	1993	NA	NA	NA	NA	NA	1993	2000	NA	Philippines|Oman|US|Germany|UK|Serbia|Mauritius|Canada|Brunei|Turkey|Indonesia|Singapore|Japan|Cuba|Bahrain|Australia|Armenia|India	Cardiovascular|Drug interactions	NA	Withdrawn because of adverse drug reactions	VZV0A4I38W	O.CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=CC(Cl)=C(N)C=C3OC
Withdrawn	Clobutinol	NA	NA	NA	Antitussive	Unclear	Cough	NA	1961	NA	NA	NA	NA	NA	2004	2007	NA	Europe|Argentina	Cardiovascular	NA	Withdrawn because of adverse drug reactions	1NY2IX043A	CC(CN(C)C)C(C)(O)CC1=CC=C(Cl)C=C1
Withdrawn	Clioquinol	NA	NA	NA	Antimicrobial	Inhibition of DNA replication	Diarrhea	NA	1934	NA	NA	NA	NA	NA	1964	1970	NA	Japan|Norway|Sweden|Denmark|UAE|Nigeria|Bangladesh|Philippines|Italy|Nepal|Dominican Republic|Zimbabwe|Spain|Hong Kong|Ethiopia|Honduras|Oman|Pakistan|Ghana|Libya|Bahrain|Netherlands|Saudi Arabia|Canada	Nervous system	NA	Withdrawn because of adverse drug reactions	7BHQ856EJ5	OC1=C2N=CC=CC2=C(Cl)C=C1I
Withdrawn	Clobenzorex	NA	NA	NA	Psychostimulant	Similar to amphetamine	Obesity	NA	1966	NA	NA	NA	NA	NA	1986	2000	NA	Mauritius|US	Drug abuse|Psychiatric	NA	Withdrawn because of adverse drug reactions	4A5352XI2A	C[C@@H](CC1=CC=CC=C1)NCC2=CC=CC=C2Cl
Withdrawn	Clofenotane	NA	NA	NA	Pesticide	Interfere with voltage-gated sodium channel	Pediculosis	NA	1945	NA	NA	NA	NA	NA	1969	1972	NA	US	Carcinogenicity	NA	Withdrawn because of adverse drug reactions	CIW5S16655	ClC1=CC=C(C=C1)C(C2=CC=C(Cl)C=C2)C(Cl)(Cl)Cl
Withdrawn	Clofibrate	NA	NA	NA	Antilipemic	Activates PPAR	Hyperlipidemia	NA	1967	NA	NA	NA	NA	NA	1973	1978	NA	Germany|Israel|Norway|Bangladesh	Accelerated deaths	NA	Withdrawn because of adverse drug reactions	HPN91K7FU3	CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
Withdrawn	Cloforex	NA	NA	NA	Psychostimulant	Similar to amphetamine	Obesity	NA	1965	NA	NA	NA	NA	NA	1967	1967	NA	Germany|Sweden|Venezuela	Cardiovascular|Drug abuse|Psychiatric	NA	Withdrawn because of adverse drug reactions	2QJT5ZC1L6	CCOC(=O)NC(C)(C)CC1=CC=C(Cl)C=C1
Withdrawn	Clomacran	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1966	NA	NA	NA	NA	NA	1970	1982	NA	UK	Liver	NA	Withdrawn because of adverse drug reactions	5B1UZF65WW	CN(C)CCCC1C2=CC=CC=C2NC3=CC=C(Cl)C=C13
Withdrawn	Clometacin	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1971	NA	NA	NA	NA	NA	1981	1990	NA	France	Liver|Skin|Urinary tract	NA	Withdrawn because of adverse drug reactions	L9M34YK25C	COC1=CC2=C(C=C1)C(C(=O)C3=CC=C(Cl)C=C3)=C(C)N2CC(O)=O
Withdrawn	Clozapine	NA	NA	NA	Antipsychotic	Unknown	Schizophrenia	NA	1972	NA	NA	NA	NA	NA	1975	1975	NA	Finland|Singapore|Norway	Cardiovascular|Hematologic	NA	Withdrawn because of adverse drug reactions	J60AR2IKIC|5V7Y54AAIG	CN1CCN(CC1)C2=NC3=CC(Cl)=CC=C3NC4=CC=CC=C24
Withdrawn	Cobalt	NA	NA	NA	Hematinic	As cobalamin	Iron-deficiency anemia	NA	1951	NA	NA	NA	NA	NA	1954	1967	NA	US|Kuwait	Cardiovascular|Liver	NA	Withdrawn because of adverse drug reactions	3G0H8C9362	[Co]
Withdrawn	Codeine	NA	NA	NA	Analgesic	G-protein receptor modulation	Analgesia	NA	1832	NA	NA	NA	NA	NA	1951	1985	NA	Bangladesh|Malaysia	Abuse	NA	Withdrawn because of adverse drug reactions	Q830PW7520	O.COC1=C2O[C@H]3[C@@H](O)C=C[C@H]4[C@H]5CC(C=C1)=C2[C@@]34CCN5C
Withdrawn	Co-proxamol	NA	paracetamol + dextropropoxyphene	NA	Analgesic	?COX-3 inhibition; agonist at mu opioid receptors	Analgesia	NA	1957	NA	NA	NA	NA	NA	1960	2007	NA	Europe|India|US|Zimbabwe|New Zealand|Iraq	Overdose; respiratory depression; cardio and hepatotoxicity	NA	Withdrawn because of adverse drug reactions	CB2TL9PS0T|362O9ITL9D	NA
Withdrawn	Coumarin	NA	NA	synthetic	Anticoagulant	Vitamin K reductase inhibition	Lymphedema post- radiation	NA	1996	NA	NA	NA	NA	NA	1996	1996	NA	France|Australia	Liver	NA	Withdrawn because of adverse drug reactions	A4VZ22K1WT	O=C1OC2=C(C=CC=C2)C=C1
Withdrawn	Cupric bisquinoline	NA	NA	NA	Antiarthritic	Antiinflammatory with penicillamine complex	Rheumatism	NA	1958	NA	NA	NA	NA	NA	1967	1978	NA	France	Neuromuscular	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Cyclandelate	NA	NA	NA	Vasodilator	Direct effect on vascular smooth muscle	Raynaud's disease	NA	1987	NA	NA	NA	NA	NA	1989	1996	NA	US	Not effective for use	NA	Withdrawn because of adverse drug reactions	4139O1OAY2	CC1CC(CC(C)(C)C1)OC(=O)C(O)C2=CC=CC=C2
Withdrawn	Cyclobarbital	NA	NA	NA	Sedative-hypnotic	GABA-A receptor receptor agonist	Hypnosedation	NA	1962	NA	NA	NA	NA	NA	1974	1980	NA	Norway|France	Drug dependence|Drug overdose	NA	Withdrawn because of adverse drug reactions	0M8A98AD9H	CCC1(C(=O)NC(=O)NC1=O)C2=CCCCC2
Withdrawn	Cyclofenil	NA	NA	NA	Anti-hormone	Estrogen receptor modulation	Scleroderma	NA	1970	NA	NA	NA	NA	NA	1980	1987	NA	France	Liver	NA	Withdrawn because of adverse drug reactions	J468V64WZ1	CC(=O)OC1=CC=C(C=C1)C(=C2CCCCC2)C3=CC=C(OC(C)=O)C=C3
Withdrawn	Cyclovalone + retinol + tiratricol	NA	NA	NA	Choleretic	Unknown	Hyperlipidemia|Dyspepsia|Obesity	NA	1964	NA	NA	NA	NA	NA	1984	1988	NA	France	Liver	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Cyproheptadine	NA	NA	NA	Antihistamine	Antihistamine, anticholinergic	Allergy|Anorexia	NA	1961	NA	NA	NA	NA	NA	1977	1982	NA	Bangladesh|Malaysia|UK	Drug abuse	NA	Withdrawn because of adverse drug reactions	2YHB6175DO	CN1CCC(CC1)=C2C3=CC=CC=C3C=CC4=CC=CC=C24
Withdrawn	Dalkon shield	NA	NA	NA	Hormones	Prevention of fertilization	Contraception (IUD)	NA	1971	NA	NA	NA	NA	NA	1974	1974	NA	US|UK|New Zealand	Septic abortions	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Danthron	NA	chrysazin	NA	Laxative	Unknown	Constipation	NA	1959	NA	NA	NA	NA	NA	1985	1987	NA	Norway|Germany|Japan|US|Singapore|Canada	Tumorigenicity	NA	Withdrawn because of adverse drug reactions	Z4XE6IBF3V	OC1=C2C(=O)C3=C(O)C=CC=C3C(=O)C2=CC=C1
Withdrawn	Datura	NA	NA	NA	Analgesic	Muscarinic receptor antagonist (atropine)	Asthma	NA	1920	NA	NA	NA	NA	NA	1962	1992	NA	France	Drug abuse	NA	Withdrawn because of adverse drug reactions	G6W4F0V8Z3	NA
Withdrawn	Dequalinium chloride	NA	NA	NA	Lozenges	Unknown	Disinfectant	NA	1956	NA	NA	NA	NA	NA	1970	1984	NA	Greece	Low efficacy|Skin reactions	NA	Withdrawn because of adverse drug reactions	XYS8INN1I6	[Cl-].[Cl-].CC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C
Withdrawn	Desensitizing vaccines	NA	NA	NA	Vaccines	Unknown	Viral infection	NA	1973	NA	NA	NA	NA	NA	1985	1989	NA	UK	Immunologic	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Dexamfetamine	NA	NA	NA	Psychostimulant	Adrenergic receptor agonist	Narcolepsy|ADHD	NA	1937	NA	NA	NA	NA	NA	1966	1973	NA	US|Turkey|Oman|Nigeria	Drug abuse and dependence	NA	Withdrawn because of adverse drug reactions	TZ47U051FI	C[C@H](N)CC1=CC=CC=C1
Withdrawn	Dexfenfluramine	NA	NA	NA	Psychostimulant	Serotonin receptor agonist	Obesity	NA	1995	NA	NA	NA	NA	NA	1995	1997	NA	US|Canada|Morocco|Philippines|Lithuania|India	Cardiovascular|Respiratory	NA	Withdrawn because of adverse drug reactions	E35R3G56OV	CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
Withdrawn	Oxyphenisatin acetate	NA	NA	NA	Laxative	Phenacetin analogue	Diarrhea	NA	1971	NA	NA	NA	NA	NA	1971	1971	NA	Australia	Liver	NA	Withdrawn because of adverse drug reactions	U0Y1YAL65X	CC(=O)OC1=CC=C(C=C1)C2(C(=O)NC3=C2C=CC=C3)C4=CC=C(OC(C)=O)C=C4
Withdrawn	Diamthazole	NA	NA	NA	Antimicrobial	Unknown	Fungal infection	NA	1951	NA	NA	NA	NA	NA	1953	1972	NA	US|France	Nervous system|Psychiatric	NA	Withdrawn because of adverse drug reactions	2KL01R8ZV1	CCN(CC)CCOC1=CC2=C(C=C1)N=C(S2)N(C)C
Withdrawn	Dibenzepine hydrochloride	NA	NA	NA	Antidepressant	Norepinephrine reuptake inhibitor	Depression	NA	1963	NA	NA	NA	NA	NA	1967	1983	NA	Sweden	Suicides	NA	Withdrawn because of adverse drug reactions	JLN0273S4Z	Cl.CN(C)CCN1C2=CC=CC=C2N(C)C3=CC=CC=C3C1=O
Withdrawn	Dibromsalan	NA	NA	NA	Antimicrobial	Unknown	Bacterial infection	NA	1962	NA	NA	NA	NA	NA	1966	1975	NA	US|Japan	Skin	NA	Withdrawn because of adverse drug reactions	N9900K2RBT	OC1=CC=C(Br)C=C1C(=O)NC2=CC=C(Br)C=C2
Withdrawn	Diclofenac sodium	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1979	NA	NA	NA	NA	NA	1979	1983	NA	Philippines|Norway	Hematologic|Tumorigenicity	NA	Withdrawn because of adverse drug reactions	QTG126297Q	[Na+].[O-]C(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
Withdrawn	Dicycloverine	NA	NA	NA	Antispasmodic	Muscarinic anticholinergic	Irritable bowel syndrome	NA	1952	NA	NA	NA	NA	NA	1974	1986	NA	Bangladesh|Norway	Nervous|Psychiatric	NA	Withdrawn because of adverse drug reactions	4KV4X8IF6V	CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
Withdrawn	Dienestrol	NA	NA	NA	Hormones	Estrogen receptor agonist	Hormone replacement therapy	NA	1947	NA	NA	NA	NA	NA	1972	1977	NA	Austria|Italy|Kuwait|Saudi Arabia	Carcinogenicity	NA	Withdrawn because of adverse drug reactions	RRW32X4U1F	C\C=C(C1=CC=C(O)C=C1)\C(=C\C)C2=CC=C(O)C=C2
Withdrawn	Diethylaminoethoxyhexestrol	NA	NA	NA	Antianginal	Unknown	Angina pectoris	NA	1964	NA	NA	NA	NA	NA	1970	1970	NA	Japan	Liver	NA	Withdrawn because of adverse drug reactions	UBR09A3IFF	CCC(C(CC)C1=CC=C(OCCN(CC)CC)C=C1)C2=CC=C(OCCN(CC)CC)C=C2
Withdrawn	Diethylstilbestrol	NA	NA	NA	Hormones	Uterine desensitization, local arteriolar constriction	Threatened abortion	NA	1938	NA	NA	NA	NA	NA	1971	1973	NA	Panama|Austria|Kuwait|Italy	Tumorigenicity	NA	Withdrawn because of adverse drug reactions	731DCA35BT	CC\C(C1=CC=C(O)C=C1)=C(\CC)C2=CC=C(O)C=C2
Withdrawn	Difemerine	NA	NA	NA	Antispasmodic	Muscarinic antagonist	GI spasms	NA	1967	NA	NA	NA	NA	NA	1980	1986	NA	Germany|France|US	Nervous system	NA	Withdrawn because of adverse drug reactions	843C4UPZ2F	CN(C)C(C)(C)COC(=O)C(O)(C1=CC=CC=C1)C2=CC=CC=C2
Withdrawn	Difenoxin	NA	NA	NA	Antispasmodic	Opioid receptor agonist	Diarrhea	NA	1970	NA	NA	NA	NA	NA	1979	1991	NA	Pakistan|Oman|South Korea|Lebanon	Atropism	NA	Withdrawn because of adverse drug reactions	3ZZ5BJ9F2Q	OC(=O)C1(CCN(CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)CC1)C4=CC=CC=C4
Withdrawn	Difurazone	NA	NA	NA	Antimicrobial	Unknown	Bacterial infection	NA	1966	NA	NA	NA	NA	NA	NA	1977	NA	Japan|Saudi Arabia|Venezuela	Superseded by safer products	NA	Withdrawn because of adverse drug reactions	4I203628MT	NC(=N)NN=C(C=CC1=CC=C(O1)[N+]([O-])=O)C=CC2=CC=C(O2)[N+]([O-])=O
Withdrawn	Dihydrostreptomycin	NA	NA	NA	Antimicrobial	Protein synthesis inhibitor	Bacterial infection	NA	1947	NA	NA	NA	NA	NA	1949	1970	NA	US|Philippines|Spain|Dominican Republic|Italy|Peru	Nervous system|Psychiatric|Sensory systems	NA	Withdrawn because of adverse drug reactions	P2I6R8W6UA	CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]3NC(N)=N)O[C@@H](C)[C@]2(O)CO
Withdrawn	Dihydroxymethylfuratrizine	NA	NA	NA	Antimicrobial	Nitrofuran analogue	Bacterial infection	NA	1975	NA	NA	NA	NA	NA	1975	1977	NA	Japan|Saudi Arabia|Venezuela	Tumorigenic	NA	Withdrawn because of adverse drug reactions	KZY81S445V	OCN(CO)C1=NC=C(\C=C\C2=CC=C(O2)[N+]([O-])=O)N=N1
Withdrawn	Diiododiethyltin	NA	NA	NA	Antimicrobial	Unknown	Bacterial infection	NA	1954	NA	NA	NA	NA	NA	1955	1957	NA	France	Nervous system	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Dilevalol	NA	NA	NA	Antihypertensive	Nonselective beta blocker; beta-2 receptor agonist	Hypertension	NA	1989	NA	NA	NA	NA	NA	1989	1990	NA	Worldwide	Liver	NA	Withdrawn because of adverse drug reactions	P6629XE33T	C[C@H](CCC1=CC=CC=C1)NC[C@H](O)C2=CC=C(O)C(=C2)C(N)=O
Withdrawn	Dinitrophenol	NA	NA	NA	Organic compound	Uncoupling of oxidative phosphorylation	Obesity	NA	1933	NA	NA	NA	NA	NA	1933	1938∆	NA	US	Cataracts|Agranulocytosis	NA	Withdrawn because of adverse drug reactions	Q13SKS21MN	OC1=C(C=C(C=C1)[N+]([O-])=O)[N+]([O-])=O
Withdrawn	Dinoprostone	NA	NA	NA	Prostaglandin	Direct vasodilator	Induction of labour	NA	1971	NA	NA	NA	NA	NA	1987	1990	NA	UK	Fetal distress; uterine hypertonia	NA	Withdrawn because of adverse drug reactions	K7Q1JQR04M	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
Withdrawn	Diphenazine	NA	quietidin	NA	Analgesic	Unknown	Analgesia	NA	1962	NA	NA	NA	NA	NA	1967	1967	NA	Hungary|Venezuela	Photosensitivity	NA	Withdrawn because of adverse drug reactions	8BEA88HVGF	CC(CC1=CC=CC=C1)N2CCN(CC2)C(C)CC3=CC=CC=C3
Withdrawn	Diphenoxylate	NA	NA	NA	Antispasmodic	Opioid receptor agonist	Diarrhea	NA	1956	NA	NA	NA	NA	NA	1969	1990	NA	Libya|Pakistan|Mexico|Nepal|Philippines|South Korea|Lebanon|Thailand	Nervous system	NA	Withdrawn because of adverse drug reactions	73312P173G	CCOC(=O)C1(CCN(CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)CC1)C4=CC=CC=C4
Withdrawn	Dithiazanine iodide	NA	NA	NA	Antihelminth	Interruption of glucose uptake in cells	Worm infestation	NA	1959	NA	NA	NA	NA	NA	1960	1964	NA	US|France|Chad|Italy|Cuba	Cardiovascular|Metabolism	NA	Withdrawn because of adverse drug reactions	8OEC3RA07X	[I-].CCN1C(SC2=C1C=CC=C2)=CC=CC=CC3=[N+](CC)C4=C(S3)C=CC=C4
Withdrawn	Dofetilide	NA	NA	NA	Antiarrhythmic	Potassium channel blocker	Cardiac arrhythmia	NA	1999	NA	NA	NA	NA	NA	1999	2004	NA	Europe	Cardiovascular	NA	Withdrawn because of adverse drug reactions	R4Z9X1N2ND	CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC2=CC=C(NS(C)(=O)=O)C=C2
Withdrawn	Dolasetron	NA	NA	NA	Propulsive	5-HT3 receptor antagonist	Emesis	NA	1997	NA	NA	NA	NA	NA	2005	2011	NA	Germany	Cardiovascular	NA	Withdrawn because of adverse drug reactions	82WI2L7Q6E	O=C(O[C@H]1C[C@@H]2C[C@@H]3C[C@@H](C1)N2CC3=O)C4=CNC5=C4C=CC=C5
Withdrawn	Domperidone	NA	NA	injectable	Propulsive	Dopamine receptor antagonist	Emesis|GERD	NA	1979	NA	NA	NA	NA	NA	1982	1985	NA	Worldwide	Cardiovascular|Drug overdose|Endocrine|Nervous system	NA	Withdrawn because of adverse drug reactions	5587267Z69	ClC1=CC2=C(C=C1)N(C3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
Withdrawn	Doxycycline	NA	NA	IV	Antimicrobial	Protein synthesis inhibitor	Bacterial infection	NA	1959	NA	NA	NA	NA	NA	1984	1989	NA	France|Morocco	Anaphylaxis	NA	Withdrawn because of adverse drug reactions	N12000U13O	O.C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C2C(=O)C4=C1C=CC=C4O
Withdrawn	Doxylamine/dicyclomine	NA	NA	NA	Antihistamine	H1-receptor blocker	Allergy|Hyperemesis	NA	1956	NA	NA	NA	NA	NA	1981	1983	NA	UK|US	Teratogenicity	NA	Withdrawn because of adverse drug reactions	95QB77JKPL|4KV4X8IF6V	NA
Withdrawn	Drotrecogin alfa	NA	NA	activated	Antithrombotic	Unclear	Sepsis	NA	2001	NA	NA	NA	NA	NA	2001	2011	NA	Worldwide	Insufficient evidence; bleeding risk	NA	Withdrawn because of adverse drug reactions	JGH8MYC891	NA
Withdrawn	Droperidol	NA	NA	NA	Antipsychotic	Dopamine 2 receptor antagonist	Psychoses	NA	1970	NA	NA	NA	NA	NA	1991	2001	NA	UK|Indonesia	Cardiovascular; deaths	NA	Withdrawn because of adverse drug reactions	O9U0F09D5X	FC1=CC=C(C=C1)C(=O)CCCN2CCC(=CC2)N3C(=O)NC4=C3C=CC=C4
Withdrawn	Droxicam	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1990	NA	NA	NA	NA	NA	1992	1994	NA	Europe	Liver	NA	Withdrawn because of adverse drug reactions	F24ADO1E2D	CN1C2=C(OC(=O)N(C2=O)C3=NC=CC=C3)C4=C(C=CC=C4)S1(=O)=O
Withdrawn	Ebrotidine	NA	NA	NA	Anti-ulcer	H2 receptor antagonist	Peptic ulcer	NA	1997	NA	NA	NA	NA	NA	1998	1998	NA	Spain|Peru	Liver	NA	Withdrawn because of adverse drug reactions	TMZ3IBW2OW	NC(=N)NC1=NC(CSCCN\C=N\S(=O)(=O)C2=CC=C(Br)C=C2)=CS1
Withdrawn	Efalizumab	NA	NA	NA	Monoclonal antibody	Inhibits CD11a	Autoimmune disease	NA	2003	NA	NA	NA	NA	NA	2008	2009	NA	EU|US|Canada|Mexico	Leukoencephalopathy	NA	Withdrawn because of adverse drug reactions	XX2MN88N5D	NA
Withdrawn	Emetin	NA	NA	ipecac syrup	Emetic	Stimulation of the CTZ, local irritation	Emesis	NA	1912	NA	NA	NA	NA	NA	1947	1982	NA	Mauritius	Cardiotoxicity	NA	Withdrawn because of adverse drug reactions	X8D5EPO80M	CC[C@H]1CN2CCC3=C(C=C(OC)C(OC)=C3)[C@@H]2C[C@@H]1C[C@H]4NCCC5=CC(OC)=C(OC)C=C45
Withdrawn	Encainide	NA	NA	NA	Antiarrhythmic	Na channel blocker	Cardiac arrhythmia	NA	1985	NA	NA	NA	NA	NA	1989	1991	NA	UK	Cardiovascular	NA	Withdrawn because of adverse drug reactions	SY3J0147NB	COC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2CCC3CCCCN3C
Withdrawn	Epinephrine	NA	NA	topical	Anesthetic	Vasoconstriction	Local anesthesia	NA	1899	NA	NA	NA	NA	NA	1963	2004	NA	Ireland|Venezuela	Cardiovascular|Nervous	NA	Withdrawn because of adverse drug reactions	YKH834O4BH	CNC[C@H](O)C1=CC(O)=C(O)C=C1
Withdrawn	Erythrityl tetranitrate	NA	NA	NA	Antihypertensive	Nitric oxide synthesis	Angina pectoris	NA	1955	NA	NA	NA	NA	NA	1987	1998	NA	US	Insufficient evidence: skin	NA	Withdrawn because of adverse drug reactions	35X333P19D	[O-][N+](=O)OC[C@@H](O[N+]([O-])=O)[C@H](CO[N+]([O-])=O)O[N+]([O-])=O
Withdrawn	Erythromycin bailleul	NA	NA	NA	Antimicrobial	Protein synthesis inhibitor	Bacterial infection	NA	1955	NA	NA	NA	NA	NA	1975	1995	NA	France	Teratogenic	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Erythromycin estolate	NA	NA	NA	Antimicrobial	Protein synthesis inhibitor	Bacterial infection	NA	1958	NA	NA	NA	NA	NA	1961	1976	NA	Singapore|Greece|Sudan|Mauritius|Bangladesh|Bahrain|Denmark|Sweden	Liver	NA	Withdrawn because of adverse drug reactions	XRJ2P631HP	CCCCCCCCCCCCOS(O)(=O)=O.CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(=O)CC)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
Withdrawn	Ethanol	NA	NA	NA	Antimicrobial	GABA-A receptor modulation, protein coagulation	Sedation|Disinfectant	NA	1850	NA	NA	NA	NA	NA	1946	1985	NA	Chile|Sri Lanka|Brazil|UAE	Neurotoxicity|Abuse	NA	Withdrawn because of adverse drug reactions	3K9958V90M	CCO
Withdrawn	Ethchlorvynol	NA	NA	NA	Sedative-hypnotic	Unknown	Hypnosedation	NA	1955	NA	NA	NA	NA	NA	1959	1978	NA	US	Drug dependence|Respiratory	NA	Withdrawn because of adverse drug reactions	6EIM3851UZ	CCC(O)(\C=C\Cl)C#C
Withdrawn	Ethinyl estradiol	NA	NA	NA	Hormones	?Gonadotropin suppression	Contraception	NA	1943	NA	NA	NA	NA	NA	1963	2004	NA	Germany|France	Venous thrombosis	NA	Withdrawn because of adverse drug reactions	423D2T571U	C[C@]12CC[C@H]3[C@@H](CCC4=CC(O)=CC=C34)[C@@H]1CC[C@@]2(O)C#C
Withdrawn	Ethyl nitrite	NA	NA	spirit	Antimicrobial	Increased GFR, nitric oxide synthesis	Diaphoresis|GI spasm	NA	1850	NA	NA	NA	NA	NA	1977	1980	NA	US	Methemoglobinemia	NA	Withdrawn because of adverse drug reactions	8C7CJ279RV	CCON=O
Withdrawn	Ethylene dichloride	NA	NA	topical	Antimicrobial	Unknown	Bacterial infection	NA	1794	NA	NA	NA	NA	NA	1977	1978	NA	Germany|Saudi Arabia	Carcinogenic	NA	Withdrawn because of adverse drug reactions	55163IJI47	ClCCCl
Withdrawn	Ethylestrenol	NA	NA	NA	Hormones	Stimulate anabolism & inhibit catabolism	Testosterone deficiency	NA	1964	NA	NA	NA	NA	NA	1965	1982	NA	Bangladesh	Inappropriate use in malnourished children	NA	Withdrawn because of adverse drug reactions	ADC79EK5Q8	CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@]12C
Withdrawn	Etomidate	NA	NA	NA	Anesthetic	GABA-A receptor modulation	Anesthesia	NA	1972	NA	NA	NA	NA	NA	1983	1985	NA	UK	Endocrine	NA	Withdrawn because of adverse drug reactions	Z22628B598	CCOC(=O)C1=CN=CN1[C@H](C)C2=CC=CC=C2
Withdrawn	Etretinate	NA	NA	NA	Retinoid	Inhibits cell differentiation & hyperkeratinization	Psoriasis	NA	1981	NA	NA	NA	NA	NA	1982	1992	NA	Norway|Brazil|France|US|Canada	Teratogenicity|Tumorigenicity|Death	NA	Withdrawn because of adverse drug reactions	65M2UDR9AG	CCOC(=O)\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)C=C(OC)C(C)=C1C
Withdrawn	Exifone	NA	NA	NA	Psychostimulant	Free radical scavenger?	Memory deficits	NA	1988	NA	NA	NA	NA	NA	1989	1989	NA	France	Liver	NA	Withdrawn because of adverse drug reactions	38K9TOD4EG	OC1=CC=C(C(=O)C2=CC(O)=C(O)C(O)=C2)C(O)=C1O
Withdrawn	Factor IX	NA	NA	NA	Anti-hemophilic	Hydrolysis of disulfide bonds	Hemophilia	NA	1952	NA	NA	NA	NA	NA	1986	1986	NA	Sweden	HIV	NA	Withdrawn because of adverse drug reactions	382L14738L	NA
Withdrawn	Factor VIII	NA	NA	NA	Anti-hemophilic	Cofactor for factor IXa	Hemophilia	NA	1965	NA	NA	NA	NA	NA	1986	1986	NA	UK	HIV	NA	Withdrawn because of adverse drug reactions	5T6B772R4Q	NA
Withdrawn	Febarbamate	NA	NA	NA	Sedative-hypnotic	GABA-A receptor receptor modulation	Hypnosedation	NA	1967	NA	NA	NA	NA	NA	1991	1997	NA	France	Liver	NA	Withdrawn because of adverse drug reactions	5Z48ONN38P	CCCCOCC(CN1C(=O)NC(=O)C(CC)(C1=O)C2=CC=CC=C2)OC(N)=O
Withdrawn	Felbamate	NA	NA	NA	Anti-epileptic	NMDA receptor antagonist	Epilepsy	NA	1993	NA	NA	NA	NA	NA	1993	1994	NA	US|European Union	Hematologic|Liver	NA	Withdrawn because of adverse drug reactions	X72RBB02N8	NC(=O)OCC(COC(N)=O)C1=CC=CC=C1
Withdrawn	Fenbutrazate	NA	NA	NA	Psychostimulant	Phenmetrazine analogue	Obesity	NA	1957	NA	NA	NA	NA	NA	1963	1969	NA	Europe	Drug abuse|Psychiatric	NA	Withdrawn because of adverse drug reactions	BKY8H56395	CCC(C(=O)OCCN1CCOC(C1C)C2=CC=CC=C2)C3=CC=CC=C3
Withdrawn	Fenclofenac	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1978	NA	NA	NA	NA	NA	1984	1984	NA	Worldwide	Skin|Tumorigenicity|Urinary tract	NA	Withdrawn because of adverse drug reactions	Y01JW64D01	OC(=O)CC1=CC=CC=C1OC2=CC=C(Cl)C=C2Cl
Withdrawn	Fenclozic acid	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1969	NA	NA	NA	NA	NA	1970	1970	NA	UK|US	Liver	NA	Withdrawn because of adverse drug reactions	58SRQ4DV53	OC(=O)CC1=CSC(=N1)C2=CC=C(Cl)C=C2
Withdrawn	Fenetylline	NA	NA	NA	Psychostimulant	Amphetamine + theophylline properties	ADHD|Narcolepsy	NA	1961	NA	NA	NA	NA	NA	1962	1991	NA	Oman|Bulgaria	Abuse	NA	Withdrawn because of adverse drug reactions	YZ0N7VL5R3	CC(CC1=CC=CC=C1)NCCN2C=NC3=C2C(=O)N(C)C(=O)N3C
Withdrawn	Fenfluramine	NA	NA	NA	Psychostimulant	Serotonin receptor antagonist	Obesity	NA	1973	NA	NA	NA	NA	NA	1996	1997	NA	Worldwide	Cardiovascular|Respiratory	NA	Withdrawn because of adverse drug reactions	2DS058H2CF	CCNC(C)CC1=CC(=CC=C1)C(F)(F)F
Withdrawn	Fenoterol	NA	NA	NA	Antiasthmatic	Beta 2 adrenergic agonist	Asthma	NA	1971	NA	NA	NA	NA	NA	1987	1990	NA	New Zealand|Australia	Death	NA	Withdrawn because of adverse drug reactions	22M9P70OQ9	C[C@H](CC1=CC=C(O)C=C1)NC[C@H](O)C2=CC(O)=CC(O)=C2
Withdrawn	Fenproporex	NA	NA	NA	Psychostimulant	Amphetamine analogue	Obesity	NA	1966	NA	NA	NA	NA	NA	1997	1999	NA	Europe	Drug abuse|Psychiatric	NA	Withdrawn because of adverse drug reactions	W0194S5FOA	CC(CC1=CC=CC=C1)NCCC#N
Withdrawn	Fentanyl hydrochloride	NA	NA	NA	Anagesic	μ-opioid receptor agonist	Analgesia|Anesthesia	NA	2006	NA	NA	NA	NA	NA	2006	2009	NA	Europe	Risk of overdose	NA	Withdrawn because of adverse drug reactions	59H156XY46	Cl.CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C3=CC=CC=C3
Withdrawn	Feprazone	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1978	NA	NA	NA	NA	NA	1981	1984	NA	UK|Germany|Greece|Egypt	Liver|Gastrointestinal|Skin|Urinary tract	NA	Withdrawn because of adverse drug reactions	7BVX6J0CGR	CC(C)=CCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
Withdrawn	Fipexide	NA	NA	NA	Nootropic	TAAR1 receptor modulation?	Memory deficits	NA	1973	NA	NA	NA	NA	NA	1990	1991	NA	France	Hematologic|Liver	NA	Withdrawn because of adverse drug reactions	TG44VME01D	ClC1=CC=C(OCC(=O)N2CCN(CC3=CC=C4OCOC4=C3)CC2)C=C1
Withdrawn	Floctafenine	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1976	NA	NA	NA	NA	NA	1976	1987	NA	Belgium	Dermatologic	NA	Withdrawn because of adverse drug reactions	O04HVX6A9Q	OCC(O)COC(=O)C1=C(NC2=CC=NC3=C(C=CC=C23)C(F)(F)F)C=CC=C1
Withdrawn	Flosequinan	NA	NA	NA	Vasodilator	Direct relaxing effects	Congestive heart failure	NA	1992	NA	NA	NA	NA	NA	1992	1993	NA	UK|US	Death	NA	Withdrawn because of adverse drug reactions	6NB119DLU7	CN1C=C([S+](C)[O-])C(=O)C2=C1C=C(F)C=C2
Withdrawn	Flosulide	NA	NA	NA	Analgesic	COX-2 inhibitor	Analgesia	NA	1994	NA	NA	NA	NA	NA	1995	1996	NA	Germany	Kidneys	NA	Withdrawn because of adverse drug reactions	GVR41S4ZHJ	CS(=O)(=O)NC1=CC2=C(C=C1OC3=C(F)C=C(F)C=C3)C(=O)CC2
Withdrawn	Flunitrazepam	NA	NA	NA	Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation	NA	1974	NA	NA	NA	NA	NA	1979	1986	NA	South Africa|Sweden	Drug abuse	NA	Withdrawn because of adverse drug reactions	620X0222FQ	CN1C2=CC=C(C=C2C(=NCC1=O)C3=CC=CC=C3F)[N+]([O-])=O
Withdrawn	Fluproquazone	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1979	NA	NA	NA	NA	NA	1984	1989	NA	US	Liver	NA	Withdrawn because of adverse drug reactions	U4K85O58HD	CC(C)N1C(=O)N=C(C2=CC=C(F)C=C2)C3=C1C=C(C)C=C3
Withdrawn	Fluvoxamine	NA	NA	NA	Antidepressant	Selective serotonin re-uptake inhibitor	Obsessive Compulsive disorder; depression	NA	1984	NA	NA	NA	NA	NA	1987	1987	NA	Iceland	Teratogenicity|Renotoxicity	NA	Withdrawn because of adverse drug reactions	O4L1XPO44W	COCCCC\C(C1=CC=C(C=C1)C(F)(F)F)=N/OCCN
Withdrawn	Furazolidone	NA	NA	NA	Antimicrobial	Disruption of bacterial DNA	Bacterial infection	NA	1954	NA	NA	NA	NA	NA	1965	1977	NA	Japan|Iraq|Malaysia|South Korea|Lebanon|Yemen|India	Skin|Hematologic|Nervous|Respiratory|Sensory	NA	Withdrawn because of adverse drug reactions	5J9CPU3RE0	[O-][N+](=O)C1=CC=C(O1)C=NN2CCOC2=O
Withdrawn	Gadofosveset trisodium	NA	NA	NA	Radiography	Binds to human serum albumin	Diagnostic imaging	NA	1988	NA	NA	NA	NA	NA	2006	2010	NA	European Union	Kidney	NA	Withdrawn because of adverse drug reactions	XM33Q67UVH	O.[Na+].[Na+].[Na+].[Gd+3].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)C[C@H](COP([O-])(=O)OC1CCC(CC1)(C2=CC=CC=C2)C3=CC=CC=C3)N(CC([O-])=O)CC([O-])=O
Withdrawn	Gallopamil	NA	NA	NA	Antiarrhythmic	Calcium channel blockers	Cardiac arrhythmia	NA	1983	NA	NA	NA	NA	NA	1985	2001	NA	Turkey	Not specified: Cardiovascular	NA	Withdrawn because of adverse drug reactions	39WPC8JHR8	COC1=CC=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C(OC)=C2)C=C1OC
Withdrawn	Ganglioside GM1	NA	NA	bovine	Glycolipids	Dimerization of neurotrophic factor tyrosine kinases	Peripheral neuropathies	NA	1975	NA	NA	NA	NA	NA	1985	1989	NA	Germany	Nervous system	NA	Withdrawn because of adverse drug reactions	562413257Z	CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@@]5(C[C@H](O)[C@@H](NC(C)=O)[C@@H](O5)[C@H](O)[C@H](O)CO)C(O)=O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)\C=C\CCCCCCCCCCCCC
Withdrawn	Gatifloxacin	NA	NA	NA	Antimicrobial	Inhibition of DNA gyrase	Bacterial infection	NA	1999	NA	NA	NA	NA	NA	2002	2011	NA	Europe|India	Dysglycemia	NA	Withdrawn because of adverse drug reactions	L4618BD7KJ	O.O.O.COC1=C(N2CCNC(C)C2)C(F)=CC3=C1N(C=C(C(O)=O)C3=O)C4CC4.COC5=C(N6CCNC(C)C6)C(F)=CC7=C5N(C=C(C(O)=O)C7=O)C8CC8
Withdrawn	Gelatin	NA	NA	NA	Coagulant	Unknown	Bleeding	NA	1915	NA	NA	NA	NA	NA	1978	1978	NA	US	Hematologic	NA	Withdrawn because of adverse drug reactions	2G86QN327L	NA
Withdrawn	Gemfibrozil	NA	NA	NA	Anticholesterol	Activates peroxisome proliferator- activated receptor-alpha (PPARα)	Dyslipidemia	NA	1982	NA	NA	NA	NA	NA	1982	1987	NA	Norway	Negative benefit-to-harm balance	NA	Withdrawn because of adverse drug reactions	Q8X02027X3	CC1=CC=C(C)C(OCCCC(C)(C)C(O)=O)=C1
Withdrawn	Gemtuzumab ozogamicin	NA	NA	NA	Monoclonal antibody	Binds to the CD33 antigen	Leukemia	NA	2000	NA	NA	NA	NA	NA	2010	2010	NA	US	Accelerated deaths	NA	Withdrawn because of adverse drug reactions	8GZG754X6M	NA
Withdrawn	Genaconazole	NA	NA	NA	Antimicrobial	Interferes with the fungal synthesis of ergosterol	Fungal infection	NA	1970	NA	NA	NA	NA	NA	1992	1992	NA	US	Hepatocellular cancer	NA	Withdrawn because of adverse drug reactions	1BFZ5CM687	C[C@H]([C@](O)(CN1C=NC=N1)C2=CC=C(F)C=C2F)S(C)(=O)=O
Withdrawn	Gentamicin	NA	NA	topical	Antimicrobial	Interruption of protein synthesis	Bacterial infection	NA	1966	NA	NA	NA	NA	NA	1976	1994	NA	Netherlands|UAE	Resistance	NA	Withdrawn because of adverse drug reactions	T6Z9V48IKG	NA
Withdrawn	Glafenine	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1965	NA	NA	NA	NA	NA	1973	1984	NA	Worldwide	Urinary tract	NA	Withdrawn because of adverse drug reactions	46HL4I09AH	OCC(O)COC(=O)C1=CC=CC=C1NC2=C3C=CC(Cl)=CC3=NC=C2
Withdrawn	Glucosamine sulphate	NA	NA	injection	Antiarthritic	Precursor in biochemical synthesis of glycosylated proteins and lipids	Rheumatism	NA	1980	NA	NA	NA	NA	NA	1981	1986	NA	Germany|Egypt	Immune: hypersensitivity	NA	Withdrawn because of adverse drug reactions	1FW7WLR731	OS(O)(=O)=O.N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO.N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO
Withdrawn	Glutethimide	NA	NA	NA	Sedative-hypnotic	Similar to barbiturates	Hypnosedation	NA	1955	NA	NA	NA	NA	NA	1962	1980	NA	Norway|Zimbabwe|Pakistan|France	Drug abuse|Drug dependence|Sensory systems	NA	Withdrawn because of adverse drug reactions	C8I4BVN78E	CCC1(CCC(=O)NC1=O)C2=CC=CC=C2
Withdrawn	Glycosaminoglycan	NA	NA	NA	Antiarthritic	Unknown	Rheumatism	NA	1975	NA	NA	NA	NA	NA	1982	1982	NA	Germany	Hematologic	NA	Withdrawn because of adverse drug reactions	268AW7000T	NA
Withdrawn	Grepafloxacin	NA	NA	NA	Antimicrobial	Inhibition of DNA gyrase	Bacterial infection	NA	1997	NA	NA	NA	NA	NA	1999	1999	NA	Worldwide	Cardiovascular	NA	Withdrawn because of adverse drug reactions	L1M1U2HC31	CC1CN(CCN1)C2=CC3=C(C(=O)C(=CN3C4CC4)C(O)=O)C(C)=C2F
Withdrawn	Guanethidine	NA	NA	NA	Antihypertensive	Sympathetic antagonist	Hypertension	NA	1973	NA	NA	NA	NA	NA	1978	1986	NA	UK	Sensory systems	NA	Withdrawn because of adverse drug reactions	ZTI6C33Q2Q	NC(=N)NCCN1CCCCCCC1
Withdrawn	Furaguanidin	NA	NA	NA	Antimicrobial	Disruption of bacterial DNA	Bacterial infection	NA	1966	NA	NA	NA	NA	NA	NA	1977	NA	Japan|Venezuela	Safer alternatives	NA	Withdrawn because of adverse drug reactions	1LBX3ODF5I	NC(=N)N\N=C\C1=CC=C(O1)[N+]([O-])=O
Withdrawn	HA-1A	NA	Centoxin	NA	Monoclonal antibody	Endotoxin lipopolysaccharide	Sepsis	NA	1991	NA	NA	NA	NA	NA	1991	1993	NA	US	Death	NA	Withdrawn because of adverse drug reactions	908FWN27WK	NA
Withdrawn	Halogenated hydroxyquinoline derivatives	NA	NA	NA	Antimicrobial	Production of free radicals	Amoebic dysentery	NA	1949	NA	NA	NA	NA	NA	1971	1978	NA	Denmark|Cyprus|Philippines|Bangladesh|Ghana|Turkey|Italy|Greece|Oman|UAE|India	Nervous	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Halogenated salicylanilides	NA	NA	NA	Antimicrobial	Production of free radicals	Bacterial infection	NA	1954	NA	NA	NA	NA	NA	1964	1975	NA	US|Japan	Skin|Eyes	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Heptabarb	NA	NA	NA	Sedative-hypnotic	GABA-A receptor modulation	Convulsion	NA	1956	NA	NA	NA	NA	NA	1984	1984	NA	Sweden	Drug abuse	NA	Withdrawn because of adverse drug reactions	V10R70ML23	CCC1(C(=O)NC(=O)NC1=O)C2=CCCCCC2
Withdrawn	Herpes simplex vaccines	NA	NA	NA	Vaccines	Herpes simplex antibodies	Viral infection (HSV)	NA	1964	NA	NA	NA	NA	NA	NA	1984	NA	Germany|Saudi Arabia|Venezuela	Potential hazards	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Hexachlorophene	NA	NA	NA	Antimicrobial	Production of free radicals	Bacterial infection	NA	1948	NA	NA	NA	NA	NA	1968	1972	NA	Germany|Japan|Turkey|Europe|USSR|Peru	Encephalopathy|Mutagenicity|Teratogenicity	NA	Withdrawn because of adverse drug reactions	IWW5FV6NK2	OC1=C(CC2=C(O)C(Cl)=CC(Cl)=C2Cl)C(Cl)=C(Cl)C=C1Cl
Withdrawn	Hexestrol	NA	NA	NA	Chemotherapeutic agent	Nonsteroidal estrogen	Prostate CA	NA	1946	NA	NA	NA	NA	NA	1977	1977	NA	Austria|Italy|Kuwait|Armenia|Saudi Arabia|Venezuela	Carcinogenic	NA	Withdrawn because of adverse drug reactions	10BI795R7D	CC[C@@H]([C@@H](CC)C1=CC=C(O)C=C1)C2=CC=C(O)C=C2
Withdrawn	Diethylaminoethoxyhexestrol	NA	beta- diethylaminoethyl ether	NA	Vasodilator	Coronary vasodilatation	Hypertension	NA	1952	NA	NA	NA	NA	NA	1963	1969	NA	Japan	Hepatotoxicity	NA	Withdrawn because of adverse drug reactions	UBR09A3IFF	CCC(C(CC)C1=CC=C(OCCN(CC)CC)C=C1)C2=CC=C(OCCN(CC)CC)C=C2
Withdrawn	Hexobarbital	NA	NA	NA	Sedative-hypnotic	GABA-A receptor modulation	Convulsion	NA	1945	NA	NA	NA	NA	NA	1962	1984	NA	Sweden	Drug abuse	NA	Withdrawn because of adverse drug reactions	AL8Z8K3P6S	CN1C(=O)NC(=O)C(C)(C1=O)C2=CCCCC2
Withdrawn	Human placental extract	NA	NA	NA	Placenta derived tissue	Unknown	Arthritis|Eczema|Acne vulgaris	NA	1956	NA	NA	NA	NA	NA	1988	1994	NA	Germany|UK|India	Neurotoxicity; Immune; skin	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Hydrochlorothiazide + sotalol	NA	NA	NA	Antihypertensive	Diuresis plus beta receptor antagonist	Hypertension	NA	1970	NA	NA	NA	NA	NA	1979	1986	NA	France	Cardiovascular|Drug interactions	NA	Withdrawn because of adverse drug reactions	0J48LPH2TH|A6D97U294I	NA
Withdrawn	Hydromorphone	NA	NA	NA	Analgesic	Opioid receptor agonist	Analgesia	NA	1926	NA	NA	NA	NA	NA	1985	2005	NA	US|Switzerland	Overdose potential	NA	Withdrawn because of adverse drug reactions	Q812464R06	CN1CC[C@]23[C@H]4OC5=C(O)C=CC(C[C@@H]1[C@@H]2CCC4=O)=C35
Withdrawn	Hyoscine methonitrate	NA	NA	NA	Antispasmodic	Muscarinic receptor antagonist	GI spasms	NA	1947	NA	NA	NA	NA	NA	1964	1981	NA	Sweden	Drug abuse	NA	Withdrawn because of adverse drug reactions	K0813KQM3V	[O-][N+]([O-])=O.C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]3O[C@@H]23)OC(=O)[C@H](CO)C4=CC=CC=C4
Withdrawn	Ibufenac	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1961	NA	NA	NA	NA	NA	1964	1968	NA	UK	Liver	NA	Withdrawn because of adverse drug reactions	5V4WIX44VI	CC(C)CC1=CC=C(CC(O)=O)C=C1
Withdrawn	Indalpine	NA	NA	NA	Antidepressant	SSRI	Depression	NA	1983	NA	NA	NA	NA	NA	1985	1985	NA	France	Gastrointestinal|Hematologic	NA	Withdrawn because of adverse drug reactions	V35562QSVT	C(CC1=CNC2=C1C=CC=C2)C3CCNCC3
Withdrawn	Indometacin	NA	Osmosin	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1963	NA	NA	NA	NA	NA	1978	1983	NA	UK	Gastrointestinal; deaths	NA	Withdrawn because of adverse drug reactions	XXE1CET956	COC1=CC2=C(C=C1)N(C(=O)C3=CC=C(Cl)C=C3)C(C)=C2CC(O)=O
Withdrawn	Indoprofen	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1976	NA	NA	NA	NA	NA	1982	1983	NA	Worldwide	Carcinogenic	NA	Withdrawn because of adverse drug reactions	CPE46ZU14N	CC(C(O)=O)C1=CC=C(C=C1)N2CC3=C(C=CC=C3)C2=O
Withdrawn	Indoramin	NA	NA	NA	Vasodilator	Alpha-1 adrenoceptor antagonist	BPH|Hypertension	NA	1981	NA	NA	NA	NA	NA	1986	2011	NA	UK	Cardiovascular	NA	Withdrawn because of adverse drug reactions	0Z802HMY7H	O=C(NC1CCN(CCC2=CNC3=C2C=CC=C3)CC1)C4=CC=CC=C4
Withdrawn	Influenza virus, split, inactivated	NA	pandremix	NA	Vaccines	Antibody production	Viral infection (influenza)	NA	2006	NA	NA	NA	NA	NA	2010	2010	NA	Europe	Narcolepsy	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Insulin, inhaled	NA	Exubera	NA	Hormones	Decreased gluconeogenesis	Diabetes	NA	2006	NA	NA	NA	NA	NA	2008	2008	NA	US|Europe	Lung cancer	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Interferon-gamma-1b	NA	NA	NA	Immunomodulator	Binds directly to the type II interferon gamma receptor IFNGR1	Idiopathic pulmonary fibrosis	NA	2002	NA	NA	NA	NA	NA	2007	2007	NA	US	Accelerated deaths	NA	Withdrawn because of adverse drug reactions	21K6M2I7AG	NA
Withdrawn	Iodinated casein	NA	NA	NA	Hormones	Thyroxine analogue	Obesity	NA	1944	NA	NA	NA	NA	NA	1964	1964	NA	US	Endocrine|Metabolism	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Iophendylate	NA	NA	NA	Radiography	Unknown	Radiocontrast imaging	NA	1946	NA	NA	NA	NA	NA	1976	1987	NA	UK	Nervous system	NA	Withdrawn because of adverse drug reactions	2990I809YH	NA
Withdrawn	Iproniazid	NA	NA	NA	Antidepressant	MAOI	Depression	NA	1952	NA	NA	NA	NA	NA	1958	1959	NA	Italy|Canada	Immunologic|Liver	NA	Withdrawn because of adverse drug reactions	D892HFI3XA	CC(C)NNC(=O)C1=CC=NC=C1
Withdrawn	Isaxonine phosphate	NA	NA	NA	Neurotrophic	Muscle reinnervation	Peripheral neuropathies	NA	1981	NA	NA	NA	NA	NA	1983	1984	NA	France|Tunisia	Hematologic|Liver	NA	Withdrawn because of adverse drug reactions	S52Q6EHI7F	OP(O)(O)=O.CC(C)NC1=NC=CC=N1
Withdrawn	Isocarboxazid	NA	NA	NA	Antidepressant	MAOI	Depression	NA	1959	NA	NA	NA	NA	NA	1966	1974	NA	Japan|Cuba|Venezuela	Metabolic	NA	Withdrawn because of adverse drug reactions	34237V843T|80CZF4GX8N	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2
Withdrawn	Isoprenaline	NA	NA	NA	Cardiac stimulant	Non-selective beta-adrenergic agonist	Bradycardia & heart block|Asthma	NA	1949	NA	NA	NA	NA	NA	1968	1992	NA	Sri Lanka|UK|Australia|New Zealand	Cardiovascular	NA	Withdrawn because of adverse drug reactions	L628TT009W	CC(C)NCC(O)C1=CC(O)=C(O)C=C1
Withdrawn	Isotretinoin	NA	NA	NA	Retinoid	Unknown; apoptosis	Cystic acne	NA	1982	NA	NA	NA	NA	NA	1983	1988	NA	Denmark|Austria|Germany|Portugal|Norway	Teratogenicity	NA	Withdrawn because of adverse drug reactions	EH28UP18IF	CC(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(C)=C\C(O)=O
Withdrawn	Isoxicam	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1983	NA	NA	NA	NA	NA	1985	1985	NA	Worldwide	Skin	NA	Withdrawn because of adverse drug reactions	8XU734C4NG	CN1C(C(=O)NC2=NOC(C)=C2)=C(O)C3=CC=CC=C3S1(=O)=O
Withdrawn	Kaolin	NA	NA	NA	Antidiarrheal	Unknown	Diarrhea	NA	1954	NA	NA	NA	NA	NA	1968	1991	NA	India|Sri Lanka	Metabolism	NA	Withdrawn because of adverse drug reactions	24H4NWX5CO	O.O.[Al+3].[Al+3].[O-][Si]([O-])([O-])O[Si]([O-])([O-])[O-]
Withdrawn	Ketoconazole	NA	NA	NA	Antimicrobial	Inhibits the cytochrome P450 14α- demethylase	Fungal infection	NA	1976	NA	NA	NA	NA	NA	1981	2013	NA	EU|Australia	Hepatotoxicity	NA	Withdrawn because of adverse drug reactions	R9400W927I	CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=CC=C(Cl)C=C5Cl)C=C2
Withdrawn	Ketoprofen	NA	NA	gel	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1980	NA	NA	NA	NA	NA	1983	2008	NA	Egypt|France	Immunologic	NA	Withdrawn because of adverse drug reactions	90Y4QC304K	CC(C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
Withdrawn	Ketorolac	NA	NA	inj	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1989	NA	NA	NA	NA	NA	1992	1992	NA	Germany|France|Jamaica	Gastrointestinal|Skin	NA	Withdrawn because of adverse drug reactions	YZI5105V0L	OC(=O)C1CCN2C1=CC=C2C(=O)C3=CC=CC=C3
Withdrawn	Lapdap	NA	chlorproguanil + dapsone	NA	Antimalarial	Inhibits dihydrofolate reductase	Malaria	NA	2003	NA	NA	NA	NA	NA	2008	2008	NA	Worldwide	Hemolytic anemia	NA	Withdrawn because of adverse drug reactions	8O3249M729|8W5C518302	NA
Withdrawn	Laropiprant	NA	NA	NA	Antilipemic	Prostaglandin receptor blocker	Facial flushing	NA	2008	NA	NA	NA	NA	NA	2008	2008	NA	Worldwide	Higher frequency of non-fatal but serious side effects	NA	Withdrawn because of adverse drug reactions	G7N11T8O78	CS(=O)(=O)C1=CC(F)=CC2=C1N(CC3=CC=C(Cl)C=C3)C4=C2CC[C@@H]4CC(O)=O
Withdrawn	Lead oxide and lead salts	NA	NA	topical	Astrigent	Unknown	Skin tightening	NA	1892	NA	NA	NA	NA	NA	1977	1980	NA	France|Denmark|Saudi Arabia|Venezuela	Nervous (encephalopathy)	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Levacetylmethadol	NA	NA	NA	Antidote	mu-opioid receptor agonist, nicotinic acetylcholine receptor antagonist	Opioid dependence	NA	1995	NA	NA	NA	NA	NA	2001	2001	NA	Europe|US	Cardiovascular	NA	Withdrawn because of adverse drug reactions	R3B637Y991	CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
Withdrawn	Levamfetamine	NA	NA	NA	Psychostimulant	Amphetamine analogue	Obesity	NA	1944	NA	NA	NA	NA	NA	1954	1973	NA	US|Oman|UAE	Drug abuse and dependence	NA	Withdrawn because of adverse drug reactions	R87US8P740	C[C@@H](N)CC1=CC=CC=C1
Withdrawn	Levamisole	NA	NA	NA	Antihelminth	Neuromuscular depolarizing blockade	Worm infestation	NA	1966	NA	NA	NA	NA	NA	1976	1999	NA	US|Canada|Vietnam	Hematologic|Nervous system	NA	Withdrawn because of adverse drug reactions	2880D3468G	C1CN2C[C@@H](N=C2S1)C3=CC=CC=C3
Withdrawn	Norepinephrine	NA	NA	NA	Vasopressor	L-norepinephrine analogue	Nonhemorrhagic shock	NA	1904	NA	NA	NA	NA	NA	1958	1973	NA	Ireland|Venezuela	Nervous|Cardiovascular	NA	Withdrawn because of adverse drug reactions	X4W3ENH1CV	NC[C@H](O)C1=CC(O)=C(O)C=C1
Withdrawn	Lindane	NA	NA	NA	Insecticide	CNS stimulation	Head lice	NA	1942	NA	NA	NA	NA	NA	1972	2001	NA	Brazil	Toxicity	NA	Withdrawn because of adverse drug reactions	59NEE7PCAB	Cl[C@H]1[C@H](Cl)[C@H](Cl)[C@@H](Cl)[C@H](Cl)[C@@H]1Cl
Withdrawn	Letrozole	NA	NA	NA	Hormone antagonist	Non-steroidal aromatase inhibitor	Hormonally-responsive breast cancer	NA	2001	NA	NA	NA	NA	NA	2005	2011	NA	India	Teratogenic	NA	Withdrawn because of adverse drug reactions	7LKK855W8I	N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
Withdrawn	Loperamide	NA	NA	syrup & drops	Antidiarrheal	Opioid receptor agonist	Diarrhea	NA	1975	NA	NA	NA	NA	NA	1990	1990	NA	Worldwide	Paralytic ileus	NA	Withdrawn because of adverse drug reactions	6X9OC3H4II	CN(C)C(=O)C(CCN1CCC(O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4
Withdrawn	Loxoprofen sodium	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1983	NA	NA	NA	NA	NA	1993	2000	NA	Singapore	Colonic ulceration	NA	Withdrawn because of adverse drug reactions	NDC2M7399S	[Na+].CC(C([O-])=O)C1=CC=C(CC2CCCC2=O)C=C1
Withdrawn	L-Tryptophan	NA	NA	NA	Antidepressant	Converted into serotonin	Depression and sleep disorders	NA	1963	NA	NA	NA	NA	NA	1989	1989	NA	Worldwide	Eosinophilia-myalgia syndrome (EMS)	NA	Withdrawn because of adverse drug reactions	8DUH1N11BX	N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O
Withdrawn	Lumiracoxib	NA	NA	NA	Analgesic	COX-2 inhibitor	Analgesia	NA	2006	NA	NA	NA	NA	NA	2007	2007	NA	Australia|US|Canada|Europe|New Zealand|Brazil|Philippines|Colombia	Liver	NA	Withdrawn because of adverse drug reactions	V91T9204HU	CC1=CC=C(NC2=C(F)C=CC=C2Cl)C(CC(O)=O)=C1
Withdrawn	Lyme disease vaccine	NA	NA	NA	Vaccines	Immunogenicity	Bacterial infection (Lyme disease)	NA	1998	NA	NA	NA	NA	NA	2001	2002	NA	US	Musculoskeletal (arthralgia)	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Lynestrenol	NA	NA	NA	Hormones	Inhibits gonadotropin, suppression of follicle maturation	Contraception	NA	1962	NA	NA	NA	NA	NA	1970	1980	NA	Australia	Tumorigenicity	NA	Withdrawn because of adverse drug reactions	N2Z8ALG4U5	C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
Withdrawn	Lysine amidotriazoate	NA	NA	NA	Radiography	Unknown	Vascular diagnostics	NA	1975	NA	NA	NA	NA	NA	1981	1995	NA	Germany	Cardiovascular|Hematologic|Immunologic|Urinary tract (safer alternatives)	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Mazindol	NA	NA	NA	Psychostimulant	Norepinephrine & dopamine reuptake inhibitor	Obesity	NA	1970	NA	NA	NA	NA	NA	1980	1987	NA	Oman	Drug abuse|Psychiatric (interaction with lithium)	NA	Withdrawn because of adverse drug reactions	C56709M5NH	OC1(N2CCN=C2C3=C1C=CC=C3)C4=CC=C(Cl)C=C4
Withdrawn	Mebanazine	NA	NA	NA	Antidepressant	MAOI	Depression	NA	1963	NA	NA	NA	NA	NA	1964	1975	NA	UK	Drug interactions|Liver	NA	Withdrawn because of adverse drug reactions	Z5R55CJ4CG	CC(NN)C1=CC=CC=C1
Withdrawn	Meclozine	NA	meclizine	NA	Antihistamine	H1 receptor antagonist	Motion sickness	NA	1953	NA	NA	NA	NA	NA	1963	1963	NA	Indonesia	Teratogenic potential	NA	Withdrawn because of adverse drug reactions	3L5TQ84570	CC1=CC(CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(Cl)C=C4)=CC=C1
Withdrawn	Medifoxamine	NA	NA	NA	Antidepressant	Dopamine reuptake inhibitor; 5HT- receptor agonist	Depression	NA	1983	NA	NA	NA	NA	NA	1991	1999	NA	Morocco|France	Liver	NA	Withdrawn because of adverse drug reactions	KWU7C2A1NT	CN(C)CC(OC1=CC=CC=C1)OC2=CC=CC=C2
Withdrawn	Mefenorex	NA	NA	NA	Psychostimulant	Amphetamine analogue	Obesity	NA	1966	NA	NA	NA	NA	NA	1995	1999	NA	Europe	Drug abuse|Psychiatric	NA	Withdrawn because of adverse drug reactions	K98M4N387W	CC(CC1=CC=CC=C1)NCCCCl
Withdrawn	Megestrol acetate	NA	NA	NA	Hormones	Progesterone receptor agonist	Contraception	NA	1963	NA	NA	NA	NA	NA	1975	1976	NA	Greece|Norway|Germany|New Zealand	Tumorigenicity	NA	Withdrawn because of adverse drug reactions	TJ2M0FR8ES	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O
Withdrawn	Mepacrine	NA	quinacrine	NA	Antimicrobial	Unclear	Non-surgical sterilization	NA	1935	NA	NA	NA	NA	NA	1953	1998	NA	India	Carcinogenicity; ectopic pregnancy; possibly political	NA	Withdrawn because of adverse drug reactions	H0C805XYDE	CCN(CC)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC3=CC=C(OC)C=C13
Withdrawn	Mepazine	NA	NA	NA	Antiepileptic	Unclear	Epilepsy	NA	1955	NA	NA	NA	NA	NA	1957	1970	NA	US	Cardiovascular|Gastrointestinal|Hematologic|Liver|Urinary tract	NA	Withdrawn because of adverse drug reactions	PH34873A38	CN1CCCC(CN2C3=CC=CC=C3SC4=CC=CC=C24)C1
Withdrawn	Mephenesin	NA	NA	NA	Muscle relaxant	Spinal reflex inhibition	Sedation|Muscle relaxation	NA	1948	NA	NA	NA	NA	NA	1955	1976	NA	Japan|Saudi Arabia	Cardiotoxicity	NA	Withdrawn because of adverse drug reactions	7B8PIR2954	CC1=CC=CC=C1OCC(O)CO
Withdrawn	Meprobamate	NA	NA	NA	Muscle relaxant	GABA-A receptor modulation	Anxiety	NA	1955	NA	NA	NA	NA	NA	1957	1981	NA	Sweden|Europe	Drug abuse	NA	Withdrawn because of adverse drug reactions	9I7LNY769Q	CCCC(C)(COC(N)=O)COC(N)=O
Withdrawn	Thimerosal	NA	thiomersal	NA	Antimicrobial	Organomercury analogue	Bacterial and fungal infections	NA	1928	NA	NA	NA	NA	NA	1996	1999	NA	UK|Malaysia|Brazil	Nervous system|Tumorigenicity|Urinary tract	NA	Withdrawn because of adverse drug reactions	2225PI3MOV	[Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O
Withdrawn	Mercury amide	NA	NA	NA	Antimicrobial	Organomercury analogue	Disinfectant	NA	1956	NA	NA	NA	NA	NA	1964	1969	NA	Japan|Brazil|Philippines|France|Nigeria|Ghana|Italy|Canada	Nervous system	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Mercurous chloride	NA	NA	NA	Antimicrobial	Organomercury analogue	Teething	NA	1796	NA	NA	NA	NA	NA	1949	1953	NA	Worldwide	Nervous system	NA	Withdrawn because of adverse drug reactions	J2D46N657D	[Cl-].[Cl-].[Hg+].[Hg+]
Withdrawn	Mesna	NA	NA	NA	Detoxifying agent	Antioxidation?	Antidote for chemotherapy	NA	1984	NA	NA	NA	NA	NA	1985	1991	NA	Germany	Anaphylaxis	NA	Withdrawn because of adverse drug reactions	NR7O1405Q9	[Na+].[O-]S(=O)(=O)CCS
Withdrawn	Metamfetamine	NA	desoxyephedrine	NA	Psychostimulant	TAAR1 receptor agonist	ADHD|Obesity	NA	1944	NA	NA	NA	NA	NA	1972	1973	NA	US|Turkey|Oman|Nigeria	Drug abuse|Drug dependence	NA	Withdrawn because of adverse drug reactions	44RAL3456C	CN[C@@H](C)CC1=CC=CC=C1
Withdrawn	Metamizole	NA	dipyrone	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1921	NA	NA	NA	NA	NA	1952	1965	NA	9 European countries|11 Asian countries|and 5 African countries|Australia|US|Mexico|Canada	Hematologic|Immunologic (agranulocytosis)	NA	Withdrawn because of adverse drug reactions	934T64RMNJ	CN(CS(O)(=O)=O)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2
Withdrawn	Methapyrilene	NA	NA	NA	Sedative-hypnotic	Histamine and cholinergic receptors' antagonist	Insomnia	NA	1947	NA	NA	NA	NA	NA	1979	1979	NA	Germany|Dominican Republic|UK|Italy|Canada|Singapore|Hong Kong|Australia|Egypt|Panama|Brazil|Philippines|UAE|India|Oman|Chile|New Zealand|US|Venezuela	Tumorigenicity	NA	Withdrawn because of adverse drug reactions	A01LX40298	CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2
Withdrawn	Methaqualone	NA	NA	NA	Sedative-hypnotic	GABA receptor agonist	Hypnosedation	NA	1965	NA	NA	NA	NA	NA	1966	1979	NA	Greece|Turkey|Oman|Zimbabwe|Pakistan|Ghana|UAE|India	Drug abuse	NA	Withdrawn because of adverse drug reactions	7ZKH8MQW6T	CC1=CC=CC=C1N2C(C)=NC3=C(C=CC=C3)C2=O
Withdrawn	Methiodal sodium	NA	NA	NA	Radiography	Unknown	Urinary tract diagnostics	NA	1964	NA	NA	NA	NA	NA	1972	1975	NA	Sweden	Muscle	NA	Withdrawn because of adverse drug reactions	3880P18UBM	[Na+].[O-]S(=O)(=O)CI
Withdrawn	Metandienone	NA	NA	NA	Hormones	Protein synthesis	Tonic	NA	1960	NA	NA	NA	NA	NA	1982	1982	NA	US|France|UK|Germany	Endocrine (masculinization)	NA	Withdrawn because of adverse drug reactions	COZ1R7EOCC	C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
Withdrawn	Methylhexanamine	NA	DMAA	NA	Nasal decongestant	Norepinephrine & dopamine transporter blockade	Nasal decongestion	NA	1948	NA	NA	NA	NA	NA	1950	1983	NA	Worldwide	Cardiovascular|Nervous	NA	Withdrawn because of adverse drug reactions	X49C572YQO	CCC(C)CC(C)N
Withdrawn	Methylphenidate	NA	NA	NA	Psychostimulant	Dopamine-norepinephrine reuptake inhibitor	ADHD	NA	1956	NA	NA	NA	NA	NA	1961	1982	NA	Turkey|Oman|Nigeria	Drug abuse	NA	Withdrawn because of adverse drug reactions	207ZZ9QZ49	COC(=O)[C@H]([C@@H]1CCCCN1)C2=CC=CC=C2
Withdrawn	Methylrosanilinium chloride	NA	NA	NA	Antimicrobial	Unknown	Bacterial & fungal infections	NA	1890	NA	NA	NA	NA	NA	1970	1998	NA	Malaysia	Immunologic	NA	Withdrawn because of adverse drug reactions	J4Z741D6O5	[Cl-].CN(C)C1=CC=C(C=C1)C(C2=CC=C(C=C2)N(C)C)=C3C=CC(C=C3)=[N+](C)C
Withdrawn	Methyprylon	NA	NA	NA	Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation	NA	1955	NA	NA	NA	NA	NA	1961	1984	NA	Zimbabwe	Drug abuse	NA	Withdrawn because of adverse drug reactions	CUT48I42ON	CCC1(CC)C(=O)NCC(C)C1=O
Withdrawn	Metipranolol	NA	NA	NA	Antihypertensive	Non-selective beta blocker	Hypertension	NA	1986	NA	NA	NA	NA	NA	1991	1991	NA	UK	Sensory systems (uveitis)	NA	Withdrawn because of adverse drug reactions	X39AL81KEB	CC(C)NCC(O)COC1=CC(C)=C(OC(C)=O)C(C)=C1C
Withdrawn	Metofoline	NA	NA	NA	Analgesic	Opioid receptor agonist	Analgesia	NA	1962	NA	NA	NA	NA	NA	1965	1965	NA	US	Sensory systems	NA	Withdrawn because of adverse drug reactions	72L4ZT2W1P	COC1=C(OC)C=C2C(CCC3=CC=C(Cl)C=C3)N(C)CCC2=C1
Withdrawn	Metrizamide	NA	NA	NA	Radiography	Unknown	Contrast medium	NA	1977	NA	NA	NA	NA	NA	1980	1992	NA	UK|Netherlands	Nervous system|Sensory systems	NA	Withdrawn because of adverse drug reactions	RHH3W8F1CO	CN(C(C)=O)C1=C(I)C(C(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO)=C(I)C(NC(C)=O)=C1I
Withdrawn	Urofollitropin	NA	NA	NA	Hormones	GnRH agonist	Invitro fertilization (IVF)	NA	1993	NA	NA	NA	NA	NA	2003	2003	NA	UK	Nervous system	NA	Withdrawn because of adverse drug reactions	W9BB98U6HP	NA
Withdrawn	Mianserin	NA	NA	NA	Antidepressant	Norepinephrine & serotonin reuptake inhibitor	Depression	NA	1975	NA	NA	NA	NA	NA	1979	1988	NA	Oman	Hematologic (agranulocytosis)	NA	Withdrawn because of adverse drug reactions	250PJI13LM	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C24
Withdrawn	Mibefradil	NA	NA	NA	Antihypertensive	Calcium channel blockers	Hypertension	NA	1997	NA	NA	NA	NA	NA	1998	1998	NA	US|UK|Peru|South Africa|Jamaica|Bulgaria|Armenia	Drug interactions|Musculoskeletal	NA	Withdrawn because of adverse drug reactions	27B90X776A	COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
Withdrawn	Miglustat	NA	NA	NA	Enzyme inhibitor	Glucocerebrosidase	Gaucher’s disease type 1	NA	2002	NA	NA	NA	NA	NA	2002	2002	NA	Israel	Unexplained cognitive dysfunction	NA	Withdrawn because of adverse drug reactions	ADN3S497AZ	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
Withdrawn	Minaprine	NA	NA	NA	Antidepressant	Reversible inhibitor of MAO-A	Depression	NA	1972	NA	NA	NA	NA	NA	1983	1996	NA	France|Spain|Germany	Drug abuse|Nervous system	NA	Withdrawn because of adverse drug reactions	00U7GX0NLM	CC1=C(NCCN2CCOCC2)N=NC(=C1)C3=CC=CC=C3
Withdrawn	Minocycline	NA	NA	NA	Antimicrobial	Protein synthesis inhibitor	Bacterial infection	NA	1967	NA	NA	NA	NA	NA	1974	1989	NA	Norway	Dizziness|Vertigo	NA	Withdrawn because of adverse drug reactions	FYY3R43WGO	CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C(O)=CC=C4N(C)C)C(=O)C3=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O
Withdrawn	Molsidomine	NA	NA	NA	Antianginal	Nitric oxide synthesis	Angina pectoris	NA	1972	NA	NA	NA	NA	NA	1975	1985	NA	Germany	Tumorigenicity	NA	Withdrawn because of adverse drug reactions	D46583G77X	CCOC(=O)[N-]C1=C[N+](=NO1)N2CCOCC2
Withdrawn	Moxisylyte	NA	thymoxamine; uroalpha	NA	Antianginal	Alpha1-adrenergic antagonist	Benign prostatic hyperplasia	NA	1989	NA	NA	NA	NA	NA	1991	1993	NA	France	Liver	NA	Withdrawn because of adverse drug reactions	PW8QYA7KI0	CC(C)C1=C(OCCN(C)C)C=C(C)C(OC(C)=O)=C1
Withdrawn	Mucopolysaccharide polysulfuric acid ester	NA	NA	NA	Antiarthritic	Endogenous hyaluronate synthesis	Rheumatism	NA	1962	NA	NA	NA	NA	NA	1987	1988	NA	Switzerland|France|Portugal|Austria	Skin: histochemical study	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	MMR vaccine	NA	Urabe	NA	Vaccines	Antibody production	Mumps virus	NA	1983	NA	NA	NA	NA	NA	1987	1988	NA	Worldwide	Nervous system|Psychiatric	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Muzolimine	NA	NA	NA	Antihypertensive	Diuresis	Hypertension	NA	1983	NA	NA	NA	NA	NA	1987	1987	NA	Worldwide	Nervous system	NA	Withdrawn because of adverse drug reactions	07Z36289ZX	CC(N1N=C(N)CC1=O)C2=CC=C(Cl)C(Cl)=C2
Withdrawn	Naftidrofuryl oxalate	NA	NA	IV	Vasodilator	5HT2 receptor antagonist	Intermittent claudication	NA	1974	NA	NA	NA	NA	NA	1976	1992	NA	France|Germany|Spain	Cardiovascular|Immunologic|Liver|Urinary tract	NA	Withdrawn because of adverse drug reactions	5ADB8D9388	OC(=O)C(O)=O.CCN(CC)CCOC(=O)C(CC1CCCO1)CC2=C3C=CC=CC3=CC=C2
Withdrawn	Nandrolone decanoate	NA	NA	injectable	Hormones	Stimulate anabolism & inhibit catabolism	Hypogonadism	NA	1962	NA	NA	NA	NA	NA	1989	1997	NA	France|Bangladesh	Drug abuse	NA	Withdrawn because of adverse drug reactions	H45187T098	CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C
Withdrawn	Nandrolone phenylpropionate	NA	NA	injectable	Hormones	Stimulate anabolism & inhibit catabolism	Hypogonadism	NA	1959	NA	NA	NA	NA	NA	1972	1982	NA	Bangladesh	Drug abuse	NA	Withdrawn because of adverse drug reactions	KF7Z9K2T3W	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2OC(=O)CCC5=CC=CC=C5
Withdrawn	Natalizumab	NA	NA	NA	Monoclonal antibody	Inhibits α4 integrin	Multiple sclerosis & Crohn's disease	NA	2004	NA	NA	NA	NA	NA	2005	2005	NA	US	Nervous (combination)	NA	Withdrawn because of adverse drug reactions	3JB47N2Q2P	NA
Withdrawn	Nebacumab	NA	NA	NA	Monoclonal antibody	Endotoxin-specific IgM	Sepsis	NA	1991	NA	NA	NA	NA	NA	1993	1993	NA	Worldwide	Infection risk; accelerated deaths	NA	Withdrawn because of adverse drug reactions	908FWN27WK	NA
Withdrawn	Nefazodone	NA	NA	NA	Antidepressant	5HT2 receptor antagonist	Depression	NA	1994	NA	NA	NA	NA	NA	1999	2003	NA	European Union|Canada|Singapore	Hepatotoxicity	NA	Withdrawn because of adverse drug reactions	59H4FCV1TF	CCC1=NN(CCCN2CCN(CC2)C3=CC=CC(Cl)=C3)C(=O)N1CCOC4=CC=CC=C4
Withdrawn	Neomycin sulfate	NA	NA	inj	Antimicrobial	Protein synthesis inhibitor	Bacterial infection	NA	1949	NA	NA	NA	NA	NA	1967	1983	NA	Bangladesh|Philippines|Nigeria|US|Canada	Drug abuse|Sensory systems|Urinary tract	NA	Withdrawn because of adverse drug reactions	057Y626693	NA
Withdrawn	Nevirapine	NA	NA	NA	Antimicrobial	Non-nucleoside reverse transcriptase inhibitor (NNRTI)	HIV	NA	1996	NA	NA	NA	NA	NA	1997	2007	NA	Brazil	Liver	NA	Withdrawn because of adverse drug reactions	99DK7FVK1H	CC1=C2NC(=O)C3=CC=CN=C3N(C4CC4)C2=NC=C1
Withdrawn	Nialamide	NA	NA	NA	Antidepressant	MAOI	Depression	NA	1959	NA	NA	NA	NA	NA	1969	1974	NA	Japan|India|Cuba|Denmark|Thailand|Venezuela|Canada	Drug interactions|Liver	NA	Withdrawn because of adverse drug reactions	T2Q0RYM725	O=C(CCNNC(=O)C1=CC=NC=C1)NCC2=CC=CC=C2
Withdrawn	Nifedipine	NA	NA	10mg	Antihypertensive	Calcium channel blockers	Hypertension	NA	1975	NA	NA	NA	NA	NA	1989	1996	NA	Australia	Cardiovascular	NA	Withdrawn because of adverse drug reactions	I9ZF7L6G2L	COC(=O)C1=C(C)NC(C)=C(C1C2=CC=CC=C2[N+]([O-])=O)C(=O)OC
Withdrawn	Nifuroxazide	NA	nifuroxazine	NA	Antimicrobial	Janus kinase inhibitor	Diarrhea and colitis	NA	1966	NA	NA	NA	NA	NA	1997	2008	NA	Belgium	Immunologic|Hematologic	NA	Withdrawn because of adverse drug reactions	PM5LI0P38J	OC1=CC=C(C=C1)C(=O)N\N=C\C2=CC=C(O2)[N+]([O-])=O
Withdrawn	Nikethamide	NA	NA	NA	Respiratory stimulant	Unclear	Tranquilizer overdose	NA	1922	NA	NA	NA	NA	NA	1953	1988	NA	Worldwide	Nervous system	NA	Withdrawn because of adverse drug reactions	368IVD6M32	CCN(CC)C(=O)C1=CC=CN=C1
Withdrawn	Nimesulide	NA	NA	NA	Analgesic	COX-2 inhibitor	Analgesia	NA	1986	NA	NA	NA	NA	NA	1998	1999	NA	Portugal|Israel|Spain|Bangladesh|Nigeria|India|Ireland|Ghana|Thailand|Vietnam	Liver	NA	Withdrawn because of adverse drug reactions	V4TKW1454M	CS(=O)(=O)NC1=CC=C(C=C1OC2=CC=CC=C2)[N+]([O-])=O
Withdrawn	Niperotidine	NA	NA	NA	Anti-ulcer	H2 receptor antagonist	Peptic ulcer	NA	1990	NA	NA	NA	NA	NA	1995	1995	NA	Italy	Hepatotoxicity	NA	Withdrawn because of adverse drug reactions	12JBD7U72K	CN(C)CC1=CC=C(CSCCNC(NCC2=CC=C3OCOC3=C2)=C[N+]([O-])=O)O1
Withdrawn	Nitrefazole	NA	NA	NA	Anti-addiction	Inhibition of aldehyde dehydrogenase	Alcohol deterrent	NA	1982	NA	NA	NA	NA	NA	1984	1984	NA	Germany|Austria	Liver	NA	Withdrawn because of adverse drug reactions	VFD629099M	CC1=NC(=CN1C2=CC=C(C=C2)[N+]([O-])=O)[N+]([O-])=O
Withdrawn	Nitrofurazone	NA	Nitrofural	NA	Antimicrobial	Unclear	Bacterial infection	NA	1946	NA	NA	NA	NA	NA	1974	1977	NA	Japan|US|Armenia	Mutagenicity	NA	Withdrawn because of adverse drug reactions	X8XI70B5Z6	NC(=O)N\N=C\C1=CC=C(O1)[N+]([O-])=O
Withdrawn	Nitroxoline	NA	NA	NA	Antimicrobial	↓ in the biofilm density of P. aeruginosa	UTI	NA	1965	NA	NA	NA	NA	NA	1966	1973	NA	Ireland|Thailand|Venezuela	Eyes	NA	Withdrawn because of adverse drug reactions	A8M33244M6	OC1=C2N=CC=CC2=C(C=C1)[N+]([O-])=O
Withdrawn	Nomifensine	NA	NA	NA	Antidepressant	Norepinephrine-dopamine reuptake inhibitor	Depression	NA	1976	NA	NA	NA	NA	NA	1980	1986	NA	Worldwide	Hematologic|Liver|Respiratory	NA	Withdrawn because of adverse drug reactions	1LGS5JRP31	CN1CC(C2=CC=CC=C2)C3=CC=CC(N)=C3C1
Withdrawn	Norpseudoephedrine	NA	Phenylpropanolamine	NA	Psychostimulant	Adrenoreceptor agonist, D1 receptor agonist	Nasal decongestion|Obesity	NA	1947	NA	NA	NA	NA	NA	1985	1987	NA	Germany|Brazil|Malaysia|Singapore|US|Oman|Canada|Cuba|India|Cameroun|Nigeria|Portugal|Temor- Leste|South Korea	Hemorrhagic stroke	NA	Withdrawn because of adverse drug reactions	27A0HLC3HH	C[C@H](N)[C@@H](O)C1=CC=CC=C1
Withdrawn	Noscapine	NA	NA	NA	Antitussive	σ–receptor agonist	Cough	NA	1959	NA	NA	NA	NA	NA	1984	1990	NA	Ireland|UK|Netherlands	Genotoxicity	NA	Withdrawn because of adverse drug reactions	8V32U4AOQU|A4C6WE7BZN	COC1=CC=C2[C@H](OC(=O)C2=C1OC)[C@@H]3N(C)CCC4=C3C(OC)=C5OCOC5=C4
Withdrawn	Novobiocin	NA	cathomycin	NA	Antimicrobial	Inhibitors of bacterial DNA gyrase	Staphylococcal infections	NA	1956	NA	NA	NA	NA	NA	1957	1987	NA	Malaysia	Hematologic	NA	Withdrawn because of adverse drug reactions	17EC19951N	CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=C(C)C3=C(C=C2)C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)O3)OC1(C)C
Withdrawn	Omeprazole	NA	NA	injectable	Anti-ulcer	Proton pump inhibitor	Peptic ulcer	NA	1989	NA	NA	NA	NA	NA	1994	1994	NA	Germany	Endocrine|Genotoxicity|Liver|Musculoskeletal|Nervous system|Sensory systems	NA	Withdrawn because of adverse drug reactions	KG60484QX9	COC1=CC2=C(NC(=N2)[S+]([O-])CC3=NC=C(C)C(OC)=C3C)C=C1
Withdrawn	Opium in antitussives	NA	NA	NA	Antitussive	Opioid receptor agonist	Recreation	NA	1812	NA	NA	NA	NA	NA	1842	1982	NA	Bangladesh|Italy	Drug dependence	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Orciprenaline	NA	metaprotenerol	NA	Bronchodilator	Beta2 adrenoceptor agonist	Asthma	NA	1961	NA	NA	NA	NA	NA	1972	2009	NA	UK	Cardiovascular	NA	Withdrawn because of adverse drug reactions	53QOG569E0	CC(C)NCC(O)C1=CC(O)=CC(O)=C1
Withdrawn	Orgotein	NA	NA	NA	Antiarthritic	Free radical scavenging	Osteoarthritis	NA	1968	NA	NA	NA	NA	NA	1987	1990	NA	Switzerland|Germany|Portugal	Immunologic	NA	Withdrawn because of adverse drug reactions	PKE82W49V1	NA
Withdrawn	Oxeladin	NA	NA	NA	Antitussive	Unclear	Cough	NA	1972	NA	NA	NA	NA	NA	1991	1994	NA	Germany|France|Armenia|Canada	Carcinogenic	NA	Withdrawn because of adverse drug reactions	SNC1080T5Y	CCN(CC)CCOCCOC(=O)C(CC)(CC)C1=CC=CC=C1
Withdrawn	Oxolamine	NA	NA	NA	Antitussive	Unclear	Cough	NA	1969	NA	NA	NA	NA	NA	1972	1984	NA	Netherlands	Nervous system: hallucination in children	NA	Withdrawn because of adverse drug reactions	90BEA145GY	CCN(CC)CCC1=NC(=NO1)C2=CC=CC=C2
Withdrawn	Oxomemazine	NA	NA	NA	Antitussive	Histamine and cholinergic receptors' antagonist	Cough	NA	1937	NA	NA	NA	NA	NA	1979	1991	NA	European Union|US	Respiratory depression in children (SIDS)	NA	Withdrawn because of adverse drug reactions	305MB38V1C	CC(CN(C)C)CN1C2=CC=CC=C2S(=O)(=O)C3=CC=CC=C13
Withdrawn	Oxyphenbutazone	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1955	NA	NA	NA	NA	NA	1974	1984	NA	Worldwide	Hematologic: Bone marrow suppression	NA	Withdrawn because of adverse drug reactions	H806S4B3NS	O.CCCCC1C(=O)N(N(C1=O)C2=CC=C(O)C=C2)C3=CC=CC=C3
Withdrawn	Oxyphenisatin	NA	NA	NA	Laxative	↑d mucosal tissue permeability	Constipation	NA	1925	NA	NA	NA	NA	NA	1970	1972	NA	Worldwide	Liver	NA	Withdrawn because of adverse drug reactions	3BT0VQG2GQ	OC1=CC=C(C=C1)C2(C(=O)NC3=C2C=CC=C3)C4=CC=C(O)C=C4
Withdrawn	Pangamic acid	NA	NA	NA	“Vitamin”	Transmethylation	Detoxification	NA	1949	NA	NA	NA	NA	NA	1980	1984	NA	Greece	Mutagenic	NA	Withdrawn because of adverse drug reactions	MPQ53A9F5C	CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O
Withdrawn	Paromomycin	NA	NA	NA	Antimicrobial	Protein synthesis inhibitor	Bacterial infection	NA	1959	NA	NA	NA	NA	NA	1970	1989	NA	Spain	Renal damage|Neuromuscular blockage and ototoxicity	NA	Withdrawn because of adverse drug reactions	61JJC8N5ZK	NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O
Withdrawn	Parecoxib	NA	NA	NA	Analgesic	COX-2 inhibitor	Analgesia	NA	2002	NA	NA	NA	NA	NA	2005	2005	NA	US|European Union	Cardiovascular|Respiratory	NA	Withdrawn because of adverse drug reactions	9TUW81Y3CE	CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(C)ON=C2C3=CC=CC=C3
Withdrawn	Pargyline	NA	NA	NA	Antihypertensive	Monoamine oxidase inhibitor	Hypertension	NA	1963	NA	NA	NA	NA	NA	1964	1979	NA	Germany	Interaction with tyramine	NA	Withdrawn because of adverse drug reactions	9MV14S8G3E	CN(CC#C)CC1=CC=CC=C1
Withdrawn	Pectin	NA	NA	NA	Antidiarrheal	↑d viscosity	Diarrhea	NA	1936	NA	NA	NA	NA	NA	1974	1991	NA	Libya|India|Sri Lanka	Metabolic	NA	Withdrawn because of adverse drug reactions	89NA02M4RX	NA
Withdrawn	Pemoline	NA	NA	NA	Psychostimulant	Dopamine agonist?	ADHD|Narcolepsy	NA	1960	NA	NA	NA	NA	NA	1973	2005	NA	Worldwide	Liver: hepatotoxicity	NA	Withdrawn because of adverse drug reactions	7GAQ2332NK	NC1=NC(=O)C(O1)C2=CC=CC=C2
Withdrawn	Pentobarbital	NA	NA	NA	Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation	NA	1930	NA	NA	NA	NA	NA	1953	1985	NA	Sweden	Drug overdose	NA	Withdrawn because of adverse drug reactions	I4744080IR	CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Withdrawn	Pentosan polysulfate sodium	NA	NA	NA	Anti-thrombotic	Protective coating to the damaged bladder wall?	Cystitis|Osteoarthritis	NA	1965	NA	NA	NA	NA	NA	1985	1994	NA	France|US	Hematologic: thrombocytopenia	NA	Withdrawn because of adverse drug reactions	914032762Y	NA
Withdrawn	Pentylenetetrazol	NA	NA	NA	Circulatory & respiratory stimulant	Unclear	Convulsion	NA	1934	NA	NA	NA	NA	NA	1954	1982	NA	US	Convulsion	NA	Withdrawn because of adverse drug reactions	WM5Z385K7T	C1CCN2N=NN=C2CC1
Withdrawn	Pergolide Mesylate	NA	NA	NA	Anti-parkinsonian	Dopamine receptor agonist	Parkinson's	NA	2002	NA	NA	NA	NA	NA	2002	2007	NA	US|Canada	Cardiovascular	NA	Withdrawn because of adverse drug reactions	55B9HQY616	CS(O)(=O)=O.CCCN1C[C@H](CSC)C[C@H]2[C@H]1CC3=CNC4=C3C2=CC=C4
Withdrawn	Perhexiline maleate	NA	NA	NA	Antianginal	Inhibits mitochondrial CPT1	Angina pectoris	NA	1974	NA	NA	NA	NA	NA	1974	1985	NA	UK|Spain|France	Hypoglycemia|Liver|Musculoskeletal|Nervous system	NA	Withdrawn because of adverse drug reactions	K7V8Y90G0H	OC(=O)\C=C/C(O)=O.C(C(C1CCCCC1)C2CCCCC2)C3CCCCN3
Withdrawn	Phenacetin	NA	NA	NA	Analgesic	Metabolized to paracetamol	Analgesia	NA	1887	NA	NA	NA	NA	NA	1948	1965	NA	16 European countries|14 Asian countries|5 African countries|4 S. American countries|New Zealand|US|Canada	Hematologic|Liver|Tumorigenicity|Urinary tract	NA	Withdrawn because of adverse drug reactions	ER0CTH01H9	CCOC1=CC=C(NC(C)=O)C=C1
Withdrawn	Phenazone	NA	antipyrine	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1883	NA	NA	NA	NA	NA	1958	1981	NA	UAE|Malaysia|Bahrain|Germany|Iraq	Hematologic	NA	Withdrawn because of adverse drug reactions	T3CHA1B51H	CN1N(C(=O)C=C1C)C2=CC=CC=C2
Withdrawn	Phenazopyridine	NA	NA	NA	Analgesic	Unclear	Urinary analgesia	NA	1927	NA	NA	NA	NA	NA	1978	1984	NA	Greece	Carcinogenic	NA	Withdrawn because of adverse drug reactions	K2J09EMJ52	NC1=NC(N)=C(C=C1)\N=N\C2=CC=CC=C2
Withdrawn	Phendimetrazine	NA	NA	NA	Psychostimulant	Norepinephrine-dopamine releasing agent	Obesity	NA	1961	NA	NA	NA	NA	NA	1979	1982	NA	Turkey	Drug abuse	NA	Withdrawn because of adverse drug reactions	AB2794W8KV|6985IP0T80	C[C@H]1[C@@H](OCCN1C)C2=CC=CC=C2
Withdrawn	Phenformin	NA	NA	NA	Hypoglycemic	↓d gluconeogenesis	Diabetes	NA	1957	NA	NA	NA	NA	NA	1963	1970	NA	15 European countries|6 Asian countries|Canada|New Zealand|Brazil|US|Ethiopia	Metabolic acidosis	NA	Withdrawn because of adverse drug reactions	DD5K7529CE	NC(=N)NC(=N)NCCC1=CC=CC=C1
Withdrawn	Phenicarbazide	NA	phenylsemicarbazide	NA	Analgesic	Unclear	Analgesia	NA	1948	NA	NA	NA	NA	NA	1950	1979	NA	Ireland	Serious adverse effects: hemolytic anemia	NA	Withdrawn because of adverse drug reactions	1LR2578324	NC(=O)NNC1=CC=CC=C1
Withdrawn	Phenmetrazine	NA	NA	NA	Psychostimulant	Norepinephrine-dopamine releasing agent	Obesity	NA	1956	NA	NA	NA	NA	NA	1959	1982	NA	Turkey|Oman|Nigeria	Drug abuse	NA	Withdrawn because of adverse drug reactions	XA501VL3VR	CC1NCCOC1C2=CC=CC=C2
Withdrawn	Phenobarbital	NA	NA	NA	Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation|Convulsion	NA	1912	NA	NA	NA	NA	NA	1929	1985	NA	Sweden|Mauritius|France	Abuse and intoxication; skin	NA	Withdrawn because of adverse drug reactions	YQE403BP4D|D2G5508Y7I	CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
Withdrawn	Phenol	NA	NA	topical	Antimicrobial	Absorption by bacteria	Bacterial infection	NA	1867	NA	NA	NA	NA	NA	1973	1983	NA	Dominican Republic|Lithuania	Safer alternatives	NA	Withdrawn because of adverse drug reactions	339NCG44TV	OC1=CC=CC=C1
Withdrawn	Phenolphthalein	NA	NA	NA	Laxative	Direct action on intestinal muscles	Constipation	NA	1902	NA	NA	NA	NA	NA	1953	1979	NA	Europe|Yemen|Bangladesh|Canada|France|Morocco|Oman|Japan|Saudi Arabia|Bahrain	Skin|Metabolic|Muscular	NA	Withdrawn because of adverse drug reactions	6QK969R2IF	OC1=CC=C(C=C1)C2(OC(=O)C3=CC=CC=C23)C4=CC=C(O)C=C4
Withdrawn	Phenoxypropazine	NA	NA	NA	Antidepressant	MAOI	Depression	NA	1961	NA	NA	NA	NA	NA	1964	1966	NA	UK	Drug interactions|Liver	NA	Withdrawn because of adverse drug reactions	8E92V52324	CC(COC1=CC=CC=C1)NN
Withdrawn	Phentermine	NA	NA	NA	Psychostimulant	TAAR1 agonist	Obesity	NA	1959	NA	NA	NA	NA	NA	1964	1981	NA	Sweden|UAE|Mauritius|Turkey|Oman|UK|Venezuela	Drug abuse	NA	Withdrawn because of adverse drug reactions	C045TQL4WP	CC(C)(N)CC1=CC=CC=C1
Withdrawn	Phentolamine mesilate	NA	NA	NA	Antihypertensive	Alpha-adrenergic antagonist	Erectile dysfunction	NA	1998	NA	NA	NA	NA	NA	1998	2000	NA	Singapore	Carcinogenicity	NA	Withdrawn because of adverse drug reactions	Y7543E5K9T	CS(O)(=O)=O.CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC=CC(O)=C3
Withdrawn	Phenylbutazone	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1949	NA	NA	NA	NA	NA	1953	1985	NA	6 European countries|6 Asian countries|3 African countries|Chile|Panama	Hematologic|Liver|Urinary tract	NA	Withdrawn because of adverse drug reactions	GN5P7K3T8S	CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
Withdrawn	Phenylephrine	NA	NA	NA	Decongestant	α1-adrenergic receptor agonist	Mydriasis	NA	1949	NA	NA	NA	NA	NA	1968	1987	NA	UK	Eyes	NA	Withdrawn because of adverse drug reactions	1WS297W6MV|RH8FKZ05H0	CNC[C@H](O)C1=CC=CC(O)=C1
Withdrawn	Phthalylsulfathiazole	NA	NA	NA	Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection	NA	1946	NA	NA	NA	NA	NA	1950	1982	NA	Bangladesh	Granulocytopenia	NA	Withdrawn because of adverse drug reactions	6875L5852V	OC(=O)C1=CC=CC=C1C(=O)NC2=CC=C(C=C2)S(=O)(=O)NC3=NC=CS3
Withdrawn	Pifoxime	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1975	NA	NA	NA	NA	NA	1975	1976	NA	France	Nervous system|Psychiatric	NA	Withdrawn because of adverse drug reactions	5947ECZ7WH	CC(=NO)C1=CC=C(OCC(=O)N2CCCCC2)C=C1
Withdrawn	Pioglitazone	NA	NA	NA	Hypoglycemic	PPARs activation	Diabetes	NA	1999	NA	NA	NA	NA	NA	2011	2011	NA	Europe	Risk of bladder CA	NA	Withdrawn because of adverse drug reactions	X4OV71U42S	CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1
Withdrawn	Pipamazine	NA	NA	NA	Emetic	Phenothiazine analogue	Emesis	NA	1959	NA	NA	NA	NA	NA	1960	1969	NA	US	Lack of efficacy	NA	Withdrawn because of adverse drug reactions	653552FH1N	NC(=O)C1CCN(CCCN2C3=CC=CC=C3SC4=CC=C(Cl)C=C24)CC1
Withdrawn	Pipenzolate	NA	NA	NA	Anti-ulcer	Muscarinic receptor antagonist	Peptic ulcer	NA	1960	NA	NA	NA	NA	NA	1990	1990	NA	Pakistan	Overdose potential	NA	Withdrawn because of adverse drug reactions	RS3K5YXV34	CC[N+]1(C)CCCC(C1)OC(=O)C(O)(C2=CC=CC=C2)C3=CC=CC=C3
Withdrawn	Piperazine	NA	NA	NA	Antihelminth	GABA receptor inhibition	Worm infestation	NA	1949	NA	NA	NA	NA	NA	1957	1983	NA	Malaysia|Armenia	Immunologic|Nervous system|Tumorigenicity	NA	Withdrawn because of adverse drug reactions	1RTM4PAL0V	C1CNCCN1
Withdrawn	Pipradrol	NA	NA	NA	Psychostimulant	Norepinephrine-dopamine reuptake inhibitor	Obesity|Narcolepsy|ADHD	NA	1953	NA	NA	NA	NA	NA	1968	1982	NA	US|Turkey|Denmark|Venezuela	Nervous|Cardiovascular	NA	Withdrawn because of adverse drug reactions	S6I030E0DA	OC(C1CCCCN1)(C2=CC=CC=C2)C3=CC=CC=C3
Withdrawn	Pirprofen	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1982	NA	NA	NA	NA	NA	1986	1990	NA	Worldwide	Gastrointestinal|Liver|Urinary tract	NA	Withdrawn because of adverse drug reactions	T7KN291890	CC(C(O)=O)C1=CC=C(N2CC=CC2)C(Cl)=C1
Withdrawn	Pituitary chorionic gonadotropin	NA	NA	injectable	Hormones	Ovulation trigger	Infertility	NA	1930	NA	NA	NA	NA	NA	1958	1972	NA	US	Immunologic	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Podophyllum resin	NA	NA	NA	Laxative	Mitotic spindle poison	Constipation	NA	1844	NA	NA	NA	NA	NA	1962	1970	NA	Italy|France|Egypt	Teratogenicity	NA	Withdrawn because of adverse drug reactions	16902YVY2B	NA
Withdrawn	Polidexide	NA	NA	NA	Antilipemic	Anion exchange	Hyperlipidemia	NA	1974	NA	NA	NA	NA	NA	1977	1977	NA	UK	Oculomucocutaneous syndrome	NA	Withdrawn because of adverse drug reactions	61TTR6T3SE	NA
Withdrawn	Polyoxyethylated castor oil	NA	NA	NA	Adjuvant	Unknown	Emulsifier	NA	1970	NA	NA	NA	NA	NA	1973	1984	NA	Worldwide	Anaphylaxis|Hyperlipidemia	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Polyvinylpyrrolidone	NA	Polyvidone; povidone	NA	Adjuvant	Permeability through circulatory system	Suspending and dispersing of IV drugs	NA	1957	NA	NA	NA	NA	NA	1967	1983	NA	Germany|Pakistan|Egypt|US	Metabolic: granulomatous lesions	NA	Withdrawn because of adverse drug reactions	FZ989GH94E	NA
Withdrawn	Potassium arsenate	NA	NA	NA	Tonic	Degradation of the aberrant retinoic acid receptor α fusion protein	Leukemia; Psoriasis	NA	1878	NA	NA	NA	NA	NA	1968	1980	NA	US	Tumorigenicity	NA	Withdrawn because of adverse drug reactions	55K74GS94Q	[K+].O[As](O)([O-])=O
Withdrawn	Potassium canrenoate	NA	NA	NA	Antihypertensive	Aldosterone antagonist	Hypertension|Ascites	NA	1968	NA	NA	NA	NA	NA	1985	1986	NA	Germany	Carcinogenic	NA	Withdrawn because of adverse drug reactions	M671F9NLEA	[K+].C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)CCC([O-])=O
Withdrawn	Potassium chloride	NA	NA	NA	Electrolyte	Replenishment of potassium stores	Hypokalemia	NA	1962	NA	NA	NA	NA	NA	1964	1989	NA	Belgium|France|US|Canada	Gastrointestinal perforation	NA	Withdrawn because of adverse drug reactions	660YQ98I10	[Cl-].[K+]
Withdrawn	Potassium nitrate	NA	NA	NA	Antihypertensive	Nitric oxide synthesis	Hypertension	NA	1901	NA	NA	NA	NA	NA	1975	1981	NA	France|Egypt|Venezuela	Tumorigenicity	NA	Withdrawn because of adverse drug reactions	RU45X2JN0Z	[K+].[O-][N+]([O-])=O
Withdrawn	Practolol	NA	NA	NA	Antihypertensive	Beta-blocker	Hypertension	NA	1970	NA	NA	NA	NA	NA	1972	1975	NA	Greece|Turkey|New Zealand|Denmark|Thailand|Singapore|UK|Mauritius|India|Germany|Norway|Venezuela	Gastrointestinal|Sensory systems|Skin	NA	Withdrawn because of adverse drug reactions	SUG9176GRW	CC(C)NCC(O)COC1=CC=C(NC(C)=O)C=C1
Withdrawn	Pramipexole dihydrochloride monohydrate	NA	NA	NA	Antiparkinsonian	Dopamine receptor agonist	Parkinson's	NA	1997	NA	NA	NA	NA	NA	1999	2006	NA	Europe	Sudden onset of sleep	NA	Withdrawn because of adverse drug reactions	3D867NP06J	O.Cl.Cl.CCCN[C@H]1CCC2=C(C1)SC(N)=N2
Withdrawn	Prenylamine	NA	NA	NA	Antianginal	Calcium channel blocker	Angina pectoris	NA	1960	NA	NA	NA	NA	NA	1973	1989	NA	Worldwide	Cardiovascular: multifocal ventricular tachycardia	NA	Withdrawn because of adverse drug reactions	K2OH82Z000	CC(CC1=CC=CC=C1)NCCC(C2=CC=CC=C2)C3=CC=CC=C3
Withdrawn	Probucol	NA	NA	NA	Antioxidant	Unclear	Hyperlipidemia	NA	1980	NA	NA	NA	NA	NA	1989	1989	NA	Germany|France|US	Cardiovascular: Torsade de pointes	NA	Withdrawn because of adverse drug reactions	P3CTH044XJ	CC(C)(SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C)SC2=CC(=C(O)C(=C2)C(C)(C)C)C(C)(C)C
Withdrawn	Proglumide	NA	NA	NA	Anti-ulcer	Cholecystokinin antagonist	Peptic ulcer	NA	1970	NA	NA	NA	NA	NA	1984	1989	NA	Japan|Germany	Respiratory	NA	Withdrawn because of adverse drug reactions	EPL8W5565D	CCCN(CCC)C(=O)C(CCC(O)=O)NC(=O)C1=CC=CC=C1
Withdrawn	Pronethalol	NA	NA	NA	Antihypertensive	Beta-blockade	Angina pectoris	NA	1963	NA	NA	NA	NA	NA	1963	1965	NA	UK	Tumorigenicity	NA	Withdrawn because of adverse drug reactions	XBP4RT1IMQ	CC(C)NCC(O)C1=CC=C2C=CC=CC2=C1
Withdrawn	Propanidid	NA	NA	NA	Anesthetic	Unclear	General anesthesia	NA	1963	NA	NA	NA	NA	NA	1965	1983	NA	UK|Norway|France	Immunologic reactions	NA	Withdrawn because of adverse drug reactions	AO82L471NS	CCCOC(=O)CC1=CC=C(OCC(=O)N(CC)CC)C(OC)=C1
Withdrawn	Propofol	NA	NA	children	Anesthetic	GABA-A receptor agonist, sodium channel blockade	Anesthesia	NA	1987	NA	NA	NA	NA	NA	1992	1992	NA	Israel|Norway|UK|Lithuania	Metabolic|Hepatic|Nervous; deaths	NA	Withdrawn because of adverse drug reactions	YI7VU623SF	CC(C)C1=CC=CC(C(C)C)=C1O
Withdrawn	Propyphenazone	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1951	NA	NA	NA	NA	NA	1980	1989	NA	Turkey|UAE|Bahrain|Ireland	Hematologic|Immunologic: Lyell's syndrome	NA	Withdrawn because of adverse drug reactions	OED8FV75PY	CC(C)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2
Withdrawn	Proxibarbal	NA	NA	NA	Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation	NA	1956	NA	NA	NA	NA	NA	1990	1998	NA	France|Italy|Spain|Portugal and Turkey	Hematologic|Immunologic	NA	Withdrawn because of adverse drug reactions	F97OMS297F	CC(O)CC1(CC=C)C(=O)NC(=O)NC1=O
Withdrawn	Pseudoephedrine	NA	NA	NA	Sympathomimetic	Direct action on adrenergic receptors	Nasal decongestion	NA	1959	NA	NA	NA	NA	NA	1963	2008	NA	Iraq|Colombia|Thailand	Nervous|GIT|Immunologic|Cardiovascular|Teratogenic	NA	Withdrawn because of adverse drug reactions	7CUC9DDI9F	CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Withdrawn	Pumactant	NA	NA	NA	Surfactant	Lowers lung surface tension	Respiratory distress	NA	1992	NA	NA	NA	NA	NA	2000	2000	NA	UK	“Accelerated deaths”	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Purified hexavalent vaccine	NA	Hexavac	NA	Vaccines	Immunogenicity	Bacterial and viral infections	NA	2000	NA	NA	NA	NA	NA	2005	2005	NA	Europe	Decreased immunogenicity	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Pyrithyldione	NA	NA	NA	Sedative-hypnotic	Similar to barbiturates	Insomnia	NA	1940	NA	NA	NA	NA	NA	1949	1997	NA	Spain	Hematologic: agranulocytosis	NA	Withdrawn because of adverse drug reactions	8AB20823CK	CCC1(CC)C(=O)NC=CC1=O
Withdrawn	Pyritinol	NA	NA	NA	Nootropic	Increased cerebrovascular blood flow	Dementia syndromes	NA	1961	NA	NA	NA	NA	NA	1973	1982	NA	Bangladesh	Insufficient therapeutic value and risk of misuse	NA	Withdrawn because of adverse drug reactions	AK5Q5FZH2R	CC1=NC=C(CSSCC2=C(CO)C(O)=C(C)N=C2)C(CO)=C1O
Withdrawn	Pyrovalerone	NA	NA	NA	Psychostimulant	Norepinephrine-dopamine reuptake inhibitor	Obesity|Chronic fatigue syndrome	NA	1974	NA	NA	NA	NA	NA	1975	1979	NA	France	Drug abuse	NA	Withdrawn because of adverse drug reactions	VOU69C02JP	CCCC(N1CCCC1)C(=O)C2=CC=C(C)C=C2
Withdrawn	Pyrrolizidine	NA	NA	NA	Antitussive	Coating effect	Cough|Sinusitis	NA	1967	NA	NA	NA	NA	NA	1968	1992	NA	Germany|Belgium|UK	Liver	NA	Withdrawn because of adverse drug reactions	U81KWZ2JKN	C1CC2CCCN2C1
Withdrawn	Rapacuronium bromide	NA	NA	NA	Anesthetic	Non-depolarizing neuromuscular blocker	Anesthesia	NA	1999	NA	NA	NA	NA	NA	1999	2001	NA	US	Respiratory: Bronchospasm	NA	Withdrawn because of adverse drug reactions	65Q4QDG4KC	[Br-].CCC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N5CCCCC5)[N+]6(CC=C)CCCCC6
Withdrawn	Remoxipride	NA	NA	NA	Antipsychotic	D2 receptor antagonist	Psychoses|Schizophrenia	NA	1991	NA	NA	NA	NA	NA	1993	1994	NA	Worldwide	Hematologic	NA	Withdrawn because of adverse drug reactions	0223RD59PE	CCN1CCC[C@H]1CNC(=O)C2=C(OC)C(Br)=CC=C2OC
Withdrawn	Rimonabant	NA	NA	NA	Psychostimulant	Cannabinoid receptor agonist	Obesity	NA	2006	NA	NA	NA	NA	NA	2006	2007	NA	Europe|India	Psychiatric	NA	Withdrawn because of adverse drug reactions	RML78EN3XE	CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=CC=C(Cl)C=C3Cl)C4=CC=C(Cl)C=C4
Withdrawn	Rofecoxib	NA	NA	NA	Analgesic	COX-2 inhibitor	Analgesia|Osteoarthritis	NA	1999	NA	NA	NA	NA	NA	2002	2004	NA	Worldwide	Cardiotoxicity	NA	Withdrawn because of adverse drug reactions	0QTW8Z7MCR	CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
Withdrawn	Rosiglitazone	NA	NA	NA	Hypoglycemic	↓d gluconeogenesis	Diabetes	NA	1999	NA	NA	NA	NA	NA	2007	2011	NA	UK|New Zealand|South Africa|India	Cardiovascular	NA	Withdrawn because of adverse drug reactions	05V02F2KDG	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C3=CC=CC=N3
Withdrawn	Rotavirus vaccine	NA	NA	NA	Vaccines	Immunogenicity	Rotavirus	NA	1998	NA	NA	NA	NA	NA	1999	1999	NA	US|UK	Gastrointestinal: intussusception	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Santonin	NA	NA	NA	Antihelminth	Paralysis of nerve impulses	Ascariasis	NA	1911	NA	NA	NA	NA	NA	1933	1978	NA	Singapore	Neurotoxicity	NA	Withdrawn because of adverse drug reactions	1VL8J38ERO	C[C@H]1[C@@H]2CC[C@@]3(C)C=CC(=O)C(C)=C3[C@H]2OC1=O
Withdrawn	Sargramostim	NA	NA	NA	Immunostimulator	Granulocyte macrophage colony- stimulating factor (GM-CSF)	Bone marrow transplantation	NA	1993	NA	NA	NA	NA	NA	1999	2008	NA	US	Immune-mediated	NA	Withdrawn because of adverse drug reactions	5TAA004E22	NA
Withdrawn	Secobarbital	NA	NA	NA	Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation|Convulsion	NA	1934	NA	NA	NA	NA	NA	1958	1990	NA	France|Norway|Netherlands|Ghana|New Zealand|Oman	Drug abuse	NA	Withdrawn because of adverse drug reactions	1P7H87IN75	CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Withdrawn	Selegiline	NA	NA	NA	Antiparkinsonian	MAO-B inhibitor	Parkinson's|Depression|Dementia	NA	1982	NA	NA	NA	NA	NA	1991	1997	NA	US	Drug interaction	NA	Withdrawn because of adverse drug reactions	2K1V7GP655|DPF682Q08V	C[C@H](CC1=CC=CC=C1)N(C)CC#C
Withdrawn	Sertindole	NA	NA	NA	Antipsychotic	5HT & D2 receptor antagonist	Psychoses	NA	1996	NA	NA	NA	NA	NA	1996	1998	NA	UK|Bulgaria|Spain	Cardiovascular|Death	NA	Withdrawn because of adverse drug reactions	GVV4Z879SP	FC1=CC=C(C=C1)N2C=C(C3CCN(CCN4CCNC4=O)CC3)C5=C2C=CC(Cl)=C5
Withdrawn	Sibutramine	NA	NA	NA	Psychostimulant	Serotonin-norepinephrine reuptake inhibitor	Obesity	NA	2001	NA	NA	NA	NA	NA	2002	2002	NA	European Union|4 Asian countries|Australia|Canada|Mexico|New Zealand|US	Cardiovascular	NA	Withdrawn because of adverse drug reactions	WV5EC51866	CC(C)CC(N(C)C)C1(CCC1)C2=CC=C(Cl)C=C2
Withdrawn	Sitaxentan sodium	NA	NA	NA	Antihypertensive	Endothelin receptor antagonist	Pulmonary arterial hypertension	NA	2006	NA	NA	NA	NA	NA	2009	2010	NA	Worldwide	Hepatotoxicity	NA	Withdrawn because of adverse drug reactions	6V9JH46E20	[Na+].CC1=NOC([N-]S(=O)(=O)C2=C(SC=C2)C(=O)CC3=C(C)C=C4OCOC4=C3)=C1Cl
Withdrawn	Sodium dibunate	NA	ethyl dibunate	NA	Antitussive	Unclear	Cough	NA	1963	NA	NA	NA	NA	NA	1968	1982	NA	Philippines	Nervous	NA	Withdrawn because of adverse drug reactions	FRS4SO3K8D	[Na+].CC(C)(C)C1=CC=C2C(C=CC(=C2S([O-])(=O)=O)C(C)(C)C)=C1
Withdrawn	Sodium bicarbonate	NA	NA	pediatric	Antacid	Counteracts acidity	Indigestion	NA	1966	NA	NA	NA	NA	NA	1983	1997	NA	Nepal	Safety concerns: metabolic	NA	Withdrawn because of adverse drug reactions	8MDF5V39QO	[Na+].OC([O-])=O
Withdrawn	Somatropin	NA	growth hormone	NA	Hormones	Binds to the human growth hormone receptor	Hypopituitary dwarfism	NA	1973	NA	NA	NA	NA	NA	1985	1985	NA	Europe|Egypt|New Zealand|US|Oman|Thailand	Infection risk: Creutzfeldt-Jakob disease	NA	Withdrawn because of adverse drug reactions	NQX9KB6PCL	NA
Withdrawn	Sorivudine	NA	NA	NA	Antimicrobial	Inhibits DNA polymerase	Herpes viral infection	NA	1993	NA	NA	NA	NA	NA	1993	1993	NA	Germany|Japan	Drug interactions with 5- fluorouracil	NA	Withdrawn because of adverse drug reactions	C7VOZ162LV	OC[C@H]1O[C@H]([C@@H](O)[C@@H]1O)N2C=C(\C=C\Br)C(=O)NC2=O
Withdrawn	Sparfloxacin	NA	NA	NA	Antimicrobial	Inhibits DNA gyrase	Bacterial infection	NA	1993	NA	NA	NA	NA	NA	1995	1995	NA	Europe|US	QTc prolongation|Phototoxicity	NA	Withdrawn because of adverse drug reactions	Q90AGA787L	C[C@H]1CN(C[C@@H](C)N1)C2=C(F)C3=C(C(=O)C(=CN3C4CC4)C(O)=O)C(N)=C2F
Withdrawn	Sparteine sulphate	NA	NA	NA	Hormone analogue	Prostaglandin stimulation?	Labour	NA	1939	NA	NA	NA	NA	NA	1963	1979	NA	US	Uterine tetany	NA	Withdrawn because of adverse drug reactions	GQ3J2TLZ7E	O.O.O.O.O.OS(O)(=O)=O.C1CCN2C[C@@H]3C[C@@H](CN4CCCC[C@H]34)[C@@H]2C1
Withdrawn	Strychnine	NA	NA	NA	Aphrodisiac	Acetylcholine receptor antagonist	Impotence	NA	1753	NA	NA	NA	NA	NA	1882	1979	NA	Canada|Brazil|Bangladesh|Japan|Pakistan|UAE|Philippines	Nervous	NA	Withdrawn because of adverse drug reactions	H9Y79VD43J	O=C1C[C@@H]2OCC=C3CN4CC[C@@]56[C@@H]4C[C@@H]3[C@@H]2[C@@H]5N1C7=CC=CC=C67
Withdrawn	Sulfacarbamide	NA	Sulfanilylurea	NA	Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection	NA	1946	NA	NA	NA	NA	NA	1959	1992	NA	Germany	Hematologic|Liver|Skin|Urinary tract	NA	Withdrawn because of adverse drug reactions	W6CD25Z4QR	NC(=O)NS(=O)(=O)C1=CC=C(N)C=C1
Withdrawn	Sulfadicramide	NA	sulfacetamide	NA	Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection	NA	1942	NA	NA	NA	NA	NA	1976	1992	NA	Germany	Negative benefit-to-harm balance: eye|Skin|Immune	NA	Withdrawn because of adverse drug reactions	7WZ5EG263C	CC(C)=CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1
Withdrawn	Sulfadimethoxine	NA	NA	NA	Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection	NA	1958	NA	NA	NA	NA	NA	1961	1966	NA	US	Skin	NA	Withdrawn because of adverse drug reactions	30CPC5LDEX	COC1=NC(OC)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1
Withdrawn	Sulfadimidine	NA	NA	NA	Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection	NA	1942	NA	NA	NA	NA	NA	1954	1992	NA	US|Germany|Armenia	Hematologic: thrombocytopenia	NA	Withdrawn because of adverse drug reactions	48U51W007F	CC1=CC(C)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=N1
Withdrawn	Sulfaguanidine	NA	NA	NA	Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection	NA	1941	NA	NA	NA	NA	NA	1969	1971	NA	Dominican Republic|Iran|Turkey|Pakistan|Nepal|Germany|UAE|Denmark|Venezuela	Hematologic: agranulocytosis	NA	Withdrawn because of adverse drug reactions	15XQ8043FN	NC(=N)NS(=O)(=O)C1=CC=C(N)C=C1
Withdrawn	Sulfamerazine sodium	NA	NA	NA	Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection	NA	1943	NA	NA	NA	NA	NA	1955	1992	NA	Germany	Hematologic; skin	NA	Withdrawn because of adverse drug reactions	JOV4UJY07O	[Na+].CC1=NC([N-]S(=O)(=O)C2=CC=C(N)C=C2)=NC=C1
Withdrawn	Sulfamethizole	NA	NA	NA	Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection	NA	1953	NA	NA	NA	NA	NA	1963	1984	NA	Sweden	Immunologic	NA	Withdrawn because of adverse drug reactions	25W8454H16	CC1=NN=C(NS(=O)(=O)C2=CC=C(N)C=C2)S1
Withdrawn	Sulfamethoxydiazine	NA	NA	NA	Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection	NA	1962	NA	NA	NA	NA	NA	1968	1988	NA	Germany	Skin	NA	Withdrawn because of adverse drug reactions	3L179F09D6	COC1=CN=C(NS(=O)(=O)C2=CC=C(N)C=C2)N=C1
Withdrawn	Sulfamethoxypyridazine	NA	NA	NA	Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection	NA	1957	NA	NA	NA	NA	NA	1958	1984	NA	Sweden|Pakistan|UAE|UK|Canada|Argentina|France	Hematologic|Skin	NA	Withdrawn because of adverse drug reactions	T034E4NS2Z	COC1=CC=C(NS(=O)(=O)C2=CC=C(N)C=C2)N=N1
Withdrawn	Sulfanilamide	NA	NA	NA	Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection	NA	1936	NA	NA	NA	NA	NA	1957	1992	NA	Germany	Sensory|Immunologic	NA	Withdrawn because of adverse drug reactions	21240MF57M	NC1=CC=C(C=C1)S(N)(=O)=O
Withdrawn	Sulfathiazole	NA	NA	NA	Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection	NA	1941	NA	NA	NA	NA	NA	1954	1970	NA	US|Philippines|Dominican Republic|France|UAE|India	Hematologic|Liver|Skin|Urinary tract	NA	Withdrawn because of adverse drug reactions	Y7FKS2XWQH	NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CS2
Withdrawn	Sulfisomidine	NA	NA	NA	Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection	NA	1952	NA	NA	NA	NA	NA	1972	1992	NA	Germany	Negative benefit-to-harm balance	NA	Withdrawn because of adverse drug reactions	W03L3ODK6E	CC1=NC(C)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1
Withdrawn	Sulfonamides	NA	NA	topical	Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection	NA	1930	NA	NA	NA	NA	NA	1957	1986	NA	Chile	Immune-mediated	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Suloctidil	NA	NA	NA	Vasodilator	Calcium channel blockade, inhibits thromboxane B2	Intermittent claudication	NA	1975	NA	NA	NA	NA	NA	1983	1985	NA	Worldwide	Liver: hepatotoxicity	NA	Withdrawn because of adverse drug reactions	XV1N1XY17K	CCCCCCCCN[C@@H](C)[C@H](O)C1=CC=C(SC(C)C)C=C1
Withdrawn	Suprifen with tussilax	NA	NA	NA	Antitussive	Unknown	Cough	NA	1971	NA	NA	NA	NA	NA	1971	1972	NA	France|Germany	Liver: hepatotoxicity	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Suprofen	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1983	NA	NA	NA	NA	NA	1986	1986	NA	Worldwide	Urinary tract	NA	Withdrawn because of adverse drug reactions	EXV5374VEY|988GU2F9PE	OC[C@@H](O)[C@@H](O)CC(=O)C=O
Withdrawn	Suxibuzone	NA	NA	NA	Analgesic 99m	COX-1 & COX-2 inhibition	Analgesia	NA	1974	NA	NA	NA	NA	NA	1982	1986	NA	Oman|Italy	Carcinogenesis	NA	Withdrawn because of adverse drug reactions	86TDZ5WP2B	CCCCC1(COC(=O)CCC(O)=O)C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
Withdrawn	technetium (99m TC) fanolesomab	NA	Tc	NA	Radiography	Radioisotope	Radiographic imaging	NA	2004	NA	NA	NA	NA	NA	2005	2005	NA	US	Cardiovascular	NA	Withdrawn because of adverse drug reactions	AMF7KOE318	NA
Withdrawn	Tegaserod	NA	NA	NA	Antispasmodic	5-HT4 receptor agonist	Irritable bowel syndrome|Constipation	NA	2002	NA	NA	NA	NA	NA	2004	2007	NA	US|Canada|India|Jordan|Australia|Switzerland|China|Argentina	Cardiovascular	NA	Withdrawn because of adverse drug reactions	458VC51857	CCCCCNC(=N)N\N=C\C1=CNC2=C1C=C(OC)C=C2
Withdrawn	Temafloxacin	NA	NA	NA	Antimicrobial	Inhibits DNA gyrase	Bacterial infection	NA	1991	NA	NA	NA	NA	NA	1992	1992	NA	Worldwide	Hematologic|Immunologic|Liver|Metabolism|Urinary tract	NA	Withdrawn because of adverse drug reactions	1WZ12GTT67	CC1CN(CCN1)C2=CC3=C(C=C2F)C(=O)C(=CN3C4=CC=C(F)C=C4F)C(O)=O
Withdrawn	Temazepam	NA	NA	gel capsules	Sedative-hypnotic	GABA-A receptor binding	Hypnosedation	NA	1969	NA	NA	NA	NA	NA	1981	1999	NA	Australia	Drug abuse	NA	Withdrawn because of adverse drug reactions	CHB1QD2QSS	CN1C2=CC=C(Cl)C=C2C(=NC(O)C1=O)C3=CC=CC=C3
Withdrawn	Terconazole	NA	NA	NA	Antimicrobial	Disrupts cell membrane permeability by cytochrome P450 14-alpha-demethylase	Fungal infection	NA	1980	NA	NA	NA	NA	NA	1988	1991	NA	Sweden|Germany	Immunologic|Skin	NA	Withdrawn because of adverse drug reactions	0KJ2VE664U	CC(C)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=NC=N4)(O3)C5=CC=C(Cl)C=C5Cl)C=C2
Withdrawn	Terfenadine	NA	NA	NA	Antihistamine	H1-receptor antagonist	Allergy	NA	1985	NA	NA	NA	NA	NA	1985	1997	NA	3 European countries|2 African countries|3 Asian countries|3 South American countries|US|Canada	Cardiovascular|Immunologic|Liver|Skin	NA	Withdrawn because of adverse drug reactions	7BA5G9Y06Q	CC(C)(C)C1=CC=C(C=C1)C(O)CCCN2CCC(CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
Withdrawn	Terodiline	NA	NA	NA	Antispasmodic	Calcium channel blockade, blocks cholinergic receptor	Urinary incontinence	NA	1965	NA	NA	NA	NA	NA	1989	1991	NA	Worldwide	Cardiovascular	NA	Withdrawn because of adverse drug reactions	70KG06964W	CC(CC(C1=CC=CC=C1)C2=CC=CC=C2)NC(C)(C)C
Withdrawn	Testosterone propionate	NA	NA	injectable	Hormones	Androgen-receptor modulation	Hypogonadism|Sexual dysfunction	NA	1937	NA	NA	NA	NA	NA	1952	1982	NA	Bangladesh	Drug abuse	NA	Withdrawn because of adverse drug reactions	WI93Z9138A	CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
Withdrawn	Tetrabamate	NA	NA	NA	Anxiolytic	Febarbamate, difebarbamate plus phenobarbital	Alcohol dependence	NA	1981	NA	NA	NA	NA	NA	1992	2001	NA	France|Spain	Liver|Skin	NA	Withdrawn because of adverse drug reactions	5Z48ONN38P|7EE4K616KK	NA
Withdrawn	Tetrachlorosalicylanilide	NA	NA	NA	Antimicrobial	Leakage of cell contents	Bacterial infection	NA	1949	NA	NA	NA	NA	NA	1961	1975	NA	US|Japan	Skin	NA	Withdrawn because of adverse drug reactions	HNE676755I	OC1=C(Cl)C=C(Cl)C=C1C(=O)NC2=CC(Cl)=C(Cl)C=C2
Withdrawn	Tetracycline	NA	NA	pediatric	Antimicrobial	Protein synthesis inhibitor	Bacterial infection	NA	1948	NA	NA	NA	NA	NA	1959	1975	NA	8 Asian countries|2 African countries|2 Australasian countries|US|Italy	Teeth; bone	NA	Withdrawn because of adverse drug reactions	F8VB5M810T	CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O
Withdrawn	Tetrazepam	NA	NA	NA	Sedative-hypnotic	Benzodiazepine site agonist	Hypnosedation	NA	1960	NA	NA	NA	NA	NA	1988	2013	NA	EU	Dermatitis	NA	Withdrawn because of adverse drug reactions	FO92091VP8	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C3=CCCCC3
Withdrawn	Thalidomide	NA	NA	NA	Immunomodulator	? CNS mechanism	Hyperemesis	NA	1957	NA	NA	NA	NA	NA	1961	1961	NA	Belgium|Finland|Indonesia|Canada|Brazil|Denmark|India|Singapore|Venezuela|UK|Germany	Nervous system|Teratogenicity	NA	Withdrawn because of adverse drug reactions	4Z8R6ORS6L	O=C1N(C2CCC(=O)NC2=O)C(=O)C3=C1C=CC=C3
Withdrawn	Thenalidine tartrate	NA	NA	NA	Antihistamine	H1-receptor blocker	Allergy	NA	1953	NA	NA	NA	NA	NA	1958	1958	NA	US|UK|Sweden|France|Cyprus|Australia|Finland|Norway|Canada	Hematologic: neutropenia	NA	Withdrawn because of adverse drug reactions	H581Q95SJA	O[C@H]([C@@H](O)C(O)=O)C(O)=O.CN1CCC(CC1)N(CC2=CC=CS2)C3=CC=CC=C3
Withdrawn	Thiobutabarbital	NA	NA	NA	Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation	NA	1939	NA	NA	NA	NA	NA	1981	1993	NA	Germany	Urinary tract	NA	Withdrawn because of adverse drug reactions	2N0251U7JH	CCC(C)C1(CC)C(=O)NC(=S)NC1=O
Withdrawn	Thioridazine	NA	NA	NA	Antipsychotic	5HT2 receptor antagonist	Psychoses	NA	1959	NA	NA	NA	NA	NA	1961	2000	NA	Worldwide	Retinopathy|Cardiovascular	NA	Withdrawn because of adverse drug reactions	N3D6TG58NI	CSC1=CC=C2SC3=CC=CC=C3N(CCC4CCCCN4C)C2=C1
Withdrawn	Thorium dioxide	NA	NA	NA	Radiography	Radiocontrast	Diagnostic imaging	NA	1928	NA	NA	NA	NA	NA	1931	1955	NA	UK	Tumorigenicity	NA	Withdrawn because of adverse drug reactions	9XA7X17UQC	[O--].[O--].[Th+4]
Withdrawn	Tick-borne encephalitis vaccine	NA	NA	NA	Vaccines	Immunogenicity	Viral infection	NA	1999	NA	NA	NA	NA	NA	1999	2000	NA	Germany	Hyperpyrexia	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Tienilic acid	NA	ticrynafen	NA	Antihypertensive	Loop diuretic	Hypertension|Kidney stones	NA	1976	NA	NA	NA	NA	NA	1979	1980	NA	Greece|Philippines|US|Brazil|Germany|Panama|France|India|Venezuela	Liver|Urinary tract	NA	Withdrawn because of adverse drug reactions	HC95205SY4	OC(=O)COC1=CC=C(C(=O)C2=CC=CS2)C(Cl)=C1Cl
Withdrawn	Tilbroquinol	NA	NA	NA	Antiprotozoal	Unknown	Diarrhea (amoebiasis)	NA	1969	NA	NA	NA	NA	NA	1996	1997	NA	France|Morocco|Saudi Arabia|Switzerland	Liver|Nervous system	NA	Withdrawn because of adverse drug reactions	P6SB125NHA	CC1=CC(Br)=C(O)C2=NC=CC=C12
Withdrawn	Timonacic acid	NA	thioproline	NA	Antioxidant	Cysteine release and restoration of glutathione concentrations	Hepatitis	NA	1975	NA	NA	NA	NA	NA	1981	1982	NA	France	Drug overdose (toxicity)	NA	Withdrawn because of adverse drug reactions	E5913T3IBL	OC(=O)C1CSCN1
Withdrawn	Tocainide	NA	NA	NA	Antiarrhythmic	Sodium channel blockade	Cardiac arrhythmia	NA	1981	NA	NA	NA	NA	NA	1986	1986	NA	US	Hematologic: agranulocytosis|Aplastic anemia	NA	Withdrawn because of adverse drug reactions	27DXO59SAN	CC(N)C(=O)NC1=C(C)C=CC=C1C
Withdrawn	Tolcapone	NA	NA	NA	Antiparkinsonian	COMT inhibitor	Parkinson's	NA	1998	NA	NA	NA	NA	NA	1998	1998	NA	UK|Australia|Ireland|Spain|Portugal|Lithuania|Bulgaria|Canada	Liver	NA	Withdrawn because of adverse drug reactions	CIF6334OLY	CC1=CC=C(C=C1)C(=O)C2=CC(O)=C(O)C(=C2)[N+]([O-])=O
Withdrawn	Tolrestat	NA	NA	NA	Hypoglycemic	Aldase reductase inhibitor	Diabetes	NA	1982	NA	NA	NA	NA	NA	1995	1996	NA	Worldwide	Liver	NA	Withdrawn because of adverse drug reactions	0T93LG5NMK	COC1=CC=C2C(=CC=CC2=C1C(F)(F)F)C(=S)N(C)CC(O)=O
Withdrawn	Tranylcypromine	NA	NA	NA	Antidepressant	MAOI	Depression	NA	1961	NA	NA	NA	NA	NA	1963	1964	NA	Italy|Belgium|Venezuela|Canada	Cardiovascular|Drug interactions	NA	Withdrawn because of adverse drug reactions	3E3V44J4Z9	N[C@@H]1C[C@H]1C2=CC=CC=C2
Withdrawn	Trazodone	NA	NA	NA	Antidepressant	Binds at 5-HT2 receptor	Depression	NA	1973	NA	NA	NA	NA	NA	1983	1985	NA	Norway	Carcinogenic	NA	Withdrawn because of adverse drug reactions	YBK48BXK30	ClC1=CC(=CC=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2
Withdrawn	Tretinoin	NA	NA	NA	Retinoid	Modulates cell-cycle progression, cellular differentiation, cell survival and apoptosis	Acne	NA	1973	NA	NA	NA	NA	NA	1977	1988	NA	Germany	Carcinogenic	NA	Withdrawn because of adverse drug reactions	5688UTC01R	CC(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(C)=C/C(O)=O
Withdrawn	Triacetyldiphenolisatin	NA	NA	NA	Laxative	↑d mucosal tissue permeability	Constipation	NA	1961	NA	NA	NA	NA	NA	1967	1971	NA	Australia|Germany|Italy|Canada|Cyprus|New Zealand|Venezuela	Photosensitivity; hepatotoxicity	NA	Withdrawn because of adverse drug reactions	ZHJ4JHL6HB	CC(=O)OC1=CC=C(C=C1)C2(C(=O)N(C(C)=O)C3=CC=CC=C23)C4=CC=C(OC(C)=O)C=C4
Withdrawn	Triazolam	NA	NA	NA	Sedative-hypnotic	GABA-A receptor binding	Hypnosedation	NA	1978	NA	NA	NA	NA	NA	1978	1979	NA	Mauritius|Europe|Brazil|Oman	Nervous system|Psychiatric	NA	Withdrawn because of adverse drug reactions	1HM943223R	CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C4=CC(Cl)=CC=C4N12
Withdrawn	Trimethobenzamide	NA	NA	suppository	Antihistamine	?Chemoreceptor trigger zone	Motion sickness|GI infections|Medication- induced nausea	NA	1959	NA	NA	NA	NA	NA	1976	2007	NA	US	Due to new FDA regulation; lack of effectiveness. Teratogenicity	NA	Withdrawn because of adverse drug reactions	W2X096QY97	COC1=CC(=CC(OC)=C1OC)C(=O)NCC2=CC=C(OCCN(C)C)C=C2
Withdrawn	Triparanol	NA	NA	NA	Antilipemic	δ 24-reductase inhibitor	Hyperlipidemia	NA	1959	NA	NA	NA	NA	NA	1961	1962	NA	US|France	Sensory systems|Skin	NA	Withdrawn because of adverse drug reactions	63S8C3RXGS	CCN(CC)CCOC1=CC=C(C=C1)C(O)(CC2=CC=C(Cl)C=C2)C3=CC=C(C)C=C3
Withdrawn	Troglitazone	NA	NA	NA	Hypoglycemic	PPARs activation	Diabetes	NA	1997	NA	NA	NA	NA	NA	1997	1997	NA	UK|Switzerland|Peru|Jamaica|Chile|US|Canada	Liver	NA	Withdrawn because of adverse drug reactions	I66ZZ0ZN0E	NA
Withdrawn	Trovafloxacin	NA	NA	NA	Antimicrobial	Inhibits DNA gyrase	Bacterial infection	NA	1997	NA	NA	NA	NA	NA	1997	1999	NA	European Union|Philippines|Syria|Vietnam|Singapore|Canada|US	Liver	NA	Withdrawn because of adverse drug reactions	9F388J00UK	N[C@H]1[C@@H]2CN(C[C@H]12)C3=NC4=C(C=C3F)C(=O)C(=CN4C5=CC=C(F)C=C5F)C(O)=O
Withdrawn	Urethane	NA	NA	NA	Solvent	?Interferes with pyrimidine metabolism	Cancer (CML)	NA	1933	NA	NA	NA	NA	NA	1943	1963	NA	Brazil|Cuba|Denmark|Egypt|Japan|Thailand|US|Canada|Italy|Greece|Denmark|Venezuela|France	Hematologic|Liver|Tumorigenicity	NA	Withdrawn because of adverse drug reactions	3IN71E75Z5	CCOC(N)=O
Withdrawn	Valdecoxib	NA	NA	NA	Analgesic	COX-2 inhibitor	Analgesia	NA	2001	NA	NA	NA	NA	NA	2003	2005	NA	US|Canada|Europe|India	Cardiovascular; skin	NA	Withdrawn because of adverse drug reactions	2919279Q3W	CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(N)(=O)=O
Withdrawn	Veralipride	NA	NA	NA	Neuroleptic	Selective antagonism of hypothalamic D2 receptors	Climacteric	NA	1979	NA	NA	NA	NA	NA	1982	2007	NA	Europe|Brazil (reference to EMA)	Psychiatric	NA	Withdrawn because of adverse drug reactions	S7064109UD	COC1=C(OC)C(=CC(=C1)S(N)(=O)=O)C(=O)NCC2CCCN2CC=C
Withdrawn	Vigabatrin	NA	gamma-vinyl- GABA	NA	Antiepileptic	Inhibits GABA transaminase (GABA-T)	Hypnosedation	NA	1989	NA	NA	NA	NA	NA	1989	1991	NA	Norway	Not medically justified; neurotoxicity	NA	Withdrawn because of adverse drug reactions	GR120KRT6K	NC(CCC(O)=O)C=C
Withdrawn	Vinbarbital	NA	NA	NA	Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation	NA	1939	NA	NA	NA	NA	NA	1975	1984	NA	Sweden	Drug abuse	NA	Withdrawn because of adverse drug reactions	7NZH2C1T6O	CC\C=C(/C)C1(CC)C(=O)NC(=O)NC1=O
Withdrawn	Vincamine	NA	NA	NA	Nootropic	Unclear	Meniere's disease|Vertigo	NA	1955	NA	NA	NA	NA	NA	1974	1980	NA	Hungary|Germany	Cardiovascular|Hematologic	NA	Withdrawn because of adverse drug reactions	996XVD0JHT	CC[C@@]12CCCN3CCC4=C([C@H]13)N(C5=C4C=CC=C5)[C@](O)(C2)C(=O)OC
Withdrawn	Vitamin B complex	NA	NA	injectable	Hematinic	Co-factor for biochemical transformation	Anemia	NA	1949	NA	NA	NA	NA	NA	1953	2008	NA	Iraq	Immunologic	NA	Withdrawn because of adverse drug reactions		NA
Withdrawn	Vitamin E	NA	NA	injectable	Antioxidant	Downregulation of ICAM-1 and VCAM-1	Retinal deterioration in neonates	NA	1983	NA	NA	NA	NA	NA	1984	1984	NA	US	Death|Hematologic|Liver|Urinary tract	NA	Withdrawn because of adverse drug reactions	H4N855PNZ1	NA
Withdrawn	Xenazoic acid	NA	xenalamine	NA	Antimicrobial	? Inhibits intracellular stages viral biological cycle	Viral infection	NA	1960	NA	NA	NA	NA	NA	1965	1965	NA	Belgium|France|Venezuela	Liver	NA	Withdrawn because of adverse drug reactions	KDU8VH09O8	CCOC(NC1=CC=C(C=C1)C(O)=O)C(=O)C2=CC=C(C=C2)C3=CC=CC=C3
Withdrawn	Ximelagatran	NA	NA	NA	Anticoagulant	Direct thrombin inhibitor	DVT|Stroke	NA	2005	NA	NA	NA	NA	NA	2006	2006	NA	Europe|Brazil	Liver	NA	Withdrawn because of adverse drug reactions	49HFB70472	CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N2CC[C@H]2C(=O)NCC3=CC=C(C=C3)C(=N)NO
Withdrawn	Zimeldine	NA	NA	NA	Antidepressant	5 HT reuptake inhibitor	Depression	NA	1982	NA	NA	NA	NA	NA	1982	1983	NA	Worldwide	Liver|Nervous system	NA	Withdrawn because of adverse drug reactions	3J928617DW	CN(C)C\C=C(\C1=CC=C(Br)C=C1)C2=CN=CC=C2
Withdrawn	Zipeprol dihydrochloride	NA	NA	NA	Antitussive	Laryngeal nerve stimulation; excitation of tracheo-bronchial receptors	Cough	NA	1971	NA	NA	NA	NA	NA	1984	1991	NA	Philippines|Brazil|Spain|Switzerland|Turkey	Drug abuse|Drug dependence|Nervous system	NA	Withdrawn because of adverse drug reactions	U6WT9D8ASL	Cl.Cl.COC(CN1CCN(CC(O)C(OC)C2=CC=CC=C2)CC1)C3=CC=CC=C3
Withdrawn	Zomepirac	NA	NA	NA	Analgesic	COX-1 & COX-2 inhibition	Analgesia	NA	1979	NA	NA	NA	NA	NA	1981	1983	NA	Worldwide	Immunologic|Urinary tract	NA	Withdrawn because of adverse drug reactions	822G987U9J	CN1C(CC(O)=O)=CC(C)=C1C(=O)C2=CC=C(Cl)C=C2
Withdrawn	Zopiclone	NA	NA	NA	Sedative-hypnotic	GABA-A receptor binding	Hypnosedation	NA	1985	NA	NA	NA	NA	NA	1985	1986	NA	Israel|Norway	Carcinogenicity	NA	Withdrawn because of adverse drug reactions	03A5ORL08Q	CN1CCN(CC1)C(=O)OC2N(C(=O)C3=C2N=CC=N3)C4=CC=C(Cl)C=N4
Withdrawn	Adenosine phosphate	NA	NA	NA	NA	NA	NA	All drug products containing adenosine phosphate.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	415SHH325A	NC1=NC=NC2=C1N=CN2[C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O
Withdrawn	Adrenal cortex	NA	NA	NA	NA	NA	NA	All drug products containing adrenal cortex.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness		NA
Withdrawn	Alatrofloxacin mesylate	NA	NA	NA	NA	NA	NA	All drug products containing alatrofloxacin mesylate.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	2IXX802851	CS(O)(=O)=O.C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]1[C@H]2CN(C[C@@H]12)C3=NC4=C(C=C3F)C(=O)C(=CN4C5=CC=C(F)C=C5F)C(O)=O
Withdrawn	Aminopyrine	NA	NA	NA	NA	NA	NA	All drug products containing aminopyrine.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	01704YP3MO	CN(C)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2
Withdrawn	Astemizole	NA	NA	NA	NA	NA	NA	All drug products containing astemizole.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	7HU6337315	COC1=CC=C(CCN2CCC(CC2)NC3=NC4=C(C=CC=C4)N3CC5=CC=C(F)C=C5)C=C1
Withdrawn	Azaribine	NA	NA	NA	NA	NA	NA	All drug products containing azaribine.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	K1U80DO9EB	CC(=O)OC[C@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)N2N=CC(=O)NC2=O
Withdrawn	Benoxaprofen	NA	NA	NA	NA	NA	NA	All drug products containing benoxaprofen.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	17SZX404IM	CC(C(O)=O)C1=CC=C2OC(=NC2=C1)C3=CC=C(Cl)C=C3
Withdrawn	Bithionol	NA	NA	NA	NA	NA	NA	All drug products containing bithionol.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	AMT77LS62O	OC1=C(Cl)C=C(Cl)C=C1SC2=CC(Cl)=CC(Cl)=C2O
Withdrawn	Bromfenac sodium	NA	NA	NA	NA	NA	NA	All drug products containing bromfenac sodium (except ophthalmic solutions).	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	8ECV571Y37	O.O.O.[Na+].[Na+].NC1=C(CC([O-])=O)C=CC=C1C(=O)C2=CC=C(Br)C=C2.NC3=C(CC([O-])=O)C=CC=C3C(=O)C4=CC=C(Br)C=C4
Withdrawn	Butamben	NA	NA	NA	NA	NA	NA	All parenteral drug products containing butamben.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	EFW857872Q	CCCCOC(=O)C1=CC=C(N)C=C1
Withdrawn	Camphorated oil	NA	NA	NA	NA	NA	NA	All drug products containing camphorated oil.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	75IZZ8Y727	NA
Withdrawn	Carbetapentane citrate	NA	NA	NA	NA	NA	NA	All oral gel drug products containing carbetapentane citrate.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	4SH0MFJ5HJ	OC(=O)CC(O)(CC(O)=O)C(O)=O.CCN(CC)CCOCCOC(=O)C1(CCCC1)C2=CC=CC=C2
Withdrawn	Casein, iodinated	NA	NA	NA	NA	NA	NA	All drug products containing iodinated casein.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness		NA
Withdrawn	Cerivastatin sodium	NA	NA	NA	NA	NA	NA	All drug products containing cerivastatin sodium.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	6Q18G1060S	[Na+].COCC1=C(C2=CC=C(F)C=C2)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C(N=C1C(C)C)C(C)C
Withdrawn	Chloramphenicol	NA	NA	NA	NA	NA	NA	All oral drug products containing chloramphenicol.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	66974FR9Q1	OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
Withdrawn	Chlorhexidine gluconate	NA	NA	NA	NA	NA	NA	All tinctures of chlorhexidine gluconate formulated for use as a patient preoperative skin preparation.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	MOR84MUD8E	OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1
Withdrawn	Chlormadinone acetate	NA	NA	NA	NA	NA	NA	All drug products containing chlormadinone acetate.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	0SY050L61N	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O
Withdrawn	Chloroform	NA	NA	NA	NA	NA	NA	All drug products containing chloroform.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	7V31YC746X	ClC(Cl)Cl
Withdrawn	Cisapride	NA	NA	NA	NA	NA	NA	All drug products containing cisapride.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	UVL329170W	CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=CC(Cl)=C(N)C=C3OC
Withdrawn	Cobalt	NA	NA	NA	NA	NA	NA	All drug products containing cobalt salts (except radioactive forms of cobalt and its salts and cobalamin and its derivatives).	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	3G0H8C9362	[Co]
Withdrawn	Dexfenfluramine hydrochloride	NA	NA	NA	NA	NA	NA	All drug products containing dexfenfluramine hydrochloride.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	PM28L0FHNP	Cl.CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
Withdrawn	Diamthazole dihydrochloride	NA	NA	NA	NA	NA	NA	All drug products containing diamthazole dihydrochloride.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	3LF09TBB5W	Cl.Cl.CCN(CC)CCOC1=CC2=C(C=C1)N=C(S2)N(C)C
Withdrawn	Dibromsalan	NA	NA	NA	NA	NA	NA	All drug products containing dibromsalan.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	N9900K2RBT	OC1=CC=C(Br)C=C1C(=O)NC2=CC=C(Br)C=C2
Withdrawn	Diethylstilbestrol	NA	NA	NA	NA	NA	NA	All oral and parenteral drug products containing 25 milligrams or more of diethylstilbestrol per unit dose.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	731DCA35BT	CC\C(C1=CC=C(O)C=C1)=C(\CC)C2=CC=C(O)C=C2
Withdrawn	Dihydrostreptomycin sulfate	NA	NA	NA	NA	NA	NA	All drug products containing dihydrostreptomycin sulfate.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	T7D4876IUE	OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]3NC(N)=N)O[C@@H](C)[C@]2(O)CO.CN[C@H]4[C@H](O)[C@@H](O)[C@H](CO)O[C@H]4O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]6NC(N)=N)O[C@@H](C)[C@]5(O)CO
Withdrawn	Dipyrone	NA	NA	NA	NA	NA	NA	All drug products containing dipyrone.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	6429L0L52Y	O.[Na+].CN(CS([O-])(=O)=O)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2
Withdrawn	Encainide hydrochloride	NA	NA	NA	NA	NA	NA	All drug products containing encainide hydrochloride.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	4CH7J36N9S	Cl.COC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2CCC3CCCCN3C
Withdrawn	Esmolol hydrochloride	NA	NA	NA	NA	NA	NA	All parenteral dosage form drug products containing esmolol hydrochloride that supply 250 milligrams/milliliter of concentrated esmolol per 10-milliliter ampule.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	V05260LC8D	Cl.COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1
Withdrawn	Etretinate	NA	NA	NA	NA	NA	NA	All drug products containing etretinate.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	65M2UDR9AG	CCOC(=O)\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)C=C(OC)C(C)=C1C
Withdrawn	Fenfluramine hydrochloride	NA	NA	NA	NA	NA	NA	All drug products containing fenfluramine hydrochloride.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	3KC089243P	Cl.CCNC(C)CC1=CC(=CC=C1)C(F)(F)F
Withdrawn	Flosequinan	NA	NA	NA	NA	NA	NA	All drug products containing flosequinan.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	6NB119DLU7	CN1C=C([S+](C)[O-])C(=O)C2=C1C=C(F)C=C2
Withdrawn	Gatifloxacin	NA	NA	NA	NA	NA	NA	All drug products containing gatifloxacin (except ophthalmic solutions).	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	L4618BD7KJ	O.O.O.COC1=C(N2CCNC(C)C2)C(F)=CC3=C1N(C=C(C(O)=O)C3=O)C4CC4.COC5=C(N6CCNC(C)C6)C(F)=CC7=C5N(C=C(C(O)=O)C7=O)C8CC8
Withdrawn	Gelatin	NA	NA	NA	NA	NA	NA	All intravenous drug products containing gelatin.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	2G86QN327L	NA
Withdrawn	Glycerol, iodinated	NA	NA	NA	NA	NA	NA	All drug products containing iodinated glycerol.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	8C0LU36AR9	NA
Withdrawn	Gonadotropin, chorionic	NA	NA	NA	NA	NA	NA	All drug products containing chorionic gonadotropins of animal origin.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	20ED16GHEB	NA
Withdrawn	Grepafloxacin	NA	NA	NA	NA	NA	NA	All drug products containing grepafloxacin.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	L1M1U2HC31	CC1CN(CCN1)C2=CC3=C(C(=O)C(=CN3C4CC4)C(O)=O)C(C)=C2F
Withdrawn	Mepazine	NA	NA	NA	NA	NA	NA	All drug products containing mepazine hydrochloride or mepazine acetate.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	PH34873A38	CN1CCCC(CN2C3=CC=CC=C3SC4=CC=CC=C24)C1
Withdrawn	Metabromsalan	NA	NA	NA	NA	NA	NA	All drug products containing metabromsalan.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	8Q21Y09R21	OC1=C(Br)C=C(Br)C=C1C(=O)NC2=CC=CC=C2
Withdrawn	Methamphetamine hydrochloride	NA	NA	NA	NA	NA	NA	All parenteral drug products containing methamphetamine hydrochloride.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	997F43Z9CV|24GNZ56D62	Cl.CN[C@@H](C)CC1=CC=CC=C1
Withdrawn	Methapyrilene	NA	NA	NA	NA	NA	NA	All drug products containing methapyrilene.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	A01LX40298	CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2
Withdrawn	Methopholine	NA	NA	NA	NA	NA	NA	All drug products containing methopholine.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	72L4ZT2W1P	COC1=C(OC)C=C2C(CCC3=CC=C(Cl)C=C3)N(C)CCC2=C1
Withdrawn	Methoxyflurane	NA	NA	NA	NA	NA	NA	All drug products containing methoxyflurane.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	30905R8O7B	COC(F)(F)C(Cl)Cl
Withdrawn	Mibefradil dihydrochloride	NA	NA	NA	NA	NA	NA	All drug products containing mibefradil dihydrochloride.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	842TUP3PQ8	Cl.Cl.COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
Withdrawn	Nitrofurazone	NA	NA	NA	NA	NA	NA	All drug products containing nitrofurazone (except topical drug products formulated for dermatologic application).	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	X8XI70B5Z6	NC(=O)N\N=C\C1=CC=C(O1)[N+]([O-])=O
Withdrawn	Nomifensine maleate	NA	NA	NA	NA	NA	NA	All drug products containing nomifensine maleate.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	76S8CUH5MR	OC(=O)\C=C/C(O)=O.CN1CC(C2=CC=CC=C2)C3=C(C1)C(N)=CC=C3
Withdrawn	Novobiocin sodium	NA	NA	NA	NA	NA	NA	All drug products containing novobiocin sodium.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	Q9S9NQ5YIY	[Na+].CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=C(C)C3=C(C=C2)C([O-])=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)O3)OC1(C)C
Withdrawn	Oxyphenisatin	NA	NA	NA	NA	NA	NA	All drug products containing oxyphenisatin.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	3BT0VQG2GQ	OC1=CC=C(C=C1)C2(C(=O)NC3=C2C=CC=C3)C4=CC=C(O)C=C4
Withdrawn	Oxyphenisatin acetate	NA	NA	NA	NA	NA	NA	All drug products containing oxyphenisatin acetate.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	U0Y1YAL65X	CC(=O)OC1=CC=C(C=C1)C2(C(=O)NC3=C2C=CC=C3)C4=CC=C(OC(C)=O)C=C4
Withdrawn	Pemoline	NA	NA	NA	NA	NA	NA	All drug products containing pemoline.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	7GAQ2332NK	NC1=NC(=O)C(O1)C2=CC=CC=C2
Withdrawn	Pergolide mesylate	NA	NA	NA	NA	NA	NA	All drug products containing pergolide mesylate.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	55B9HQY616	CS(O)(=O)=O.CCCN1C[C@H](CSC)C[C@H]2[C@H]1CC3=CNC4=C3C2=CC=C4
Withdrawn	Phenacetin	NA	NA	NA	NA	NA	NA	All drug products containing phenacetin.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	ER0CTH01H9	CCOC1=CC=C(NC(C)=O)C=C1
Withdrawn	Phenformin hydrochloride	NA	NA	NA	NA	NA	NA	All drug products containing phenformin hydrochloride.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	91XC93EU03	Cl.NC(=N)NC(=N)NCCC1=CC=CC=C1
Withdrawn	Phenylpropanolamine	NA	NA	NA	NA	NA	NA	All drug products containing phenylpropanolamine.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	683H0R9659|33RU150WUN	NA
Withdrawn	Pipamazine	NA	NA	NA	NA	NA	NA	All drug products containing pipamazine.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	653552FH1N	NC(=O)C1CCN(CCCN2C3=CC=CC=C3SC4=CC=C(Cl)C=C24)CC1
Withdrawn	Polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride, and bisacodyl	NA	NA	NA	NA	NA	NA	All drug products containing polyethylene glycol 3350, sodium chloride, sodium bicarbonate, and potassium chloride for oral solution, and 10 milligrams or more of bisacodyl delayed-release tablets.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness		NA
Withdrawn	Potassium arsenite	NA	NA	NA	NA	NA	NA	All drug products containing potassium arsenite.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	HQE48MPP30	[K+].[O-][As]=O.O[As](O)O
Withdrawn	Potassium chloride	NA	NA	NA	NA	NA	NA	All solid oral dosage form drug products containing potassium chloride that supply 100 milligrams or more of potassium per dosage unit (except for controlled-release dosage forms and those products formulated for preparation of solution prior to ingestion).	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	660YQ98I10	[Cl-].[K+]
Withdrawn	Povidone	NA	NA	NA	NA	NA	NA	All intravenous drug products containing povidone.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	FZ989GH94E	NA
Withdrawn	Propoxyphene	NA	NA	NA	NA	NA	NA	All drug products containing propoxyphene.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	II2G62OV6F|S2F83W92TK	CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C2=CC=CC=C2
Withdrawn	Rapacuronium bromide	NA	NA	NA	NA	NA	NA	All drug products containing rapacuronium bromide.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	65Q4QDG4KC	[Br-].CCC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N5CCCCC5)[N+]6(CC=C)CCCCC6
Withdrawn	Reserpine	NA	NA	NA	NA	NA	NA	All oral dosage form drug products containing more than 1 milligram of reserpine.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	8B1QWR724A	CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
Withdrawn	Rofecoxib	NA	NA	NA	NA	NA	NA	All drug products containing rofecoxib.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	0QTW8Z7MCR	CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
Withdrawn	Sibutramine hydrochloride	NA	NA	NA	NA	NA	NA	All drug products containing sibutramine hydrochloride.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	OGM0YHD1WF	O.Cl.CC(C)CC(N(C)C)C1(CCC1)C2=CC=C(Cl)C=C2
Withdrawn	Sparteine sulfate	NA	NA	NA	NA	NA	NA	All drug products containing sparteine sulfate.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	GQ3J2TLZ7E	O.O.O.O.O.OS(O)(=O)=O.C1CCN2C[C@@H]3C[C@@H](CN4CCCC[C@H]34)[C@@H]2C1
Withdrawn	Sulfadimethoxine	NA	NA	NA	NA	NA	NA	All drug products containing sulfadimethoxine.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	30CPC5LDEX	COC1=NC(OC)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1
Withdrawn	Sulfathiazole	NA	NA	NA	NA	NA	NA	All drug products containing sulfathiazole (except for those formulated for vaginal use).	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	Y7FKS2XWQH	NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CS2
Withdrawn	Suprofen	NA	NA	NA	NA	NA	NA	All drug products containing suprofen (except ophthalmic solutions).	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	EXV5374VEY|988GU2F9PE	OC[C@@H](O)[C@@H](O)CC(=O)C=O
Withdrawn	Ethyl nitrite	NA	NA	NA	NA	NA	NA	All drug products containing sweet spirits of nitre.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	8C7CJ279RV	CCON=O
Withdrawn	Tegaserod maleate	NA	NA	NA	NA	NA	NA	All drug products containing tegaserod maleate.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	E5XNT3RF5A	OC(=O)\C=C/C(O)=O.CCCCCNC(=N)N\N=C\C1=CNC2=C1C=C(OC)C=C2
Withdrawn	Temafloxacin hydrochloride	NA	NA	NA	NA	NA	NA	All drug products containing temafloxacin hydrochloride.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	OC5IGJ7J6I	Cl.CC1CN(CCN1)C2=CC3=C(C=C2F)C(=O)C(=CN3C4=CC=C(F)C=C4F)C(O)=O
Withdrawn	Terfenadine	NA	NA	NA	NA	NA	NA	All drug products containing terfenadine.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	7BA5G9Y06Q	CC(C)(C)C1=CC=C(C=C1)C(O)CCCN2CCC(CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
Withdrawn	3,3-,4-,5-tetrachlorosalicylanilide	NA	NA	NA	NA	NA	NA	All drug products containing 3,3-,4-,5-tetrachlorosalicylanilide.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	HNE676755I	OC1=C(Cl)C=C(Cl)C=C1C(=O)NC2=CC(Cl)=C(Cl)C=C2
Withdrawn	Tetracycline	NA	NA	NA	NA	NA	NA	All liquid oral drug products formulated for pediatric use containing tetracycline in a concentration greater than 25 milligrams/milliliter.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	F8VB5M810T	CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O
Withdrawn	Ticrynafen	NA	NA	NA	NA	NA	NA	All drug products containing ticrynafen.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	HC95205SY4	OC(=O)COC1=CC=C(C(=O)C2=CC=CS2)C(Cl)=C1Cl
Withdrawn	Tribromsalan	NA	NA	NA	NA	NA	NA	All drug products containing tribromsalan.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	6MCE3VTF0O	OC1=C(Br)C=C(Br)C=C1C(=O)NC2=CC=C(Br)C=C2
Withdrawn	Trichloroethane	NA	NA	NA	NA	NA	NA	All aerosol drug products intended for inhalation containing trichloroethane.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	113C650IR1	CC(Cl)(Cl)Cl
Withdrawn	Troglitazone	NA	NA	NA	NA	NA	NA	All drug products containing troglitazone.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	I66ZZ0ZN0E	NA
Withdrawn	Trovafloxacin mesylate	NA	NA	NA	NA	NA	NA	All drug products containing trovafloxacin mesylate.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	0P1LKO80WN	CS(O)(=O)=O.N[C@H]1[C@@H]2CN(C[C@H]12)C3=NC4=C(C=C3F)C(=O)C(=CN4C5=CC=C(F)C=C5F)C(O)=O
Withdrawn	Urethane	NA	NA	NA	NA	NA	NA	All drug products containing urethane.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	3IN71E75Z5	CCOC(N)=O
Withdrawn	Valdecoxib	NA	NA	NA	NA	NA	NA	All drug products containing valdecoxib.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	2919279Q3W	CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(N)(=O)=O
Withdrawn	Vinyl chloride	NA	NA	NA	NA	NA	NA	All aerosol drug products containing vinyl chloride.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	WD06X94M2D	ClC=C
Withdrawn	Zirconium	NA	NA	NA	NA	NA	NA	All aerosol drug products containing zirconium.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	C6V6S92N3C	[Zr]
Withdrawn	Zomepirac sodium	NA	NA	NA	NA	NA	NA	All drug products containing zomepirac sodium.	NA	NA	NA	NA	NA	NA	NA	NA	NA	US	NA	NA	Withdrawn or removed from the market for reasons of safety or effectiveness	Y0185WZ209	O.O.[Na+].CN1C(CC([O-])=O)=CC(C)=C1C(=O)C2=CC=C(Cl)C=C2
shortage	ADEKs Chewable Tablets	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2011-07-26	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=811	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Alefacept Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2012-01-11	2012	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=885	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Aminohippurate Sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2015-07-14	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1135	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins	SUO3KVS1O9	[Na+].NC1=CC=C(C=C1)C(=O)NCC([O-])=O
shortage	Ammonium Chloride Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2017-01-31	2017	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=933	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Amphotericin B Cholesteryl Sulfate Complex Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2014-10-20	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=894	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Aripiprazole Short-Acting Intramuscular Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2015-07-30	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1203	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Asparaginase Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2013-02-07	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=958	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Bismuth Subsalicylate/Metronidazole/Tetracycline (Helidac Therapy)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2014-04-25	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1098	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Boceprevir Capsules	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2015-12-09	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1154	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Buprenorphine and Naloxone Tablets	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2013-01-23	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=967	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Carisoprodol and Aspirin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2017-05-22	2017	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1275	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Castor Oil, Balsam Peru, and Trypsin Topical Products	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2016-02-01	2016	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1179	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Chloral Hydrate Oral Solution and Capsules	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2012-11-05	2012	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=902	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Cyclophosphamide Tablets	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2014-08-11	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1116	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Denileukin Diftitox Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2015-03-25	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1009	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Droperidol Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2015-06-11	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=818	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Drotrecogin Alfa (Activated) Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2011-10-26	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=855	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Edrophonium Chloride and Atropine Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2015-08-20	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1204	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Emergency Drug Syringes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2010-08-05	2010	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=602	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Epinephrine Metered Dose Inhaler	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2012-05-24	2012	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=848	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Ergonovine Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2011-02-09	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=732	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Erythromycin Ethylsuccinate and Sulfisoxazole Oral Suspension	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2014-07-17	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1113	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Ethinyl Estradiol 50 mcg and Norethindrone 1 mg Tablets	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2012-11-12	2012	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=904	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Ezetimibe and Atorvastatin Tablets	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2015-09-16	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1084	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Flunisolide Oral Inhaler	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2010-12-15	2010	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=688	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Formoterol Fumarate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2016-05-26	2016	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=720	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins	W34SHF8J2K	O.O.OC(=O)\C=C\C(O)=O.COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC(NC=O)=C(O)C=C2)C=C1.COC3=CC=C(C[C@@H](C)NC[C@H](O)C4=CC(NC=O)=C(O)C=C4)C=C3
shortage	Ganciclovir Capsules	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2013-05-24	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=539	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Gatifloxacin 0.3% Ophthalmic Solution	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2011-03-09	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=745	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Gemtuzumab Ozogamicin Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2010-10-19	2010	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=692	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Gold Sodium Thiomalate Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2011-12-12	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=725	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Heparin Sodium (Beef) injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2010-11-18	2010	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=702	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Hexachlorophene 3% Detergent Cleanser (Phisohex)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2013-10-02	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1059	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Inamrinone Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2011-05-04	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=430	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Ipecac Syrup	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2010-10-12	2010	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=468	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins	62I3C8233L	NA
shortage	Iron Polysaccharide Oral Liquid	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2011-01-26	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=617	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Japanese Encephalitis Virus Inactivated Vaccine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2013-05-22	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=735	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Kanamycin Sulfate Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2013-01-31	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=522	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Lepirudin Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2012-05-23	2012	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=924	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Levothyroxine (Levothroid) Oral Tablets	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2013-07-11	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1041	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Mannitol Inhalation Capsules	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2014-09-12	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1096	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Mebendazole Tablets	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2011-10-27	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=750	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Mephobarbital Tablets	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2011-02-03	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=730	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Mesalamine 400 mg Delayed-Release Tablet (Asacol)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2013-04-05	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1017	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Multivitamin Oral Liquid	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2016-11-15	2016	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1257	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Neomycin Oral Solution	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2012-02-28	2012	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=825	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Neostigmine Bromide Tablets	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2014-05-14	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1060	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Norfloxacin Tablets (Noroxin)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2014-04-29	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1099	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Nystatin Vaginal Tablets	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2012-11-13	2012	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=865	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Oral Sodium Phosphate (Over-the-Counter) Solution	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2013-06-12	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=549	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Otic Unapproved Prescription Preparations Containing Benzocaine or Chloroxylenol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2015-07-28	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1202	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Oxycodone/Acetaminophen Oral Solution	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2015-05-13	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1117	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Permethrin 1% Lotion	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2015-09-23	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1211	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Pilocarpine Ophthalmic Gel	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2013-08-06	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1048	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Piperacillin Sodium for Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2011-04-22	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=756	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Prenatal Multivitamins with Minerals	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2014-04-23	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1095	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Reserpine Oral Tablets	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2016-04-15	2016	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=975	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Scopolamine Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2015-02-19	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=39	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Scopolamine Hydrobromide Ophthalmic Solution	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2013-03-05	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=953	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Synthetic Conjugated Estrogen	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2016-08-05	2016	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1087	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Tetanus Toxoid Adsorbed	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2014-09-04	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1125	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins	K3W1N8YP13	NA
shortage	Tetracaine Topical Solution	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2010-08-03	2010	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=567	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Thiopental Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2011-01-21	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=563	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Ticarcillin Clavulanate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2014-11-17	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=802	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Ticlopidine Tablets	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2015-04-01	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=661	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Tinzaparin Sodium Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2011-07-01	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=749	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	TriHIBit – Diphtheria, Tetanus Toxoid, and Acellular Pertussis with Haemophilus b Conjugate Vaccine (DTaP with Haemophilus b Conjugate)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2011-04-08	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=763	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Tripedia – Diphtheria, Tetanus Toxoid, and Acellular Pertussis Vaccine (DTaP)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2011-04-08	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=764	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Tromethamine Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2016-05-20	2016	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=687	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Verapamil Extended Release Tablets	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2012-06-20	2012	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=928	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Vitamin E Aqueous Oral Solution	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2017-01-25	2017	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=965	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
shortage	Warfarin for Injection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2014-07-01	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1110	NA	NA	NA	NA	NA	NA	Discontinued drug bulletins		NA
Marketed (restrictions)	Alosetron	Lotronex	NA	NA	5HT3receptor antag	NA	NA	NA	2000	NA	NA	NA	NA	NA	NA	2000	NA	US	Severe colitis	2002	Survey of drug withdrawals over the period of 1998–2008	13Z9HTH115	CN1C2=CC=CC=C2C3=C1CCN(CC4=C(C)N=CN4)C3=O
Withdrawn	Diethylpropion hydrochloride	Tenuate dospan	NA	NA	Antiobesity	NA	NA	NA	1971	NA	NA	NA	NA	NA	NA	2000	NA	EU	Primary pulmonary hypertension	NA	Survey of drug withdrawals over the period of 1998–2008	19V2PL39NG	Cl.CCN(CC)C(C)C(=O)C1=CC=CC=C1
Withdrawn	Amineptine	Survector	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2000	NA	SP	Hepatotoxicity	NA	Survey of drug withdrawals over the period of 1998–2008	27T1I13L6G	OC(=O)CCCCCCNC1C2=CC=CC=C2CCC3=CC=CC=C13
Withdrawn	Aprotinin	Trasylol	NA	NA	Perioperative blood loss	NA	NA	NA	1993	NA	NA	NA	NA	NA	NA	2007|2008	NA	US	Increased risks of complications or death	NA	Survey of drug withdrawals over the period of 1998–2008	04XPW8C0FL	NA
Withdrawn	Astemizole	Hismanal	NA	NA	Antihistamine	NA	NA	NA	1988	NA	NA	NA	NA	NA	NA	1999	NA	US	Fatal arrhythmia	NA	Survey of drug withdrawals over the period of 1998–2008	7HU6337315	COC1=CC=C(CCN2CCC(CC2)NC3=NC4=C(C=CC=C4)N3CC5=CC=C(F)C=C5)C=C1
Withdrawn	Benzbromarone	Desuri	NA	NA	Hyperuricmic	NA	NA	NA	1976	NA	NA	NA	NA	NA	NA	2003	NA	FR	Cytolytic liver damage	NA	Survey of drug withdrawals over the period of 1998–2008	4POG0RL69O	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C3=C(O1)C=CC=C3
Withdrawn	Bromfenac	Duract	NA	NA	NSAID	NA	NA	NA	1997	NA	NA	NA	NA	NA	NA	1998	NA	US	Liver toxicity	NA	Survey of drug withdrawals over the period of 1998–2008	864P0921DW	NC1=C(CC(O)=O)C=CC=C1C(=O)C2=CC=C(Br)C=C2
Withdrawn	Cerivastatin	Baycol	NA	NA	Statin	NA	NA	NA	1997	NA	NA	NA	NA	NA	NA	2001	NA	US	Muscle damage leading to kidney failure	NA	Survey of drug withdrawals over the period of 1998–2008	AM91H2KS67	COCC1=C(C2=CC=C(F)C=C2)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
Withdrawn	Chloral hydrate	Notec|Somnos	NA	NA	Hynotic	NA	NA	NA	1869	NA	NA	NA	NA	NA	NA	2001	NA	FR|US	Mutagenic/carcinogenic in animals	NA	Survey of drug withdrawals over the period of 1998–2008	418M5916WG	OC(O)C(Cl)(Cl)Cl
Withdrawn	Cisapride	Propulsid	NA	NA	Gastrointestinal/heartburn	NA	NA	NA	1993	NA	NA	NA	NA	NA	NA	2000	NA	US	Fatal arrhythmia	NA	Survey of drug withdrawals over the period of 1998–2008	UVL329170W	CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=CC(Cl)=C(N)C=C3OC
Withdrawn	Cloforex	NA	NA	NA	Anorexiant sympathominietic	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2000	NA	EU	CV toxicity	NA	Survey of drug withdrawals over the period of 1998–2008	2QJT5ZC1L6	CCOC(=O)NC(C)(C)CC1=CC=C(Cl)C=C1
Withdrawn	Droperidol	NA	NA	NA	Schizophrenia	NA	NA	NA	1970	NA	NA	NA	NA	NA	NA	2001	NA	US|UK	QTc prolongation	NA	Survey of drug withdrawals over the period of 1998–2008	O9U0F09D5X	FC1=CC=C(C=C1)C(=O)CCCN2CCC(=CC2)N3C(=O)NC4=C3C=CC=C4
Withdrawn	Ebrotidine	Ebrocit	NA	NA	H2 antagonist	NA	NA	NA	1997	NA	NA	NA	NA	NA	NA	1998	NA	Sp	Hepatotoxicity	NA	Survey of drug withdrawals over the period of 1998–2008	TMZ3IBW2OW	NC(=N)NC1=NC(CSCCN\C=N\S(=O)(=O)C2=CC=C(Br)C=C2)=CS1
Withdrawn	Etretinate	Tegison	NA	NA	Antipsoriatic	NA	NA	NA	1986	NA	NA	NA	NA	NA	NA	1999	NA	US	Birth defects	NA	Survey of drug withdrawals over the period of 1998–2008	65M2UDR9AG	CCOC(=O)\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)C=C(OC)C(C)=C1C
Withdrawn	Eudipine	Parkinson	Bupidine	NA	Muscarinic and NMDA receptor antagonist	NA	NA	NA	1979	NA	NA	NA	NA	NA	NA	2000	NA	Ger	Severe CV risks and arrhythmias	NA	Survey of drug withdrawals over the period of 1998–2008	864V2Q084H	OS(=O)(=O)C1=CC=CC=C1.CCOC(=O)C2=C(COCCN)NC(C)=C(C2C3=CC=CC=C3Cl)C(=O)OC
Withdrawn	Febarbamate	Atrium|Tymium	NA	NA	w/phenobarbital	NA	NA	NA	1967	NA	NA	NA	NA	NA	NA	1997-2001	NA	FR	Cytoytic hepatitis	NA	Survey of drug withdrawals over the period of 1998–2008	5Z48ONN38P	CCCCOCC(CN1C(=O)NC(=O)C(CC)(C1=O)C2=CC=CC=C2)OC(N)=O
Withdrawn	Grepafloxacin	Raxar	NA	NA	Anti-infective/quinolone	NA	NA	NA	1997	NA	NA	NA	NA	NA	NA	1999	NA	US	Fatal arrhythmia	NA	Survey of drug withdrawals over the period of 1998–2008	L1M1U2HC31	CC1CN(CCN1)C2=CC3=C(C(=O)C(=CN3C4CC4)C(O)=O)C(C)=C2F
Withdrawn	Levomethadyl	ORLAAM	NA	NA	Opiate dependence	NA	NA	NA	1993	NA	NA	NA	NA	NA	NA	2003	NA	US|EU	Fatal arrhythmia	NA	Survey of drug withdrawals over the period of 1998–2008	QZH7WR4VKJ	CC[C@H](O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
Withdrawn	Lumiracoxib	Prexige	NA	NA	NSAID (cox-2)	NA	NA	NA	2005	NA	NA	NA	NA	NA	NA	2007	NA	EU	Benefits don’t outweigh risks	NA	Survey of drug withdrawals over the period of 1998–2008	V91T9204HU	CC1=CC=C(NC2=C(F)C=CC=C2Cl)C(CC(O)=O)=C1
Withdrawn	Medifoxamine	Cledial	NA	NA	Antidepressant	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1999	NA	FR	Hepatocellular damage	NA	Survey of drug withdrawals over the period of 1998–2008	KWU7C2A1NT	CN(C)CC(OC1=CC=CC=C1)OC2=CC=CC=C2
Withdrawn	MIbefradil	Posicar	NA	NA	Antihypertensive	NA	NA	NA	1997	NA	NA	NA	NA	NA	NA	1998	NA	US	Fatal arrhythmia	NA	Survey of drug withdrawals over the period of 1998–2008	27B90X776A	COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
Withdrawn	Mixed amphetamine salts	Adderall XR	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2005	NA	Canada	Stroke risk	NA	Survey of drug withdrawals over the period of 1998–2008		NA
Withdrawn	Nefazodone	Dutonin|Serzone|Nefardar|Reseril|Rulivan|Serzonil	NA	NA	Phenypiperazine derivative antidepressant	NA	NA	NA	1995-1999	NA	NA	NA	NA	NA	NA	2003	NA	EU|US	Liver failure	NA	Survey of drug withdrawals over the period of 1998–2008	59H4FCV1TF	CCC1=NN(CCCN2CCN(CC2)C3=CC=CC(Cl)=C3)C(=O)N1CCOC4=CC=CC=C4
Withdrawn	Nimesulide	Nimed|Antofloxil|Guaxan|Aulin	NA	NA	NSAID	NA	NA	NA	1986|1995	NA	NA	NA	NA	NA	NA	2002	NA	EU	Hepatotoxicity	NA	Survey of drug withdrawals over the period of 1998–2008	V4TKW1454M	CS(=O)(=O)NC1=CC=C(C=C1OC2=CC=CC=C2)[N+]([O-])=O
Withdrawn	Pemoline	Cylert	NA	NA	ADHD	NA	NA	NA	1998	NA	NA	NA	NA	NA	NA	1999|2005	NA	UK|US	Cytolytic hepatotoxicity/liver disease	NA	Survey of drug withdrawals over the period of 1998–2008	7GAQ2332NK	NC1=NC(=O)C(O1)C2=CC=CC=C2
Withdrawn	Phentermine	Duromine	NA	NA	Antiobesity	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2000	NA	EU|US	Valve disease	NA	Survey of drug withdrawals over the period of 1998–2008	C045TQL4WP	CC(C)(N)CC1=CC=CC=C1
Withdrawn	Phenylpropanolamine	Dexatrim|propagest	NA	NA	Antiobesity	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2000	NA	NA	Stroke risk	NA	Survey of drug withdrawals over the period of 1998–2008	683H0R9659|33RU150WUN	NA
Withdrawn	Rapacuronium	Raplon	NA	NA	Anesthetic	NA	NA	NA	1999	NA	NA	NA	NA	NA	NA	2001	NA	US	Severe breathing difficulties	NA	Survey of drug withdrawals over the period of 1998–2008	GG1LBM463S	CCC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N5CCCCC5)[N+]6(CC=C)CCCCC6
Withdrawn	Rimonabant	Acomplia	NA	NA	Cannabinoid	NA	NA	NA	2006	NA	NA	NA	NA	NA	NA	2008	NA	EU	Depression and suicide risk	NA	Survey of drug withdrawals over the period of 1998–2008	RML78EN3XE	CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=CC=C(Cl)C=C3Cl)C4=CC=C(Cl)C=C4
Withdrawn	Rofecoxib	Vioxx	NA	NA	NSAID (cox-2)	NA	NA	NA	1999	NA	NA	NA	NA	NA	NA	2004	NA	US	Heart attack/stroke	NA	Survey of drug withdrawals over the period of 1998–2008	0QTW8Z7MCR	CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
Withdrawn	Sertindole	Serdolect	NA	NA	Antipsychotic	NA	NA	NA	1996	NA	NA	NA	NA	NA	NA	1998	NA	UK|SP	Torsades de pointe QTC prolongation sudden death	NA	Survey of drug withdrawals over the period of 1998–2008	GVV4Z879SP	FC1=CC=C(C=C1)N2C=C(C3CCN(CCN4CCNC4=O)CC3)C5=C2C=CC(Cl)=C5
Marketed (restrictions)	Sibutramine	Reductil|Meridia|Reduxate|Ectiva	NA	NA	Antiobesity	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2002	NA	IT	Arrythmia and hypertension	2002	Survey of drug withdrawals over the period of 1998–2008	WV5EC51866	CC(C)CC(N(C)C)C1(CCC1)C2=CC=C(Cl)C=C2
Withdrawn	Tegaserod	Zelnorm	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2007	NA	NA	Heart attack/stroke	NA	Survey of drug withdrawals over the period of 1998–2008	458VC51857	CCCCCNC(=N)N\N=C\C1=CNC2=C1C=C(OC)C=C2
Withdrawn	Terfenadine	Seldane	NA	NA	Antihistamine	NA	NA	NA	1985	NA	NA	NA	NA	NA	NA	1998	NA	US|OM|FR|GER	Fatal arrhythmia	NA	Survey of drug withdrawals over the period of 1998–2008	7BA5G9Y06Q	CC(C)(C)C1=CC=C(C=C1)C(O)CCCN2CCC(CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
Withdrawn	Tetrabamate	Atrium	NA	NA	Alcohol dependence	NA	NA	NA	1981	NA	NA	NA	NA	NA	NA	2001|2002	NA	FR|SP	Hepatocellular necrosis intracellular cholestasis	NA	Survey of drug withdrawals over the period of 1998–2008	5Z48ONN38P|7EE4K616KK	NA
Withdrawn	Tolcapone	Tasmar	NA	NA	Anti-parkinonian COMT inhibitor	NA	NA	NA	1998	NA	NA	NA	NA	NA	NA	1998	NA	EU	Hepatocellular toxicity	NA	Survey of drug withdrawals over the period of 1998–2008	CIF6334OLY	CC1=CC=C(C=C1)C(=O)C2=CC(O)=C(O)C(=C2)[N+]([O-])=O
Withdrawn	Trovafloxacin	Trovan	alatrovafloxacin	NA	Anti-infective	NA	NA	NA	1997|1998	NA	NA	NA	NA	NA	NA	1999|2001	NA	US|EU	Liver toxicity	NA	Survey of drug withdrawals over the period of 1998–2008	9F388J00UK	N[C@H]1[C@@H]2CN(C[C@H]12)C3=NC4=C(C=C3F)C(=O)C(=CN4C5=CC=C(F)C=C5F)C(O)=O
Withdrawn	Troglitazone	Rezulin	NA	NA	Antidiabetic	NA	NA	NA	1997	NA	NA	NA	NA	NA	NA	2000	NA	US	Liver toxicity	NA	Survey of drug withdrawals over the period of 1998–2008	I66ZZ0ZN0E	NA
Withdrawn	Valdecoxib	Bextra	NA	NA	NSAID (cox-2)	NA	NA	NA	2001	NA	NA	NA	NA	NA	NA	2005	NA	US	Skin disease	NA	Survey of drug withdrawals over the period of 1998–2008	2919279Q3W	CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(N)(=O)=O
Withdrawn	Ximelagatran	Exanta	melagatran	NA	Stroke/thromboembolic	NA	NA	NA	2005	NA	NA	NA	NA	NA	NA	2006	NA	EU	Hepatotoxicity	NA	Survey of drug withdrawals over the period of 1998–2008	49HFB70472	CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N2CC[C@H]2C(=O)NCC3=CC=C(C=C3)C(=N)NO
Withdrawn	Terfenadine	Seldane	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1998	1998-02-01	NA	NA	NA	Removed/restricted because of drug interactions	7BA5G9Y06Q	CC(C)(C)C1=CC=C(C=C1)C(O)CCCN2CCC(CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
Withdrawn	Mibefradil	Posicor	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1998	1998-06-01	NA	NA	NA	Removed/restricted because of drug interactions	27B90X776A	COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
Withdrawn	Astemizole	Hismanal	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1999	1999-07-01	NA	NA	NA	Removed/restricted because of drug interactions	7HU6337315	COC1=CC=C(CCN2CCC(CC2)NC3=NC4=C(C=CC=C4)N3CC5=CC=C(F)C=C5)C=C1
Withdrawn	Cisapride	Propulsid	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2000	2000-01-01	NA	NA	NA	Removed/restricted because of drug interactions	UVL329170W	CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=CC(Cl)=C(N)C=C3OC
Withdrawn	efalizumab	RAPTIVA	NA	NA	NA	NA	NA	NA	2003	2003-10-28	US	NA	NA	NA	NA	2009	2009-04-08	US	NA	NA	Approved after 1992, and later withdrawn from the market for safety reasons	XX2MN88N5D	NA
Withdrawn	trasylol	APROTININ	NA	NA	NA	NA	NA	NA	1993	1993-12-29	US	NA	NA	NA	NA	2007	2007-11-05	US	NA	NA	Approved after 1992, and later withdrawn from the market for safety reasons	04XPW8C0FL	NA
Withdrawn	tegaserod	ZELNORM	NA	NA	NA	NA	NA	NA	2002	2002-07-24	US	NA	NA	NA	NA	2007	2007-03-30	US	NA	NA	Approved after 1992, and later withdrawn from the market for safety reasons	458VC51857	CCCCCNC(=N)N\N=C\C1=CNC2=C1C=C(OC)C=C2
Withdrawn	gatifloxacin	TEQUIN	NA	NA	NA	NA	NA	NA	1999	1999-12-17	US	NA	NA	NA	NA	2006	2006-05-01	US	NA	NA	Approved after 1992, and later withdrawn from the market for safety reasons	L4618BD7KJ	O.O.O.COC1=C(N2CCNC(C)C2)C(F)=CC3=C1N(C=C(C(O)=O)C3=O)C4CC4.COC5=C(N6CCNC(C)C6)C(F)=CC7=C5N(C=C(C(O)=O)C7=O)C8CC8
Withdrawn	technetium (99m TC) fanolesomab	NEUTROSPEC	NA	NA	NA	NA	NA	NA	2004	2004-07-02	US	NA	NA	NA	NA	2005	2005-12-19	US	NA	NA	Approved after 1992, and later withdrawn from the market for safety reasons	AMF7KOE318	NA
Withdrawn	hydromorphone	PALLADONE	NA	NA	NA	NA	NA	NA	2004	2004-09-24	US	NA	NA	NA	NA	2005	2005-07-13	US	NA	NA	Approved after 1992, and later withdrawn from the market for safety reasons	Q812464R06	CN1CC[C@]23[C@H]4OC5=C(O)C=CC(C[C@@H]1[C@@H]2CCC4=O)=C35
Withdrawn	valdecoxib	BEXTRA	NA	NA	NA	NA	NA	NA	2001	2001-11-16	US	NA	NA	NA	NA	2005	2005-04-07	US	NA	NA	Approved after 1992, and later withdrawn from the market for safety reasons	2919279Q3W	CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(N)(=O)=O
Withdrawn	natalizumab	TYSABRI	NA	NA	NA	NA	NA	NA	2004	2004-11-23	US	NA	NA	NA	NA	2005	2005-02-28	US	NA	NA	Approved after 1992, and later withdrawn from the market for safety reasons	3JB47N2Q2P	NA
Withdrawn	rofecoxib	VIOXX	NA	NA	NA	NA	NA	NA	1999	1999-05-20	US	NA	NA	NA	NA	2004	2004-09-29	US	NA	NA	Approved after 1992, and later withdrawn from the market for safety reasons	0QTW8Z7MCR	CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
Withdrawn	levomethadyl	ORLAAM	NA	NA	NA	NA	NA	NA	1993	1993-07-09	US	NA	NA	NA	NA	2003	2003-09-02	US	NA	NA	Approved after 1992, and later withdrawn from the market for safety reasons	QZH7WR4VKJ	CC[C@H](O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
Withdrawn	cerivastatin	BAYCOL	NA	NA	NA	NA	NA	NA	1997	1997-06-26	US	NA	NA	NA	NA	2001	2001-08-08	US	NA	NA	Approved after 1992, and later withdrawn from the market for safety reasons	AM91H2KS67	COCC1=C(C2=CC=C(F)C=C2)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
Withdrawn	rapacuronium	RAPLON	NA	NA	NA	NA	NA	NA	1999	1999-08-18	US	NA	NA	NA	NA	2001	2001-03-30	US	NA	NA	Approved after 1992, and later withdrawn from the market for safety reasons	GG1LBM463S	CCC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N5CCCCC5)[N+]6(CC=C)CCCCC6
Withdrawn	alosetron	LOTRONEX	NA	NA	NA	NA	NA	NA	2000	2000-02-09	US	NA	NA	NA	NA	2000	2000-11-28	US	NA	NA	Approved after 1992, and later withdrawn from the market for safety reasons	13Z9HTH115	CN1C2=CC=CC=C2C3=C1CCN(CC4=C(C)N=CN4)C3=O
Withdrawn	cisapride	PROPULSID	NA	NA	NA	NA	NA	NA	1993	1993-07-29	US	NA	NA	NA	NA	2000	2000-03-24	US	NA	NA	Approved after 1992, and later withdrawn from the market for safety reasons	UVL329170W	CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=CC(Cl)=C(N)C=C3OC
Withdrawn	troglitazone	REZULIN	NA	NA	NA	NA	NA	NA	1997	1997-01-29	US	NA	NA	NA	NA	2000	2000-03-21	US	NA	NA	Approved after 1992, and later withdrawn from the market for safety reasons	I66ZZ0ZN0E	NA
Withdrawn	grepafloxacin	RAXAR	NA	NA	NA	NA	NA	NA	1997	1997-11-06	US	NA	NA	NA	NA	1999	1999-08-11	US	NA	NA	Approved after 1992, and later withdrawn from the market for safety reasons	L1M1U2HC31	CC1CN(CCN1)C2=CC3=C(C(=O)C(=CN3C4CC4)C(O)=O)C(C)=C2F
Withdrawn	bromfenac	DURACT	NA	NA	NA	NA	NA	NA	1997	1997-07-15	US	NA	NA	NA	NA	1998	1998-06-22	US	NA	NA	Approved after 1992, and later withdrawn from the market for safety reasons	864P0921DW	NC1=C(CC(O)=O)C=CC=C1C(=O)C2=CC=C(Br)C=C2
Withdrawn	mibefradil	POSICOR	NA	NA	NA	NA	NA	NA	1997	1997-06-20	US	NA	NA	NA	NA	1998	1998-06-08	US	NA	NA	Approved after 1992, and later withdrawn from the market for safety reasons	27B90X776A	COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
Withdrawn	dexfenfluramine	REDUX	NA	NA	NA	NA	NA	NA	1996	1996-06-01	US	NA	NA	NA	NA	1997	1997-09-15	US	NA	NA	Approved after 1992, and later withdrawn from the market for safety reasons	E35R3G56OV	CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
